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ALGEMENE SAMENVATTING. 
Aangezien niet usruacht mag Dorden dab е п ev/entueel geinteressaerde 
lezer oog п kennis van вп molekulair v/iroloog heeft is hier een 
'populaire' samenuatting op zijn plaats. 
Ongeveer vier jaar geleden uerd in onze werkgroep een onderzoek gestart 
naar de molekulair-biologische aspecten van leukemie bij muizen die door 
bepaalde virussen veroorzaakt utordt. Reeds in het begin van deze eeuui had 
men ontdekt dat muizeleukemie veroorzaakt kan morden door een oelvrij fil-
traat van bloed, afkomstig van een muis met leukemie, in een gezonde muis 
in te spuiten. Later bleek dat de ziekteverwekker een virus is, dat tot 
de groep van de zogenaamde C—type virussen behoort. Deze virussen worden 
tot de familie van de retrovirussen gerekend, die als belangrijkste karak­
teristiek het enzym reverse transcriptase hebben, een enzym dat RNA over 
kan schrijven in DNA. Een C-type partikel bestaat uit een min of meer ronde 
compacte kern, bestaands uit RNA an'eiwitten, omgeven door een mantel. 
De mantel is afkomstig van de plaemamambraan van ds gastheercel. De virale 
envelop-eiwitten bevinden zich in deze mantel. Het belangrijkste virale 
envelop-ewit, het 70k glycoproteins, vormt knopachtige structuren op de 
mantel van het viruspartikel. C-type virussen onderscheiden zich van de 
andere typen (B,D, en E—typen) door hun beelden in de elektronenmicros­
coop. De C-type virussen hebben een elektronen-dicht centrum. Verder be­
zitten deze virussen geen opvallende uitsteeksels aan het oppervlak van 
het partikeltje. Het virale genoom van een muize-leukemievirus bestaat 
uit twee identieke enkelstrengs RNA subeenhsden van ongeveer 8-10 kilo-
bassparen lang. Elk van dezs RNA's bevat de genetische informatie over­
eenkomend met een drietal genen: 1) het gag—gen, dat codeert voor eiwitten 
die т.п. in het binnenste van het virusdeeltje voorkomen, 2) het pol—gen, 
dat codeert voor het enzym reverse transcriptase, en 3) het env-gen, dat 
codeert voor het manteleiiuit van het virusdeeltje. Dit manteleiwit is een 
glycoproteine met een molekuulgewicht van 70k, dat op de van de cel af­
komstige plasmamembraan voorkomt die het centraal gedeelte van het virus 
omhult. Geen van bovengenoemde eiwitprodukten kon in het verleden aange­
wezen worden als zijnde verantwoordelijk voor de door het virus veroorzaakte 
leukemie. Het glycoproteine, gecodeerd door het env-gen werd wel gekarak­
teriseerd als het eiwit dat verantwoordelijk is voor het feit of het be­
treffende leukemievirus al dan niet een bepaalde cel kan binnendringen. 
De structuur van het envelop-eiwit bepaalt dus reeds a priori of een be­
paald virus een cel al dan niet kan penetreren. Alleen wanneer het envelop-
eiwit een interactie aangaat met de juiste receptoren op een celoppervlak 
kan een infectie tot stand komen. 
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meerdere normale muizegenen b i j b e t r o k k e n , шаагиап de e r f e l i j k e i n f o r m a t i e 
ingebouwd kan worden i n het M—MuLV g e n o o m . Een bepaald gedeelte van het 
oorspronkelijke ПЧЧіО genoom g a a t h i e r b i j v e r l o r e n . De zo ontstane nieuwe 
virussen worden dan ook r a c o m b i n a n t e v i r u s e e n genoemd. De vorming van d i t 
type v i r u s l i j k t nu een n o o d z a k e l i j k e s t a p i n de o n t w i k k e l i n g van leukemie 
bij muizen. De manier waarop d e z e v i r u s s e n betrokken zijn bij de o n t w i k k e l i n g 
en het i n stand houden uan de l e u k e m i s c h e t o e s t a n d , d ie gekarakter iseerd 
wordt door een ongebreidelde g r o e i v a n bepaalde l y m f a t i s c h e c e l l e n , wordt 
bediscussieerd i n Hoofdstuk I ( z i e m . n · d i s c u s s i e ) . Deze samenvatting van 
l i teratuurgegevens geeft t e v e n s a a n , d a t ondanks veel f e i t e n m a t e r i a a l het 
antwoord op de basale vraag v o o r a l s n o g o n d u i d e l i j k i s , waarom z ich een 
tumorcel a l s autonoom zo n i e t a n a r c h i s t i s c h i n d i v i d u gedraagt. 
In de volgende hoofdstukken w o r d t v e r d e r een m o l e k u l a i r - b i o l o g i s c h e 
analyse gegeven van de door 1*1—nuLU v e r o o r z a a k t e leukemie i n v e r s c h i l l e n d e 
muizenstammen. U i t de gegewens v a n H o o f d s t u k I I b l i j k t , dat tijdens de o n t ­
wikkel ing van leukemie г een v e r m e n i g v u l d i g i n g van p r o v i r a l e genomen 
p laatsv indt i n lymfatische o r g a n e n . D i t ii/erd v a s t g e s t e l d door gebruik t e 
maken van een techniek, die h e t m o g e l i j k maakt om provirussen t e detecteren 
die op v e r s c h i l l e n d e plaatsen v a n h e t gastheercel—DNA ingebouwd zi jn. Het 
belangrijkste obstakel voor een d e r g e l i j k e a n a l y s e vormde het f e i t dat DNA 
van iedere normale muizecel e e n g r o o t a a n t a l prov i russen bevat (endogene 
v i russen), d i e op n u c l s i n e z u u r n i v e a u e r g v e e l homologie hebben met het 
genoom van M-PluLV. Radioactief g e m e r k t DNA van M-FluLV werd eerst gezuiverd 
van die DNA stukken die homologie h e b b e n mat a l l e endogene muizevirussen 
van de betref fende muizenstam. V e r v o l g e n s u e r d het overblijvende DNA, dat 
al leen nog M-MuLV provirale DNA s t u k k e n k a n herkennen, gebru ikt a ls r a d i o ­
a c t i e f merkmiddel teneinde n i e u w e ΓΊ—TluLV/ DNA's op t e sporen i n c e l DNA 
van a l l e r l e i weefsels en van l y m f a t i s c h e m e a f s e l s . Teneinde nieuw i n ­
gebouwde ΓΊ-fluLV provirussen op t e s p o r e n werd e e r s t het c e l DNA geknipt 
i n ongeveer 1 mi l joen DNA f r a g m e n t e n , d i e vervo lgens naar grootte ge­
scheiden werden. Bij het knippen u e r d g e b r u i k gemaakt van bepaalde r e s t r i c t i e -
enzymen. Deze enzymen herkennen en k n i p p e n bepaalde basenvolgordes i n het 
DNA. Bovendien werd voor de b e p a l i n g v a n nieuwe inbouwplaatsen van M-MuLU 
provirussen van een r e s t r i c t i e — e n z y m g e b r u i k gemaakt, dat n i e t i n het M-
NuLl/ DNA k n i p t maar wel in n a b i j g e l e g e n c e l DNA. Door het r a d i o a c t i e f 
gemerkte DNA t e gebruiken voor de o p s p o r i n g van H-MuLU provirussen i n 
cel DNA fragmenten van v e r s c h i l l e n d e g r o o t t e s kon het volgende worden 
vastgesteld: 
1) het ovarervende M-fluLV genoom v a n B a l b / M o muizen i s aanwezig i n êên 
cel DNA fragment van een k a r a k t e r i s t i e k e g r o o t t e . 
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2) ДІІе п in lymfat ische o r g a n e n , d i e betrokken zijn bij de leukemie, kon 
een vermenigvuldiging van M-WuLU p r o virussen worden vastgesteld, die op 
verschil lende p laa t sen van h e t c e l DNA kunnen worden ingebouud. 
3) Een deel van deze півише i n g e b o u u j d e provirussen heeft een verandering 
ondergaan in de g e n o o m s t r u c t u u r · . 
4) Het erfelijk overgedragen Π—TOuLV/ provirus, dat in cel len van lymfatische 
ueefsels op dezelfde p l a a t s i n g e b o u u d zit a ls in andere organen, ondergaat 
geen aantoonbare v e r a n d e r i n g e n i n DNA structuur. 
Hoofdstuk I I I beschrijft de m o l e k u l a i r e klonering in eer· bacteriepl v:.rus, 
van een prov i raa l DNA f r a g m e n t u i t de lever van і_-.п Balb/rio muis. Hel 
gekloneETdE DNA f ragmen- b e i / a t de e e r s t e 5400 baseparen van het M-nuLU 
DNA, dat afkomstig i s van h e t e r f ö l i j k overgedragen provi rus . Verder bevat 
het fragment nog 35Ü0 ü a s e p a r a n , d i a afkomstig zij.i vai) het ce l lu la i re DMA 
u/aarin hsL genetisch o v p r e c v e n d Π—MuLV ргз ігиз in Balb/Vlo muizen i s 
ge lokal i seerd. In d i t h o o f d s t u k w o r d t verder aangetoond dat het erfelijk 
proviraal M-^ uLV genoom, z o a l s g e ï s o l e e r d u i t l everce l DMA, in principe 
in s t aa t i s om a c t i e f v i r u s t e produceren . De redenen uiaarom het endogeen 
M-PluLV provirus in l e v e r c e l l e n g e e n aanleiding geeft t o t productie van 
virus worden besproken. Tuee moge l i j ke verklaringen die gegeven worden 
voor het i n a c t i e f zijn van h e t αv/erervende 1*1-Ч*1иИ/ genoom zijn: 
a) de driedimensionale s t r u c t u u r v a n het chromatins (DMA + gebonden 
eiwit ten) uaarin het e n d o g e e n M—MuLV is gelokaliseerd, en 
b) een plaatseli jke c h e m i s c h e v/erandering van het DNA. 
Een combinatie van b e i d e f a c t o r e n i s umarschijnlijk veranturoordelijk voor het 
n i e t a c t i e f zijn van h e t o v e r e r \ / e n d e M-fluLV genoom. Dit ii/ordt verder u i t ­
gewerkt in Hoofdstuk V. 
Hoofdstuk IV beschri j f t e e n a a n t a l nieuwe technieken, die het mogelijk 
hebben gemaakt om de шаагп т і п д п zoals in Hoofdstuk I I beschreven verder 
u i t te werken. Hierbij u e r d g e b r u i k gemaakt van een tweetal typen radio­
act ie f gemerkte DNA f r a g m e n t e n , tene inde alleen M-MuLV-type provirale 
DMA stukken in c e l DNA f r a g m e n t e n t e kunnen detecteren. Het eerste type 
kon gebruikt worden om p r o v i r a l e DNA stukken op t e sporen die van a l l e 
delen van het рго і г а і genoom afkomstig konden zijn. Het tweede type 
rad ioact ie f gemerkte DNA h e r k e n d e alleen bepaalde stukjes van het M-MuLl/ 
DNA. Met behulp van d i t t u e e d e t y p e konden we bepalen waar eventuele sub-
genoom DMA fragmenten op h e t ГЛ—CluLV DMA gelokaliseerd moesten worden. 
Het tweede type r a d i o a c t i e f g e m e r k t DNA werd verder gebruikt om de 
s t ructuur van nieuw i n g e b o u u j d e provirussen te bepalen die nog s lechts 
gedeeltelijk bestaan u i t h e t oorspronkeli jke rWluLV DNA. Ter opheldering 
van A) de p l a a t s van n i e u u e p r o v i r a l e genomen in het cel DNA van lym-
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fatisoha weefsels, п В) de structuur van deze пі иш genomen, iderd de 
volgende procedure gekozen: 
i) cel DNA van verschillende weefsels werd geknipt met restrictie-enzymen 
zodat ongeveer 1 miljoen fragmenten werden verkregen die vervolgens naar 
grootte gescheiden werden. 
2) Na scheiding op grootte uerden deze fragmenten overgebracht naar een 
vaste drager waaraan het DNA covalent gebonden werd. 
3) De vaste drager, die het patroon van de naar grootte gescheiden cel 
DNA fragmenten bevat, werd vervolgens geinkubeerd met radioactief gemerkte 
DNA's die FI-PluLV genoomstukken herkennen. 
Na binding van de radioactieve DNA's werd vervolgens de plaats van binding 
opgespoord door op de vaste drager een rBntgenfilm te plaatsen. Na ontwikke­
len werd zo een zichtbaar beeld verkregen van die plaatsen waar het radio­
actief gemerkt DNA zich had gebonden. Daar bij scheiding van DNA fragmenten 
ook fragmenten van bekends grootte meegenomen werden, kon ook de grootte 
van de op de rBntgenfilm zichtbaar geworden fragmenten vastgesteld worden. 
Bij het knippen van het cel DNA werd gebruik gemaakt van twee typen 
restrictie-enzymen: 1) een enzym dat niet in het PI-MuH/ genoom knipt, en 
2) enzymen die op de eerste plaats in de LTR knippen, welke aan beide 
uiteinden van het ingebouude virus voorkomt, en vervolgens nog op andere 
plaatsen in het virale DNA. Met behulp van het eerste type enzym werden 
nieuwe inbouwplaatsen van M-CluLV genomen in cel DNA opgespoord. Het tweede 
type enzym werd gebruikt om de interne structuur van provirale DNA's op 
te helderen. Het gebruik van de bovengenoemde technieken leverde de 
volgende nieuwe inzichten op die relevant lijken voor door M-PluH/ ver­
oorzaakte leukemie: 
1) preleukemische weefsels (vertonen nog geen vergroting van het orgaan) 
bevatten alleen normale PMIuLV genomen, die op een groot aantal min of meer 
toevallige plaatsen in het cel DNA ingebouwd zijn. 
2) In uitgegroeide tumoren, afkomstig van verschillende anatomische 
plaatsen uit êên muis, bevinden zich de nieuw ingebouwde provirussen op 
dezelfde plaatsen in het cel DNA. Dit bewijst dat tumoren binnen SSn dier 
grotendeels afkomstig zijn van êSn of enkele tumorcellen en zogenaamd 
klonaal zijn. 
3) Uitgegroeide tumoren bevatten zowel normale M-PluLV/ genomen, als pro-
virale genomen die nieuwe structurele informatie hebben verkregen. 
4) De provirale genomen, die nieuwe structurele informatie hebben verkregen 
vormen een heterogene groep van provirussen. Toch hebben al deze nieuwe 
provirale DNA's een aantal gemeenschappelijke kenmerken: 
a) de nieuwe genetische informatie bevindt zich bij al de nieuwe provirale 
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DNA's op ongev/θβΓ dezelfdg plaats, en usi in hst gebied dat uoor het 
manteleiidit codeert. 
b) De nieuu) ingebouyde informatie bezit zeer sterke overeenkomstige 
kenmerken in tumor DNA van alle leukemische muizen. 
De gegevens beschreven in Hoofdstuk IV suggereren dan ook dat de provirale 
genomen die піеише structurele informatie hebben ingebouwd, essentieel 
zijn voor de ontwikkeling van en het in stand houden van de leukemische 
toestand, l/erder suggereert de homologie die er tussen al de nieuwe 
recombinante provirale DMA's bestaat, dat hun nieuw ingebouwde informatie 
in alle muizen afkomstig is van mogelijk êên en hetzelfde muizegen, of 
van een familie van sterk gelijkende muizegenen. Er worden dan ook ver-
schillende mogelijkheden tegen elkaar afgewogen, die kunnen verklaren hoe 
de nieuwe genetische informatie in de recombinanten verantwoordelijk kan 
zijn voor de kwaadaardige uitgroei van lymfatische cellen (zie hiervoor т.п. 
de discussie van Hoofdstuk l). 
Tenslotte worden in Hoofdstuk V/ bewijzen aangevoerd voor het feit dat 
de recombinante provirussen zich op bepaalde plaatsen in het tumorcel DNA 
bevinden. Deze plaatsen worden gekenmerkt door een driedimensionale 
DNA-eiwit structuur, waarin het provirale DNA plaatselijk een hoge 
gevoeligheid heeft voor een DNA—afbrekend enzym. Dit is een karakteristiek 
kenmerk voor genetisch materiaal dat actief gebruikt wordt in een bepaalde 
cel. Verder worden bewijzen aangevoerd voor het feit dat nieuw ingebouwde 
provirale DNA·s in tumoren een lage mate van chemische veranderingen 
door methylgroepen hebben ondergaan. De afwezigheid, of althans geringe 
aanwezigheid van dergelijke methylgroepen in het DNA is ook een karakteris­
tiek kenmerk van actief in gebruik zijnde genetische informatie in de cel. 
Verder blijkt het genetisch overgedragen M-MuLV DNA in Balb/Mo muizen 
volgens de genoemde kriteria inactief te zijn in zowel tumor als niet-
tumor weefsels. 
Concluderend kan gesteld worden dat leukemie bij muizen, die door M-nuLV 
wordt veroorzaakt, is gebaseerd op de vorming en activiteit van provirale 
genomen, die cellulaire genetische informatie hebben ingebouwd in het 
env-gen gebied, waarbij de oorspronkelijke informatie van M-PluLV uit dat 
gebied is verdwenen. Deze nieuwe virussen worden waarschijnlijk geselecteerd 
via chronische stimulatie van het immuunsysteem zodat de provirale 
structuren van recombinante virussen in uitgegroeide tumoren sterke 
overeenkomsten vertonen. 
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SUIWRY. 
Noloney Murine Leukamia Virus (М-СІиЦ/) was isolated by D.B. Moloney 
from a mouse tumor (3. Natl. Cancer Inst. 24: 933-947, 1960; Natl. Cancer 
Inst. Monogr. 22: 139-142, 1966). M-FluLV is a replication-competent, 
non-defective type-C retrovirus. The virus has bean propagated in tissue 
culture and used as a model system to study the molecular biology of C-
type retroviruses including their replication cycle, their encoded poly-
proteins and subsequent cleavages into smaller functional and structural 
subunits, and their encoded RNAs and splicing products. 
M-PluLV has also been usad to study the in vivo effects of C-type virus 
infections. When injected into neiuborn mice, M-PluLV gives risa to develop­
ment of mostly leukemias of T-cell origin. In exceptional events inocula­
tion of M-MuLV into animals generated transforming replication-defective 
sarcoma viruses. The sarcoma viruses arose by recombination of M-MuLU 
with endogenous cellular sequences of the host animal. The п шіу acquired 
sequences of the sarcoma viruses are responsible for their acute trans­
forming capacity. Нош ег, the authentic M-MuLV genome does not encode 
a product which is knoun to have laukemogenic capacity. So far only three 
genas have been mapped namaly from 5'- to S'-end of the genome, respectively 
the gag—polyprotein which subsequently is cleaved into several smaller 
proteins constituting mainly the core of the virion; further, in the 
middle of the genome the gene encoding the reverse transcriptase is 
located, and the S'-end of the genome encodes the envelope proteins 
gp70 (gp= glycoprotein) and p15E which are located on the surface of the 
virion. The gp70 determinas the host range properties of a particular 
C-type virus by its capacity to bind to cell-surface receptors on certain 
host calls. 
One of the main characteristics of МЧЧиИ/—induced leukamogenesis is 
the long latency of the disease in contrast to the acute diseases caused 
by sarcoma viruses. Mice uhich carry МЧЧиІ as an endogenous Mendelian 
inherited рго ігиз (Balb/Mo mica) do not develop leukemia before around 
9 months of age although virus-expression is detectable from directly 
after birth and reaches maximal levala after a few weaks. Infection of 
newborn mice with M-MuLU also leads to development of lymphatic leukemia 
after a latency of 2.5—6 months only, dependent on the amount of infectious 
particles used for injection and also on the inbred mouse strain used 
as a host. Many data, gathered from a great variety of both biological 
and biochemical experiments now indicate that development of M-MuLU-
induced leukemogenesis in mice is dependent on a large number of genetic 
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factors of both the host animal and the particular virus used to infect 
animals of a certain inbred strain of mice. Chapter I summarizes data 
from literature uhich indicate that MuLV-induced leukemogenesis in mice 
is dependent on host factors like the major histocompatibility complex 
(H-2), the Fu-1 gene of the host, some maternally transmitted factors, 
the thymic environment, the expression of endogenous viral genomes, and 
also mainly on the capacity of the CluLU to generate in a particular host 
animal recombinant proviruses with a general type of genomic structure. 
The generation of such recombinants seems to be a prerequisite for the 
development of leukemia, and the шау these viruses may be involved in 
the onset and maintenance of the leukemic state is discussed in the final 
part of Chapter I. 
The follouing chapters describe studies uhich resolve the structures of 
both authentic N-CluLV and recombinant MuLV proviral DNAs as they are found 
integrated in several tissues of M-PluLV-induced leukemic Balb/no, Balb/c, 
and 129 mice. Chapter II deals uith a major problem one has to face when 
studying specific integrated MuLU proviral sequences in the mouse genome. 
The mouse genome contains a large number of endogenous proviral sequences 
uhich shoui considerable homology with sequences present in the M-CluH/ 
genome. Therefore, in order to establish the integration of M-MuLV spe­
cific sequences in mouse cellular DNAs, a cDNA probe uhich exclusively 
detects M-MuLU specific sequences, was prepared by selection procedures. 
By using this probe it was established that Pl-TluLV-induced tumors in 
Balb/Mo and newborn infected Balb/c mice contain additional reintegrated 
M-WuLl/ specific sequences in many neu chromosomal sites of tumor tissues. 
Chapter III describes the cloning and restriction mapping of part of 
the genetically transmitted H-MuLV genome (Nov-l) in Balb/PIo mice. The 
clone, containing 3.5 kilobasepairs (kbp) of cellular sequences and the 
first 5,-5.4 kbp sequence of the ñov-l PWIuLV genome, was derived from 
Balb/Mo mouse liver DNA. This tissue does not express PWIuLV. However, 
after cloning and ligating the a.9 kbp fragment to restriction fragments 
which contain the S'-part of the МЧЧиИ/ genome (these fragments were 
derived from cloned unintegrated closed oicular FI-FluH/ DNA) these re­
constructed genomes were able to produce biologically active virus. The 
fact that the Mov-I M-CluLV genome is not expressed in tissues like liver 
(non-target-tissue) or even in tumor tissues (see last chapter) may be 
ascribed to the large extent of methylation and to the structure of the 
chromatin encompassing the По -І M-fluLV proviral DNA as discussed in 
Chapter V. 
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Chapter IV describes tha integration and structure of recombinant 
prouiruses in M-MuLU-induced tumors of Balb/Plo, Balb/c, and 129 mice. 
The state of integration and amplification of proviral DNA mas established 
by using tuo kinds of molecular probes to detect FI-PluLV specific sequences. 
Since the integration of a certain recombinant prov/iral DNA structure 
is a ubiquity observed for all M-MuLV-induced outgroun tumors this lends 
credence to the notion that a certain recombinant structure is a prere-
quisite for development of leukemia. Also, some other observations seem 
relevant to virus (N-PluHO-induced leukemogenesis: 
1) authentic M-NuLV genomes are integrated randomly in the DNA of pre-
leukemic tissues whereas such tissues do not shou detectable amounts of 
recombinant proviral DMAs, 
2) outgroun tumors contain both authentic FWIuLV as umll as recombinant 
genomes integrated in unique sites of chromosomal DNA, 
3) tumors are largely composed of descendants of one or a feu transformed 
cells, 
4) the recombinant proviral DMAs constitute a heterogeneous group of 
proviruses but characteristic molecular markers are conserved among many 
individual recombinants: a) they are all env-gena recombinants, and b) 
they all have acquired endogenous-virus-like sequences at almost identi-
cal map positions, and further c) the neuly acquired sequences in all 
recombinants display similar restriction sites. Therefore, the data 
discussed in this chapter strongly favor a hypothesis uhich defines a 
recombinant provirus as a structure essential for the onset and mainte-
nance of the leukemic state. The large homology of all recombinant pro-
viral DMAs integrated in DMA from outgroun tumors further suggests that 
the parental cellular sequences that recombine ulth M-CluLV to generate 
such recombinants are either highly related or even identical for all 
different lymphomas. The possible uay by uhich the recombinants exert 
their effect during leukemogenesis is discussed in the last section of 
Chapter I. 
Finally, the results discussed in the last chapter support the hypothesis 
that the expression of a recombinant provirus is a prerequisite for the 
onset and maintenance of the leukemic state. DNase I probing studies of 
chromatin have provided convincing evidence that transcriptionally active 
chromatin has an altered, more accessible configuration. Furthermore, 
hypomethylation uas also shoun to be a characteristic, though not sufficient 
marker for DNA of active genes. Chromatin comprizing proviral genomes in 
outgroun tumors is divided in three different DNase I sensitivity classes 
i.e. in configurations resistant, moderately sensitive, and hypersensitive 
16 
to DNase I. The genetically transmitted copy (flou-l) шаз found to be 
extensively methylated at certain restriction endonuclease sites and 
displayed a DNase I resistant configuration. These data strongly support 
tha hypothesis that the Flou-I locus is probably only active in a feu 
cells early in life of the Ва1Ь/Ио mouse but not in tumor and non-tumor 
tissues of a mature mouse. Somatically acquired proviral genomes were 
all hypomethylated. In addition most somatically acquired MuH/ sequences 
displayed moderate sensitivity to DNase I whereas some proviruses dis­
played a configuration hypersensitive to DNase I. This hypersensitive 
site шаз found at the S'-cellular DNA-viral LTR junction of integrated 
recombinant proviral DNA. Since such hypersensitive sites are closely 
associated with active genes the data strongly support the hypothesis 
that an active recombinant proviral DNA structure is required during 
leukemogenesis. 
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 Chapter I . 
LEUKEMOGENESIS IN MICE. 
INTRODUCTION. 
M u r i n e l e u k e m i a s can be caused by s e v e r a l agents l i k e : 
— leukemogenie ( c a r c i n o g e n i c / m u t a g e n i c ) c h e m i c a l s , 
— r a d i a t i o n , 
— endogenous and exogenous RNA tumor viruses. 
Up till ποω the expression of C-type viruses (in contrast to A, B, D, 
and E-type particles) has been mainly associated uith development of 
spontaneous leukemias in mice (200). Since the discovery of leukemia-
transmission by cell-free extracts from the high leukemic AKR strain, 
developed by Dacob Fürth in 1933 (43), the role of C-type viruses in 
mouse leukemias has been investigated. 
A vast amount of evidence has been accumulated which indicates that 
the expression of C—type viruses in mice is associated with leukemogenesis. 
The mouse genome contains a large number of C-type related sequences. 
Some of these sequences seem to contain only part of the coding infor-
mation for a C-type virus whereas others comprize sequence information 
for a complete endogenous MuLV (purine leukemia virus). Endogenous MuLVs 
are viruses resulting from the expression of chromosomally integrated 
viral genomes transmitted as Mendelian traits. 
The expression of C-type provirus related sequences can result either 
in the production of 1) infectious C-typs particles (encoded by non-
defective proviruses), of 2) non-infectious C-type particles (encoded 
by defective or mutant proviruses), or can result in 3) the expression 
of virus-related proteins without production of C-type particles (21, 
69,171). Most mouse strains do express virus-related proteins without 
producing virus. A protein indistinguishable from a viral envelope protein 
gp70 (gp= glycoprotein) is r*ften seen on the surface of cells, without 
concomitant synthesis of other virus-encoded proteins; this is presumably 
a consequence of the partial expression of an endogenous virus (6,22, 101, 
13Θ). The prototype structure of a C-type virus, its life-cycle, and 
virus-encoded RNAs and proteins have been reviewed in detail elsewere 
(3,66a,212a), and will therefore not be part of the present discussion. 
Env-related gp70 proteins can be expressed in complete absence of repli­
cating virus (44). Partial expression of virus-related proteins like gp70 
without the presence of infectious virus particles is a generally observed 
phenomenon in normal healthy mice of many strains. Other virus-related 
proteins are known which appear only in the presence of replicating virus 
e.g. Moloney Cell Surface Antigen (MCSA) and Gross CSA which appear only 
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in the presence of replicating Moloney (FWIuLV) or Rauscher (R-PluLV) 
murine leukemia virus and AKR-^uLU respectively; FICSA is an duLV-env-
related protein (66), and GCSA is a glycosylated polyprotein containing 
antigenic determinants of viral gag-proteins (98,99,205); the gag-gene 
is encoding the proteins of the viral core (p15,p12,p30, and plO, in this 
order from NH^-terminus to CO.H-terminus). The presence of replicating 
virus and the expression of infectious C-type particles is in most cases 
associated with clinical manifestations of diseases like different kinds 
of T-cell leukemias (e.g. in AKR and Balb/Мо mice) or autoimmune disease 
(e.g. in NZB mice; 102-104). 
Experimentally one can mimic the expression of an endogenous virus by 
injecting newborn mice with a certain MuLV-stock. The time of appearance 
of the disease is greatly dependant on: 
1) the number of infectious virus-particles used for injection, and 
2) the transforming capacity of the virus in e particular host. 
The exogenous virus can only infect target—tissues and generally does 
not infect germ line cells or cells of non-target tissues. This phenomenon 
is known as organ-tropism; organ—tropism and host—range of a particular 
virus are determined by the envelope glycoprotein on the surface of the 
virion. The target cell varies from one virus strain to another, e.g. 
M-CluLV is known to infect and transform different classes of prothymocytes 
(cells of T-cell lineage), while Rauscher PluLV exerts its effect on 
erythroid cells, and AKR-^uLV acts mainly on mature T-cells. 
The role of the authentic viruses like ΓΊ-ΛΙυίΙ/ and AKR-fluLU during the 
onset of leukemogenesis has been questioned many times since these viruses 
do not carry a transforming gene like the acute leukemia virus Abelson 
MuH/ (167), and the disease is characterized by a long latency. The 
discovery of certain types of recombinant viruses, first isolated from 
a preleukemic thymus of an AKR mouse suggested a role for recombinant 
viruses in the process of leukemogenesis (65). Recombinant viruses with 
a general type of structure and phenotypic characteristics have now been 
isolated from both preleukemic and leukemic tissues (thymus and also from 
spleen) of several high leukemic mouse strains (169). The major charac­
teristics of these recombinants are summarized below and a general 
structure is shown in Figure 1 : 
1) they have been isolated from preleukemic and leukemic tissues only 
(thymus and leukemic spleen; 169), 
2) they are formed by somatic recombination of two types of endogenous 
viruses or virus-related sequences, an ecotropic virus and probably a 
xenotropic viral sequence (11): ecotropic NuLl/ can succesfully adsorb 
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to and penetrate mouse cells uhereas xenotropic viruses can only infect 
heterologous cells i.e. cells from other species, 
3) they are env-gene recombinants: the putative S'-end of the pol-gene 
(coding for the viral reverse transcriptase) and part of the NhL-terminal 
sequence but probably even the uihole gp7D encoding part of the env-gene 
seems to be involved in the recombinational event (159,206) as shoun in 
Figure 1, 
4) they have a dualtropic host-range i.e. they can infect both mouse cells 
and other types of cells (65), 
5) they display MCF-nature i.e. they form cytopathic foci on mink cells 
(lylCF= Nink Cell Focus-inducinq virus; 65), 
6) their pISE—coding sequences seem to be mainly derived from the ecotropic 
parent (206), 
7) their 3·—LTR (Large Terminal Repeat) often contains xenotropic-HuLV-
derived (or similar cellular) sequences (110), 
e«l&tUO MB 4 1 M Ч І 
ECO RI ИрЛІ Эвкьр ^ ^ ^ ^ » 
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Figure 1: Structure of authentic n-CluLV and recombinant proviral DNA in 
M-MuLV-induced tumors. 
The upper line represents the restriction map of the genetically trans­
mitted Mov-I Fl-nuLV DNA as integrated in both tumor and non-tumor tissue 
DNA from Balb/rno mice. The two Іошег linas shou the structures of the 
recombinant Kpn I DMA fragments from tumor DNA of Balb/do mouse Ю (5.4 
kbp) and Balb/c mouse 503 (4.0 kbp), respectively; the пвшіу acquired 
sequences in the mink cell focus-inducing (MCF)-type proviral DNAs are 
indicated by a double line. The neuly acquired restriction endonuclease 
recognition sites are also shoun, as well as the position of the recom-
binant-specific Bam HI (2.2 kbp) and Kpn I- Ceo RI (3,6 kbp) DNA fragments 
detected in all tumors and diagnostic for recombinant proviral DNA (159, 
206). The louest part of the Figure indicates the location of the env-
gene uhich starts at position 6.4 kbp (C. van Beveren, personal communi­
cation). 
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In contra3t to the parental eootropic viruses and different xenotropic 
viruses, none of uhich does accelerate leukemia dev/elopment uhen injected 
into newborn mice of high leukemic strains like AKR (so called leukemia-
acceleration test), some of the recombinant viruses do accelerate leukemia 
markedly in appropriate hosts (141). However, many recombinant viruses 
hava ηοω been isolated which do not accelerate leukemia. Therefore 
skepticism has accumulated on the role of these viruses in the onset and 
maintenance of the leukemic state. The integration of defined recombinant 
proviral DNAs, however, seems now directly related to clonal outgrowth of 
lymphoma cells during leukemogenesis (159,206). Therefore, a direct role 
of the recombinant in the switch from preleukemic to leukemic state and 
probably also in the maintenance of the leukemic state has been suggested 
(206). Although the recombinant viruses do not seem to play a role in the 
formation of preleukemic cells, their presence in leukemic cells of many 
mice probably reflects a specific property that enables the infected 
cells to complete the different final steps in the metastatic process. 
The formation of preleukemic cells can probably be ascribed to effects 
generated by the authentic parental ecotropic viruses and the switch 
from normal to preleukemic cells seems already to occur very early during 
lymphocyte maturation in the bone marrow (58), at a stage when no 
recombinants have yet been detected. The long latency of the disease 
generally observed for leukemogenesis seems to be dependant on the 
formation of recombinant viruses, and further on several host factors 
like thymic environment, the major histocompatibility complex (MHC) H-2, 
the Fv-1 genotype, the expression of xenotropic virus, and a chronic 
immune response. These aspects will be discussed below. 
ENDOGENOUS C-TYPE l/IRUS-RELATED SEQUENCES. 
Figure 2 shows some examples of C—type endogenous viral sequences as 
they are present in the genomes of many mouse strains. Further, different 
recombinational pathways are indicated, which have been detected between 
different endogenous viral sequences as well as between viral and cellular 
sequences. A variety of recombinations can give rise to different recom­
binant viruses; each of these recombinant viruses seems to be associated 
with typical manifestations of a disease e.g. the sarcoma virusea trans­
form fibroblasts in vitro and form fibrosarcomas in vivo (3); the dual-
tropic viruses and their parental viruses like M-CluLV and AKR-PluLV are 
mainly associated with the formation of lymphatic leukemias of T-cell 
origin (although there havs been reports that AKR-MuLV can induce B-cell 
lymphomas in rare cases; 137). Ab-PluLV is associated with a typical pre-B 
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ENDOGENOUS SOnATIC DISEASES 
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Figure 2: Recombination of C-type sequences in the mouse. 
Numbers indicate references. Abbreviations: Mo-MSV, Moloney murine sarcoma 
virus; Ha-MSU, Harvey murine sarcoma virus; Ki-PlSV, Kirsten murine sarcoma 
virus; abl indicates the cellular gene homologous to the cell-derived 
sequences present in the genome of Ab-duLU. Amphotropic viruses grow both 
in mouse cells as шеіі as in cells from heterologous species but do not 
form foci on mink cells like dualtropic MuLV. The gp70 gene family consists 
of cellular genes (both viral and non-viral) which code for 70k glyco­
proteins e.g. the gp70 found in serum. Fibroblasts, infected with N-, 
B-, or NB-tropic virus are recorded by their ability to cause XC-plaques 
when overlayed with XC-cells (65): l\l-tropic on NIH/SUJÍSS mouse fibroblasts, 
B—tropic on Balb/c mouse fibroblasts; N-tropic viruses are restricted 
in growth on B-tropic cells and vice versa, an effect mediated by the 
cellular Fv-1 gene, which dictates dominant though not absolute restric-
tion. NB-tropic viruses (e.g. M-MuLV) are not restricted and grow equally 
well on cells with different Fv-1 alleles (see section on Fv-1). 
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or null c-all leukemia (166); SFFV (Splesn Focus-ForminQ Virus) is asso­
ciated with the development of erythroleukemia (172,173,201,202); Rauscher 
MCF induces also erythroleukemia (162). In general the acquisition of 
oncogenicity seems to be associated uiith recombination betuieen different 
type-C genomes or between different type—С genomes and host genes. A 
possible function of RNA tumor viruses may therefore be to act as vehicles 
for the intra- or intercallular movement of genes and therefore they 
could be elements of "selfish" DNA (33,147). Intercellular movement of 
genes can occur uithin one organism, from one individual to another, 
or even from one species to another. Furthermore, the putative capacity 
of RNA tumor viruses to move genes intraoellularly implicates the 
possibility that the enzyme—system of the virus might actually have 
cellular counterparts which have normal physiological functions. 
Many of the recombinant viral genomes were generated in exceptionally 
rare events and therefore have to be classified as unique structures 
e.g. SFFV, Ab-MuLV, and various sarcoma viruses (KirstenMSV/, HarveyMSV, 
Moloney Mouse SV). An intriguing observation, houever, is that some 
types of recombination seem to be more general phenomena associated with 
the development of T-cell leukemias and myelomas in mice. The formation 
of MCF-type viruses, first reported in 1977 by Hartley et al.(65), is a 
generally observed phenomenon during T-cell leukemogenesis. However, 
other types of recombinant molecular species have been detected in some 
leukemias. Some of these examples are discussed below. 
1. THE AKR SYSTEN. 
nice of the AKR strain (43) express high levels of ecotropic endogenous 
AKR virus (17) from soon after birth (170), and by 6 months of age most 
thymus cells produce N—ecotropic virus. Different AKR substrains contain 
various numbers (2-6 copies per haploid genome equivalent) of АКРЧ*1иИ/ 
proviral genomes as endogenous proviruses (159,159a), Xenotropic virus 
is detected in the thymus at approximately 6 months of age (86). Poly-
tropic nCF-type viruses have been isolated from preleukemic and leukemic 
tissues (thymus, spleen) of AKR mice of 6 months of age and older (65). 
The emergence of this neu virus, not present as an endogenous proviral 
entity, seems to be of critical importance to leukemia development in 
the AKR strain (30,159,190): 1) these viruses appear in close temporal 
association with the development of spontaneous leukemia at 7-12 months 
of age in nearly 100 % of the mice (110,169). 2) When injected into new­
born AKR mice, some of the recombinant viruses accelerate leukemia de­
velopment markedly, in contrast to the parental ecotropic and various 
xenotropic viruses (30,110,169,190). 3) A certain recombinant proviral 
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DNA із detscted as an integrated entity in all outgrown tumors of AKR 
mice (159). 4) The structure of these recombinant oroviral DNAs is si­
milar to the structure of HCF-type viral RNA, isolated from virions or 
cell lines derived from leukemic tissues (19,36,159). The general restric­
tion map for these recombinant proviral DNAs as detected in tumors from 
mice of different inbred AKR sublines is similar to the map shown in 
Figure 1 for recombinant proviral DNAs characteristic for ïï-CluLV-induced 
leukemias (159,206); the recombination is located in the same position 
on the map and also carries the tuo пеш restriction sites Bam HI and 
Eco RI at similar positions (159). 
Another class of retroviruses produced by spontaneous AKR leukemias 
are the SL-viruses, which do not cause XC-plaques or mink cell foci. 
Lymphoma cell supernatants containing these SL-viruses are pfficient in 
leukemia-acceleration in young AKR hosts. Their role as potential 
leukemogenic agents is still unclear although recently cloned SL-viruses 
ишгв obtained which induced louk^mia but did not display a MCF-type 
substitution in the env-qene; these viruses retained differences in 
structure with Gross AKR passage A virus within the S'-terminal 1000 
nucleotides. This suggests that sequences outside the gp70 coding sequences 
and located proximal to the S'-end of the genome encode determinants of 
leukemogenic activity (150). However, the structure of integrated proviral 
DNAs in tumors induced by SL-viruses is not yet established so whether 
additional recombinations take place during tumorgenesis is not known. 
Therefore, leukemia-acceleration by such viruses might be due to their 
putative enhanced capacity to recombine and form leukemoqenic recombinant 
viruses. 
2. Balb/Vlo AND NEWBORN INFECTED Balb/c AND 129 HICE. 
3aehnisch has introduced Cl-CluLU into the germ line of Balb/c mice by 
infecting preimplantation mouse embryos at the 4-8 cell stage (77). The 
Balb/Mo strain carries M-PluLV as an endogenous virus at a single Hendelian 
locus (Поу-1;7В) on chromosome number 6 (14)| the virus is integrated 
in a characteristic Eco RI DNA fragment of 27 kbp (-207). Balb/Mo mice 
are viremic from birth (7 ) and develop after a latency of 7-9 months 
a thymus-dependant leukemia of viral (M-MuLV) etiology (132). On the 
other hand Balb/c and 129 mice do not develop this disease spontaneously 
at this age. When newborn Balb/c or 129 mice are infected with N-nuLV, 
however, a thymus-dependent leukemia follows the expression of high titers 
of the virus in the blood (80,153). This was also observed for M-MuLl/-
induced leukemias in NIH/Swiss mice (191). 
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Leukemogenesis in Balb/flo and neiubom infected ВаІЬ/с, 129, and NIH/ 
Swiss mice is accompanied by somatic amplification (76,79) and reinte­
gration of l*luLU DNA sequences in neu chromosomal sites of tumor tissues 
(75,206,207). Spleen and thymus cells of Balb/no mice synthesize M-PluLV 
specific RNA soon after birth and v/irue expression reaches high levels 
at 3-6 weeks of age (79). This level remains constant throughout life 
of the animal and the expression is target-specific i.e. confined to 
lymphatic tissues (although many organs like liver, kidney, gut etc. 
show both viral DNA and RNA amplification, due to infiltration by lym­
phatic cells at final stages of the disease; 79). The DNA amplification 
seems to occur in tuto steps. A first step to approximately two copies 
per haploid genome equivalent in target tissues of preleukemic mice. 
A second step to approximately 3-4 copies is observed in leukemic 
tissues (79). Preleukemic tissues seem to contain only authentic M-MuLV 
genomes, reintegrated "randomly" in п ш chromosomal sites (75,206). 
Unintegrated forms of И-ІЧиИ/ viral DNA appear in target tissues (mainly 
thymus) of preleukemic Balb/Mo mice (75). The occurrence of free proviral 
DNA suggested that superinfection of target cells with endogenous N-PluH/ 
is involved in the leukemic transformation process. The second DNA ampli­
fication step is associated with leukemic transformation (79). The suiitch 
from preleukemic to leukemic stage uas shown to be associated with clonal 
outgrowth of tumor cells. Outgrown tumor tissues within each animal 
display a specific pattern of reintegrated proviral DNAs (75,206); although 
tumors in each animal are largely monoclonal, different mice display 
different proviral integration patterns (75,206), Outgrown tumors contain 
both authentic FWIuLl/ genomes as well as recombinant FICF-like proviral 
DNAs integrated in many different sites of the chromosomal DNA (206). 
Recombinant PICF—type viruses have been isolated from thymoma cell lines 
of Balb/Mo mice and seem to be present in every thymoma cell line (211). 
Although the recombinants constitute a heterogeneous group of proviral 
DNA structures, they are all env—gene recombinants which have acquired 
"xenotropic"-like sequences in the NI-L-terminal part of the env-gene 
and the putative carboxy-terminal part of the pol-gene (206). Ulhether 
this has any consequence for the pol-protein is not known but since the 
mature pol-protein is 84k (210), the recombination only effects a sequence 
whose product has not yet been detected after processing of the gag—pol 
precursor protein. 
The structural similarities of integrated recombinant viral DNAs 
as observed in a large number of N-TluLV-induced lymphomas in several 
mouse strains strongly supports the hypothesis that the formation of 
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these recombinants is related to leukemic transformation (206). Some 
possibilities for their role will be discussed later on. The recombinants 
in different tumors are clearly structurally related, but are not identical. 
This structural heterogeneity is probably related to the phenotypic 
diversity as detected by cell-surface differentiation antigens, of thymo-
maa induced by H-MuLV (152,183). The diverse phenotypic patterns of 
expression of differentiation antigens on cells of H-MuLV-induced 
leukemias as ш іі as the structural heterogeneity among integrated 
recombinant proviruses are consistent uith the hypothesis that the 
putative transforming recombinants arise by random gene hic recombinabion 
(35). 
Balb/c mice shou a moderate incidence of lymphoreticular tumors (63,87). 
Occasionally, Balb/c mice show B-tropic virus activity in their tissues 
with advanced age (155), and this virus has been associated with leukemia 
development (63,B7). This virus, u/hen injected into neuiborn Balb/c mice, 
shoued acceleration of leukemia development (153,154). The Balb/c genome, 
houraver, does not harbor a B—tropic MuLV since no such virus can be in­
duced while an N-tropic virus can be induced (1,192). The Balb/c genome 
contains one N-tropic AKR—type endogenous provirus which is detectable 
in an Eco RI DNA fragment of 19 kbp (9,16,94,159,165,207). The B-tropic 
virus seems to be generated by a somatic recombinational event (44,165); 
it harbors genetic informa bion for a xerotropic-flüLV-like рЗО prot-ein 
in the gac-region (45). Since Balb/c ce]Is are relatively resistant to 
N-tropic virus replication (64,157,176), the recombination leads to the 
formation of a virus which can now easily grow in "alb/c cells because 
of its B-tropism. 
Recombinant dualtropic MCF-type viruses have not only been detected 
in association with T-cell leukemias in Balb/c mice, but in addition 
such viruses have been isolated from Balb/c myelomas. The viruses 1*10-21, 
FL-1 (IBI), and СВ20 (23) were originally produced by different Balb/c 
myelomas. The cloned preparations have a polytropic host range and exhibit 
MCF activity (109). Additional features were found in common with other 
MCF-type viruses e.g. normal Balb/c serum effectively neutralized the 
infectivity of the two isolates 140-21 and FL-1 (41,65). Although MO-21 
and FL-1 have many features of normal MCF-type viruses, some remarkable 
characteristics were found. Although the viral gp70 envelope protein 
had several peptides in common with ecotropic and xenotropic gp70, the 
structure of the qp70 of М0-21 and FL-1 (and also of СВ20 ) seems, 
however, not totally due to a reqular MCF-type env-recombination since 
they contain unique peptides not found in any of the other putative 
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parental virusas testad (1ΘΘ). A remarkable feature of the tuo independent 
isolates N0-21 and FL-1 uas their virtually indistinguishable gp70 pep-
tidesf uhile previous MCF isolates were always found to display unique 
peptides for each isolate. The common gp70 structure suggests that М0-21, 
FL-I and CB20B were not generated by independent recombinational events 
in the env-gene region as was observed for other MCF isolates, but might 
have a common precursor molecule. This might well be a cellular differen­
tiation antigen which bears structural relationship with xenotropic MuLU 
gp70 molecules. ΠΟ-ΣΙ and FL-1, produced by various cell lines (like the 
wild mouse embryo SC-1 cells) contained also an additional gp70-like 
protein distinguishable from the viral functional gp70 (1 8), while this 
protein was not observed when the viruses were grown in other cell lines 
(like the mink lung Nvl cells). Several possibilities for the appearance 
of this env-related gp70 molecule have been postulated; it might be due 
to the presence of a mixture of viruses (probably not true since after 
extensive cloning of viruses by tissue culture techniques no other virus 
was found), to the rescue of an endogenous virus, to the induction of 
a defective virus or virus-related cellular gp70, or it might be due to 
an incompletely modified or processed precursor of the viral gp70 (1B8). 
Induction of an endogenous virus-related gp70 seems a very likely 
possibility because this can occur in probably every cell line, even in 
cell lines initially characterized as virus-negative (i.e. no virus could 
be induced) like NIH (ΓΊ. Vogt, personal communication). 
3. HRS STRAIN. 
The HRS mouse strain carries the hairless gene (hr). Hairless homozygotes 
show high incidence of spontaneous lymphoma (72%), whereas heterozygotes 
show a much lower incidence (20$). Both hr/hr and hr/+ mice have high 
levels of ecotropic viruses. However, only hr/hr mice express in addition 
a xenotropic virus in their thymuses shortly before developing lymphoma 
(67). Each cloned isolate of recombinant MCF-type virus from HRS/o mice 
has been shown to contain unique oligonucleotide sequences in its env-
gene region and clone-specific peptides in its gp70 (51). This hetero­
geneity is also known for MCF-type recombinants of AKR origin (110). 
The diversity of polytropic viral gp70 is also reflected by the extensive 
phsnotypic diversity among spontaneous thymic leukemias of both HRS/D 
(51,21B) and AKR/!! mice (95,114). Tumors within one strain did have 
common features (218) e.g. expression of T-cell specific Thy-1.2 antigen; 
a high percentage of thymocytes expressing MuLl/ antigens; a low expression 
of the MHC-antigen I (HRS/D) or high expression in AKR/D (21Θ). The surface 
28 
phenotypas of Иугтгатаэ induced by cloned leukemogenic ñCF-type viruses 
from HRS/Э mice ы ге alujays found to be characteristic for a given clone 
(51,218). Recombinant-virus-induced leukemias have been shouin to produce 
the specific recombinant virus which induced them (51), although minor 
modifications on genomic level can not be excluded because of limitations 
of the RNA-fingerprinting technique. It seems therefore unlikely that a 
п ы recombinant virus caused the leukemias. Recently, a single dominant 
gene (probably encoding a thymocyte cell-surface receptor) was found to 
determine susceptibility to a certain cloned recombinant virus (177): 
leukemogenicity of such polytropic viruses is, however, restricted to 
certain inbred strains of mica (177). The ікау by which the wild-type hr 
allele can suppress xenotropic virus expression and therefore probably 
lymphomagenesis is not known. A primary effect of the hr-allelss on lym­
phoid cells has been suggested since hr/hr mice also show abnormal 
numbers of certain types of T-cells (164). 
4. RADIATION-INDUCED LEUKEMIAS. 
A) C57BL MICE (56). 
Radiation-induced C57BL lymphomas do not overtly express MuH/ (only 
2-45È harbor Radiation Leukemia Virus, RadLU; 52,70). The transmissible 
leukemogenic agent, RadLU, isolated from such lymphomas and subsequently 
passed through tissue culture for many years now, has unique env-gene 
characteristics (29). This isolate has retained its leukemogenic potential. 
The in vivo counterpart of RadLV can be consistently isolated from lymphoid 
tumors of the thymus which develop after controlled X-irradiation of 
C57BL/Ka mice (03,174); this has become possible by using very sensitive 
tissue-culture techniques. RadLV is a highly oncogenic virus capable of 
inducing neoplastic transformation in susceptible cells in the thymus, 
bone marrow, spleen and fetal liver and transforms cells of the T-lympho-
cyte lineage. RNA from RadLV/VL3, a virus produced by a permanent cell 
line derived from a radiation-leukemia-virus-induced thymic lymphoma 
of C57BL/Ka mice consists of two components (112). Except for an 8 kb 
subunit, which is also found in a non-oncogenio endogenous virus of the 
same strain of mice, a 5.6 kb RNA was detected. The 5.6 kb RNA codes for 
a 100k protein which can react with antibodies directed against the gag 
p15 (=anti-p15) from Rauscher MuLV (the R-MuLV gag-gene protein-order is 
NH„-p15-p12-p30-p10-C07H; 128) but not with anti-рЗО, and therefore contains 
sequences at the S'-end coding for the viral protein p15 and p12. In 
addition RadLV/VL3-virus-producing cells contain a 1.6 kb polyA cyto-
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plasmic RNA uhich shows very little homology to the θ kb RNA sequences 
(112). The acute defectiue leukemia viruses like Ab-MuLV contain partial­
ly deleted gag and enu-qene region and completely deleted pol-gene region 
idhen compared uith their helper viruses, with non-helper RNA sequences 
inserted between these regions (167). The neoplastic disease induced by 
RadLV is not acute since mice develop lymphomas 3 months or later after 
virus inoculation. It is not clear whether all other virus- or radiation-
induced thymic lymphomas display a 100k protein with serological charac­
teristics similar to the protein translated from the 5.6 kb RNA, and 
whether these lymphomas also contain both the θ kb and 5.6 kb RNAs, 
Therefore, the role of the smaller RNA of 1.B kb as detected in the 
RadLU-producing cell line is also still obscure. 
B) Swiss NICE. 
Radiation—induced leukemia development in Swiss mice does not lead 
to expression of type-C viruses (71). V/irus—free X—ray—induced lymphomas 
in an outbred Swiss mouse were shown to express a unique surface 
recombinant-HuLU-like glycoprotein gp70 on thymoma cells (40). A lympho­
blastic cell line derived from such a thymoma did not produce infectious 
virus nor C-type particles, but showed specific viral interference with 
recombinant PluLl/s. Peptide mapping of the purified gp70 revealed that it 
was highly related to an endogenous xenotropic gp70, but in addition 
had peptide characteristics of recombinant FICF-like gp70. The origin of 
the recombinant-like gp70 is obscure for the moment. It could be encoded 
by a defective or intact provirus, by a cellular gene, or it might have 
resulted from internal recombination. Also, the role of the gp70 molecule 
in leukemogenesis is not clear. It was postulated (40) that the recom­
binant gp70 induces a chronic immune stimulation which results in blasto-
genesis. This model relates very closely to the model proposed by McGrath 
and Ueissman (117) who shoued the existence of receptors for recombinant 
MuLV gp70s in a specific T-cell subpopulation of AKR mice (see also 
discussion). 
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THE THYMUS. 
A) HISTOLOGICAL CHANGES DURING LEUΚΕΠΟ GENESIS. 
The thymus of a mouse reaches maximal size after a feu ueeks of age 
and starts reducing in size after about 6 ш екз of age. Figure 3 shows 
a schematic representation of a part of a neonatal thymus. 
blood vessel 
thymic lobule ___ 
Hassalls corpuscule 
medulla 
Figure 3: Thymus of a neonatal mouse. 
The thymus consists of tuo lobes, while each lobe consists of thousands 
of lobules. Each lobule contains a cortical and medullary component. The 
lymphatic tissue, unlike that of lymph nodes, is not arranged in nodules 
(lymphoid follicles); such nodules contain closely packed lymphocytes 
and often display a lighter staining central area, the germinal centers, 
and during an active phase small lymphocytes are produced by the cells 
of the germinal centers and are pushed outuard into a zone which becomes 
the cortex of the nodule. In the thymus lobes are encapsulated by connec­
tive tissue and extensions from it (septa) delineate the lobules. The 
reticular connective tissue of the thymus differs from that of other 
lymphoid organs since it arises from entoderm rather than from mesenchyme: 
it displays epithelioid characteristics. The cortex contains small 
lymphocytes (thymocytes), which are very densily packed among a few 
reticulum cells while the medulla contains less thymocytes and more 
reticulum cells. Hassalls corpuscules consist of a concentric formation 
of epithelial cells (for review· see ref. no. 120)? 
The main histological changes observed in the thymus from the high 
leukemia AKR strain before the onset of leukemia are: 
a) the thymic cortex is reduced in size and structures resembling lymphoid 
follicles and germinal centers appear in the medulla (120), 
b) spontaneous leukemia arises only in one lobe of the thymus (120,185), 
c) this lobe displays cortical inversion i.e. selective depletion α f 
capsula 
connective 
tissue 
septa 
(separate 
lobuli) 
intralobular 
trabeculae 
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cortical thymocytes and enlargement of the medullary region, 
d) with aging focal pockets of blast-like cells appear in the outer edge 
of the thymus, 
e) these cells are finally displaced by rapidly dividing leukemia cells. 
Metcalf (122) concluded from these observations that progression of 
leukemogenesis is associated uiith a graduated commitment of lymphoid, 
preleukemic cells to the malignant phenotype. The depletion of cortical 
thymocytes and the appearance of structures resembling lymphoid follicles 
in the thymus medulla led people to suggest that the preleukemic thymus 
may be the site of an autoimmune reaction (120). This could in some uiay 
initiate the leukemogenic process. Facts consistent with the idea that 
AKR mice are undergoing an immunological reaction to antigens o f thymic 
origin, present on preleukemic and leukemic thymocytes are: 
a) the finding of immunoglobuline with MuLV reactivity in glomeruli of 
AKR kidney (145,146), 
b) the observations that leukemic cells are selectively destroyed after 
injecting AKR mice with complement (84), and that Ιοω levels of viral 
antibody can be detected in the serum of AKR mice (72,134). 
The source of the antigens could be either or both of the endogenous 
viruses (ecotropic and xenotropic) which are expressed in the thymus 
or a recombinant NCF-type virus that is generated in the thymus (65). 
B) ROLE OF THE THYMUS DURING LYMPHONAGENESIS. 
["lost leukemias discussed in this ге і ш like those induced by M-PluLV 
and AKR-CluLl/ are characterized by proliferation of either prothymocytes 
or mature T—cells. Therefore, some basic characteristics of T-cell 
ontogeny are discussed in relation to thymus-function in normal mice 
and mice prone to leukemia development. 
The thymic environment is of critical importance in the differentiation 
and functional maturation of T-cells. During embryogenesis stem cells 
migrate into thymic epithelial remnant at about day 11 of gestation. 
Precursor bone marrou cells (prothymocytes) migrate to the thymus in 
post-natal animals (15,199). After processing these cells become 
functionally competent and are exported into spleen, lymph nodes, 
blood, and other peripheral lymphoid systems like Peyer's Patches along 
the gut (14B). Changes in cell-surface antigens mark the various stages 
of T-cell ontogeny (160) e.g. for the murine system the following 
simplified scheme has been developed (15,118,198): 
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STCn CELL (bone marrouj) 
PROTHYHOCYTES: T l ." ; T h y - 1 ~ ; Ly~ 
i n THYCIUS: v a s t m a j o r i t y o f l y m p h o c y t e s аг 
T h y - 1 + ; r L + ; L y - l í " 2* 3 + 
nATURATION 
I 
SUBPOPULATIONS 
CYTOTOXIC T-CELLS ( l - A + ) 
AND 
SUPPRESSOR T-CELLS (l-3+): 
Thy-1+; TL"; Ly-2t 3+ 
INTERMEZZO: l) The Thy-1 locus is on chromosome 9, and has tuo alleles 
Thy-1 and Thy-1 which code for Thy-1.1 and Thy-1.2 respectively; Thy-1 
is an antigenic marker specific for T-cells. 2) The TL-locus is described 
in the next section. 3) The Ly-1 locus is on chromosome 19 and has tuo 
alleles which code for 67k glycoproteins! Ly-2 and Ly-3 are two closely 
linked loci on chromosome 6 and encode specificities on two closely 
associated molecules or probably even on one molecule (118). Cytotoxic 
T-cells are directly cytotoxic when in intimate contact with appropriate 
targets. Helper T-cells help B-cells to produce IgG antibodies. Suppressor 
T-cells regulate immune respons by suppressing the activities of other 
Τ and B-cells. Cytotoxic T-cells express the MHC product I-A, while 
suppressor T-cells express 1-3. Helper and cytotoxic T-cells can bind 
to antigen only when it appears in close association with an MHC product 
on the cell-surface, while suppressor cells can bind free antigen. Helper 
T-cells react with I-region déterminants and cytotoxic T-cells interact 
with Κ/θ products like suppressor cells (for review see ref. 49,91). 
Several models have been presented, which indicate further differentiation 
of thymocytes in both the thymus and periphery and which give rise to the 
different peripheral thymocyte populations like helper T-cells, cytotoxic 
T-cells, and suppressor T-cells (118). Tumors induced by AKR-NuLV and 
N-CluLV have been typed mainly as Thy-1 , indicating a T-cell origin, but 
heterogeneity appeared in expression of Ly and TL antigens. Similarly, 
radiation-induced tumors in C57BL/6 or C57BL/10 mice have been shown to 
be all Thy-1 but very heterogeneous with respect to the other T-cell 
differentiation antigens (IIB). 
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The thymus has been considered previously to be the principal organ 
in uihich both leukemic transformation and proliferation occurs (25,120)ι 
a) most mice develop large thymic lymphomas; the thymus is the first site 
of recognizable disease, 
b) other lymphoid organs become subsequently enlarged, 
c) invasion of non-hematopoietic organs (e.g. liver, kidney) is observed 
during terminal stages of the disease, 
d) most of these leukemias have T-cell markers indicating that the cells 
have undergone some phases of differentiation in the thymus (144), 
e) thymectomy in early life drastically reduces the incidence of overt 
leukemia (both spontaneous and induced) development in mice (42,82), 
f) subcutaneous thymus-grafting in thymectomized mice restores tumor 
development; the neoplastic cells are often from host cell origin, 
although leukemia develops in the thymus graft itself (56). 
Tuo basic hypothesis on the role of the thymus in leukemogenesis have 
been postulated: 
1. The thymus is the major organ uhich provides cells that are most 
susceptible to neoplastic transformation by leukemic agents (Θ3). 
2. The thymus maintains the appropriate environment uherein potential 
leukemic cells initially transformed in any of the hematopoietic organs 
can proliferate actively into autonomous leukemic cells (25,124). 
Most data ηοω clearly support the second hypothesis. 
Preleukemic cells with leukemogenic potential have ηοω been detected 
in bone таггош of intact and adult thymectomized irradiated C57BL/6 mice 
and in irradiated bone-marrou protected mice. Similar results шег 
obtained following treatment uith a chemical carcinogen. Spontaneous 
occurrence of preleukemic cells has also been demonstrated in the bone 
marrou of C57BL/6 mice in relation to age increase. Further, bone marrow 
cells from 14 or 30 day old AKR/З mice can induce a high incidence of 
leukemia of AKR/D origin, follouing transplantation into irridiated 
recipients (57,59). Therefore, the initial transformation, spontaneous 
or induced, into preleukemic cells often occurs in the bone marrou rather 
than in the thymus (58). Although the target organ for overt leukemia 
development of most spontaneous or induced murine lymphoid tumors is the 
thymus (25), it does not imply that all phases occurring during thymoma 
development take place in the thymus. Thymectomy prevents leukemia 
development in AKR mice, but this does not a priori indicate that pre­
vention of leukemia development is caused by removing thymic lymphoid 
cells susceptible to neoplastic conversion. These mice carry preleukemic 
cells that are capable of repopulating and causing leukemia development 
34 
in subcutaneous thymus grafts. Since the normal thymus consists mainly 
of turo basic components, a lymphoid component and the epithelium and 
reticulum cell complex, it is very suggestive that these non-lymphoid 
elements effect the conversion of preleukemic cells into leukemic celle 
iidthin the environment of thymic tissue (25,61,97). Several studies 
strengthen this hypothesis; 
a) thymic remnants (mainly composed of epithelial reticulum cells) from 
AKR mice restore a high lymphoma incidence in Gross AKR-virus-infected 
thymectomized mice (54), 
b) leukemic tissues of AKR mice, in contrast to non-leukemic tissues, 
contain enlarged reticulum cells and large phagocytic cells derived from 
reticuloendothelial cells (121); lymphoma cells in contact uith these 
enlarged reticulum cells are shown to have heigher mitotic activity than 
lymphoma cells situated in other sites of the thymic cortex (121). A 
potential problem in these studies was the presence of small numbers of 
lymphoid cells in the reticulum cell preparations that might display a 
high mitotic activity and therefore could have significantly contributed 
to the observed phenomenon. 
In conclusion, several studies suggest that thymic epithelial reticulum 
cells might be considered as a frameurork and favorable site for the 
proliferation of transformed cells (25,53,151,212). The expression of 
xenotropic virus, the putative parental molecules of uhich are involved 
in the formation of recombinant leukemogenic MCF-type viruses, is also 
confined probably exclusively to the thymus; since this xenotropic virus-
expression seems also to be a neccessary step in the process of MuLV-
induced leukemogenesis, its thymus-restricted appearance is also suggestive 
for the framework hypothesis. The interaction of lymphoma cells with 
large reticulum cells embedded in the thymic matrix might be essential 
for the continued proliferation of lymphoma cells in primary lymphomas. 
Whether "Thymic Nurse Cells" play an important role in this process is 
not known. These epithelial cells carry large numbers of engulfed lympho-
cytes which are released after a certain period. TNCs also contain high 
amounts of ñHC-determinants (κ/θ and I-A) and were therefore suggested 
to play a role in the process of "self-recognition" by thymocytes (213; 
see also discussion). 
C) CHANGES IN CELL-SURFACE ANTIGENS. 
Animals show an immune response to the surface of cells infected with 
RNA tumor viruses. This response is due both to 1) the expression of 
viral structural antigens, as well as to 2) virus-induced cell surface 
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antigens (96). The viral structural proteins proved to be markers for 
a classification of different stages that can be seen during leukemo— 
genesis. Noudnski and Doyle (135) divided the amplification of viral 
gene expression as detected by the appearance of viral cell surface 
antigens into four discrete stages: 
1) loid numbers of cells from thymuses of young (2 month old) AKR mice 
express p30 (less than 0.255?) and gp70 (2-75?) antigens; gp70 is only 
expressed on the large cells in the subcapsular region of the thymus; 
this phenomenon was also observed after inoculation of mice uiith RadLU 
or other exogenous MuLl/s (2Θ). 
2) Thymuses of 6 month old AKR mice shou/ a selective depletion of cortical 
thymocytes uiith a concomitant increase in the medullary region of the 
thymus. Increased numbers of cells express an elevated concentration of 
p3D and gp70 antigens. Viral antigens are found on the cell surface of 
all large cells of the subcapsular region of the thymus and in variable 
numbers (2-85^) on small cells of the cortical and medullary regions. 
3) Thymuses of some θ month old AKR mice show selective hypertrophy of 
a single thymic lobe. This enlarged lobe contains a population of cells 
that are intermediate in size between small cortical cells and the large 
leukemic blast cells. These intermediate-sized cells express significant 
levels of p30 and gp70 viral antigens. However, transfer of high numbers 
of these cells (about 10 per injection) to syngeneic hosts did not induce 
transplantable disease, so these cells are not leukemic. It was suggested 
that these cells of intermediate size represent preleukemia cells. 
4) Thymuses of mice with overt leukemia contain primarily large leukemic 
blast cells which probably arise as clonal descendants of one or a few 
preleukemic cells that have acquired transforming capacity. The large 
2 3 leukemic blast cells (10 -10 per injection) are causing leukemia after 
transplantation and they also express high levels of viral antigens on 
their cell surface. The gp70 antigenicity was found in a 70k polypeptide 
on the cell surface and corresponded to the viral envelope protein, while 
the p30 antigenicity was contained in two polypeptides of 85k and 95k; 
these both correspond to glycosylated forms of the polyprotein product 
of the gag—gene. 
The high expression of viral antigens, which is mainly detected on the 
large thymocytes, occurs contemporary with the process of cortical 
inversion (117,135) and this might suggest a causal relationship between 
these two phenomena. 
The age related antigenic changes observed in 5 to 6 month old AKR 
preleukemic thymocytes (in contrast to the 2-month-old thymus) are 
36 
restricted to the thymus and are not found in spleen or lymph nodes. 
The level of xenotropic MuLV is markedly increased (a 100 fold) and 
correlates uiith the amplified expression of MuLV-relatsd antigens (25, 
135), but the amount of ecotropic MuLl/ in 2 and 6 month old AKR thymus 
increases only about a 10 fold (86). 
Additional antigens related to nuLU-Gross (GR„DA:,» ^ Ш П '
 a n d GAKSL2^ 
are detected on leukemias and normal lymphoid tissues of strains like 
AKR, С5 , and СЗН/Гд which all display a high incidence of leukemia, 
GRi.n.T-antigen uias defined by naturally occurring antibodies directed 
predominantly against N-tropic viruses (140), G_DI -antigen by natural 
type-specific antibodies against xenotropic virus (197), and G . „-
antigen by natural antibodies specific for NCF-type dualtropic viruses 
(197). GRflDn-r» G ι , and G -antigens are expressed at Іош levels 
on normal thymocytes of 2-month-old AKR mice like the antigens GCSA and 
GIX (an antigenic determinant on the gp70 molecule; see follouing section). 
All five MuLV-related cell-surface antigens ars amplified on AKR thymo­
cytes at 5-6 months of age. This age-dependent antigen—amplification is 
correlated uiith increased expression of xenotropic MuLl/ and the emergence 
of dualtropic NuLV in the thymus (141). Testing a variety of cloned 
dualtropic viruses from AKR mice shoued three different env-gene pheno-
types: i = и х + / с
Я Д 0 Д І 7 п 7 G A K S L 2 + ; n = GUVG^^/G^/G^^, 
111= G I X / G R A D A I ~ / G E : R L D /GA|<SL2"/. А Н dualtropic isolates induced GIX 
and G_D1 r,, probably reflecting ecotropic and xenotropic characteristics 
respectively in the recombinant env-gene of dualtropic viruses. Viruses 
of phenotypes I and II induced GCSA (indicating an ecotropic NuLV-
derived gag-gene) uhile phenotype III dualtropic viruses displayed only 
partial absorption of GCSA. This indicates that these type III dualtropic 
viruses contain non-ecotropic FluLV sequences which extend into the gag-
gene. Recently, recombinations extending into or near to the gag-gene 
have also been detected by restriction mapping of proviral DMAs of 
several dualtropic viruses (Chattopadhyay, S.K., personal communication). 
In conclusion, AKR dualtropic NuLVs are quite heterogeneous as shoun by 
their different antigen-phenotypes, restriction maps, and also by their 
different infectivities on mouse and mink cells (141). Whan AKR dual­
tropic FluLVs uere tested for their ability to amplify MuLV-relatsd cell 
surface antigens on thymocytes of 6-8 шеек old AKR recipients it appeared 
that antigen-amplification and leukemia-acceleration are tuio distinct 
phenomena. Only dualtropic viruses with phenotypes I and II (GIX /G—. _, / 
G.j,-. _ ) induced antigen-amplification but not all these isolates 
accelerated leukemia development. No marker has yet been found which can 
distinguish between the antigen-amplification and leukemia-acceleration 
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phenomena on a molecular basis. Recently, it mas suggested that there 
might be a correlation between the presence or absence of certain 
restriction sites on dualtropic MuLV prov/iral DNA and leukemia-
acceleration capacities of the respective viruses (Chattopadhyay, S.K., 
personal comminication). These data, however, are to preliminary; viruses 
obtained after transfection of cloned dualtropic MuH/ proviral DNA have 
not yet been tested for their leukemia-acceleration properties. Positive 
results from such experiments would suggest that antigen-amplification 
and leukemia-acceleration are phenomena which can be distinguished on 
a molecular basis (i.e. the exact range which spans the recombination). 
Since the dualtropic MCF-specific antigen G „ „ is also expressed in 
low amounts on AKR thymus and bone marrow at two months of age (197) it 
was suggested that G ia a determinant of a differentiation product 
of lymphoid cells related to a xenotropic NuLV gp70 molecule that also 
contains the Gfll._. „ determinant. Recombinant dualtropic MuH/s that have 
acquired such a cellular gp70 encoding sequence might display extended 
host range properties and antigen-amplification, and also rarely leukemia-
acceleration characteristics. O'Donnell et al., (141) have postulated 
that the hypothetical AKR thymocyte gp70 could be encoded by a genetic 
locus analogous to Gv-1 locus of 129 mice encoding GIX antigen (for review 
see ref. 141). 
2) Virus-induced cell-surface antigens. 
All leukemias induced by Gross AKR virus have a common surface antigen, 
GC5A, while those leukemias induced by rwiuLV and R-CluLV express NCSA 
(66,8Β,Θ9). Antisera to GCSA recognize determinants expressed on the 
viral internal components p30 and pi 5, and is expressed on the cell 
surface in the form of a glycosylated MuLV gag-gene-coded polyprotein 
(99,122,123,186,205), while antisera to I*1CSA recognize an env-related 
protein distinct from the exogenous M-PluLl/ envelope protein (66). In 
M-PluLV-inoculated viremic mice the target tissue for M-PluLV leukemogenesis, 
the thymus primarily, is the first organ to express MCSA. NCSA positive 
cells in lymph nodes or spleen occur only after overt leukemia. NCSA 
positive cells (thymus) are non-malignant since these cells do not grow 
as progressive tumors in syngeneic recipients (81). This indicates that 
NCSA expression is associated with viral gene amplification preceding 
leukemia development i.e. a high level of viral protein expression in 
the preleukemic thymus of AKR mice (85,86,135). 
Another MuLV-Gross associated determinant is the GIX antigen, which 
was initially detected on the lymphocytes of some strains like С5 , A, 
за 
СЗн/Fg, AKR, NZB, and 129 (193,195). GIX is an antigenic determinant on 
the gp70 molecule expressed on thymocytes, sperm, and other tissues from 
several mouse strains, even in the absence of productive viral infection 
(139). The expression of the antigen in the prototype 129 strain is 
dependent on tuo unlinked genes: Gv-1 on chromosome 17 and Gv-2 on 
chromosome 1 (196). The expression of GIX requires the presence of both 
Gv-1 and Gv-2 positive alleles (193). In contrast to 129 strain, in AKR 
mice the Gv-1 locus maps on chromosome 4, suggesting a rather complex 
genetic linkage system (13,74). Earlier observations suggested that only 
ecotropic riuLU could induce the expression of GIX in mice or cell lines 
which have been characterized as shouing no GIX expression (132), but 
more recent studies suggest that GIX gp7D is in fact coded by a xeno-
tropic viral genome (37,203). The GIX specificity differs from GCSA in 
the fact that GIX can be expressed in the absence of replicating virus 
and productive viral infection as in strain 129 (105,138,204). Infection 
by most ecotropic viruses, particularly by N-tropic viruses, generally 
leads to expression of GIX antigen, even in strains classified as being 
GIX like ЭаІЬ/ü (143). The GIX antigen often app-ars on leukemic cells 
even in mouse strains uhnre it is not detectable nn nomai tissue cells. 
Other cell surface changes in spcntaneous and induced murine T-cell 
leukemias are reduced levels of the differentiation alloantigen Thy-1 
and increased levels of H-2 alloantigens (18,85). These are all surface 
characteristics of the minor thymus cell subpopulation and therefore it 
шаэ suggested that these transient changes in thymus subpopulations might 
provide a favorable milieu for the migration of preleukemic cells from 
the site of their induction in the bone таггоы into the thymus (57). 
Antigens of the TL series (TL= Thymus Leukemia; 118), regulated by the 
TLa locus, show irregular expression on thymic lymphoma cells. The TL-
antigen is probably coded for by the TLa locus adjacent to the H-2D locus 
on chromosome 17 (for review see ref. 118). The TLa locus governs cell-
surface differentiation alloantigens which are found on thymocytes of 
some strains (TL ), but not in other strains (TL ). Mice bearing malig­
nancies of T—cell origin do express TL antigens on leukemic cells even 
if the strain is classified as TL-· TL-products resemble the К and D 
products of H-2. There is no known relationship between molecules 
bearing TL antigens and any virus-encoded molecule. The cell-surface 
thymocyte-specific alloantigen TL is expressed on thymocytes shorlty after 
irradiation of C57BL/6 mice. It was therefore suggested that activation 
of the TLa locus occurs during preleuketìic phase of radiation-induced 
leukemogeneais and that TL might be a marker for preleukemic changes in 
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the thymus after X-irradiation-induced leukemogsnesis (194). The TLa 
locus defines several specificities found on thymocytes and leukemic 
cells, but absent from normal peripheral lymphocytes or other tissues. 
The TL specificities seem to be the only ones found exclusively on 
intrathymic T-cells (118). Because of the irregular expression pattern 
of the TL locus during HuLV-induced leukemogenesis its role is still 
obscure in this process. 
LATENT PERIOD OF THE DISEASE. 
The spontaneous and induced development of murine T-cell laukemias is 
characterized by a long latent period up to 9 months in e.g. Balb/ño and 
AKR mice. The characteristic long latency of leukemogenesis is illustrated 
by the follouing examples: 
a) AKR mice display overt leukemia 6 to 9 months after birth, although 
this strain stems from prolonged inbreeding and selection for leukemia 
(the AKR strain is a derivative from the Ak strain (ill) developed by 
Jacob Fürth (43)). 
b) Inoculation of the potent leukemogenic virus RadLU into newborn C57BL 
mice also involves several months before overt leukemia is obvious (55). 
c) Balb/rio and AKR mice, which carry and express M-MuLV and AKR-MuLV 
endogenous provirus respectively, also do not develop leukemia before 
9 months of age, although M-MuLV expression in Balb/Mo mice occurs from 
about 3 weeks after birth (79), and AKR-PluLV expression was detected in 
prenatal AKR mice already. 
d) Inoculation of M-MuLl/ into nauiborn Balb/c and 129 mice also involves 
a long latent period. The length of this period is grossly dependent on 
the number of infectious particles used for inoculation e.g. 10 infectious 
n-PluLV/ particles (аз assayed by XC-plaque formation; 171 ) yield a latent 
period of about 10-12 weeks, while 10-20 infectious particles yield a 
latency of about 6- months (76,163,206). 
These observations suggested that the long latency of leukemia development 
may represent the time required for neoplastic transformation and proli­
feration of target cells, or it may reflect a series of changes occurring 
in both target cells and host. Leukemic cells seem to undergo a series of 
sequential changes defined as phases occurring during tumor development. 
The expression of overt leukemia might depend on the completion of a 
sequence of events involving tumor-cell-host interactions like those 
summarized in the following scheme (modified from ref. 57): 
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Leukamogenie 
treatment 
(chemicals, 
radiation, 
viruses) 
(Preleukemic cells not responsive 
to host factors (e.g. Nude mice: 
no immune respons by T-calls) 
Preleukemic cells controlled by 
host factors: 
1) anti-viral antibodies and 
cell-mediated immune responses 
2) influence by H-2 haplotype 
3) influence by Fv-1 alleles 
4) maternal suppression i 
Cell proliferation 
^ Overt 
leukemia 
Differentiation Changes in 
chromosome 
number i 
A l t e r a t i o n s at DNA-level 
e . g . a m p l i f i c a t i o n of 
p r o v i r a l genomes 
Leukemic ce l ls^ 
1 
Progressive growth of tumor 
Overt leukemia 
The development of overt leukemia can Ьв markedly delayed or aven can be 
suppressed because of the influence of host factors like anti-viral anti­
bodies and cell-mediated immune responses, the H-2 haplotype, the Fv-1 
alleles, and certain not yet molecularly characterized maternal factors. 
1) Anti-viral antibodies and cell-mediated immune responses. 
Lymphocytes and antibodies that react against virus-envelope antigens 
may exert beneficial effects against oncogenesis because they reduce 
viremia and the number of secondary infections (32,68,175). Further, 
such antibodies may kill the virus-infected cells due to the virus-
envelope antigens expressed on the cell-surf ace-membrane (96). 
A factor, uihich also influences the delay of leukemogenesis is the 
transient immunoprevention of preleukemic cell proliferation. Ultimately, 
hoiuever, this proliferation is followed by breakdown of immunity preceding 
overt tumor development. Antiviral neutralizing activity is detected up 
to several weeks before overt leukemia occurs in C57BL/6 mice, injected 
when newborn with RadLU (59,60). The delayed appearance of leukemia in 
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these animals is H-2 linked and involves an arrest of leukemia development 
at the preleukemic stage (57)f so these animals carry immunogenic pre-
leukemic cells (59,60). The abrupt disappearance of antiviral noutralizing 
activity shortly before overt leukemia is not yet inderstood. Such an 
effect might be due for example to a gross imbalence between numbers of 
suppressor T-cells and other T-cells (129). 
Studies nn immunization of mice with syngeneic Moloney lymphoma cells 
also suggested that mainly antibodies to preleukemic cells rather than 
antiviral antibodies р г эе might be able to interfere with preleukemic 
cell proliferation. This antibody response to preleukemic cells may prevent 
or delay overt leukemia development (39,184). However, since antiviral 
antibodies (anti-gp70 and anti-p15E) also neutralize surface—antigens 
of virus-infected cells it is hard to discriminate the biological 
consequences of a pure antiviral and anti-preleukemic-cell antibody 
response. Only preleukemic AKR mice ш г found to contain immunocompetent 
lymphocytes that can participate in different immune reactions, since 
only lymphoid cells from preleukemic AKR mice ш г reactive (62). 
Preleukemic AKR mice also display specific antitumor antibodies and 
a non—T—cell spontaneous antilymphoma killing reaction (50). 
The presence of preleukemic cells at a stage when mice do not shou 
clinical manifestations of a disease has been shown in several mice (57). 
Preleukemic cells present in the bone marrow shortly after X-ray induction 
(61,97) as well as in some of the early spontaneously occurring preleuke­
mic cells in AKR mice have been shown by several criteria to be committed 
precursor T-cells (prothymocytes; 59). Transplantation studies further 
indicated that proliferation of these preleukemic cells is dependent on 
specific host environments (e.g. intact thymus; H-2 haplotype) as con­
trasted to leukemic cells which can proliferate without an intact thymic 
environment (57). 
2) The influence of the H-2 haplotype. 
The capacity of the host to mount an effective immune response is 
markedly influenced by its genetic constitution with respect to the 
major histocompatibility complex, H-2 on chromosome 17 (123,156,158,1B5a). 
This chromosomal region carries closely linked determinants of a great 
number of immunological phenomena (91). The K—end and the D-end genes 
of the H-2 region influence the.occurrence of an effective immune response, 
capable of destroying cells infected with or transformed by type-C viruses. 
The K-end genes seem to exert their effect on the responding lymphocytes, 
while the D-end genes appear to influence the immunogenicity of the virus-
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infected cells themselves (10Θ). The latter is examplified by the follow­
ing observations. The most important immune response to virus-infection 
consists of generation of a population of cytotoxic T—lymphocytes (CTL) 
capable of lysing virus-infected cells (24). The modification of these 
CTLs to killer cells specific for virus-infected target cells appears 
to be dependent on the recognition of tura different types of molecules 
on the stimulating cells: a) certain viral molecules expressed on the 
cell surface and b) molecules governed by the H-2K and/or H-2D genes 
of the cell (114af217)» e.g. Friend-virus-encoded molecules become 
associated with H-2D molecules on the surface of infected cells and 
this protein complex induces the CTL response and is recognized by the 
effector CTL population (10). 
H-2 linked genes also seem to exert an influence on the capacity of 
the host to produce anti-type-C virus antibodies (133,136), Helper T-
cells can recognize viral antigens in association with I-A antigen and 
stimulate B-cells to produce anti-gp70 (133,136). These antibodies can 
prevent virus-spreading to some extent and may therefore also be able 
to delay the leukemogenic process (132,175). This was also shown 
experimentally by injecting anti-gp7D antibodies into neuborn Balb/flo 
(132) and AKR mice (69,175); the largest suppression was observed when 
animals ware injected with antibodies within the first three days after 
birth (178). 
3) The influence of the Fv-1 alleles. 
The non-H-2 linked host gene, Fv-1 (106), is an additional factor which 
is involved in sensitivity or resistance to preleukemic but not to 
leukemic cell proliferation. The Fv-1 gens is involved in the regulation 
of virus-spreading (107,168) and acts at a level before integration of 
viral DMA into the host genome (215). Ths viral targets for the Fv-1 
restriction mechanism are probably located in the gag-proteins p30 and 
p12 (for review see ref.44,27), while also a requirement for intact 355 
genome RNA has been implicated (7). Evidence has been presented that a 
complex between the pol-gene-product and p30 may enhance reverse trans­
criptase activity (4). Although the Fv—1 alleles regulate at a level 
before integretion of viral DNA into host cell DNA, the different alleles 
fall into two classes according to their effect on altered viral DNA 
formation in с ЭІз with restrictive Fv-1 alleles: 1) in Fv-1 (DBA/2) 
cells inoculated with B-tropi3 virus, as uell as in Fv-1 (Balt/o and 
C57BL/6) cells inooulated with N-tcopic virus, the generation of two 
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CQUalüntly closed circular siip^ rcoildd v/tral DNA duplex (form I) was 
dnprossed but linear full-length viral DMA duplex (form III) was synthe-
sized in normal quantities. 2) In Fu-1 (NIH Swiss mouse embryo) cells 
inoculated with B-tropic virus, synthesis of fcnim III viral DNA mas 
markedly inhibited. Also, B-tropic virus that is able to escape restric-
tion in DBA cells by mutating to the NB -phenotype, is still restric-
ted in NIH cells (106). Peptide analysis of p30 also revealed that the 
change from B-tropic to NB -tropic and to NB -tropic is associated 
with tura different changes in primary structure of p3D (44). Since the 
Fv-1 locus can regulate to some extent preleukemic cell proliferation 
it mas suggested that a second viral event might be involved in the 
process leading to autonomous proliferation (57). 
The influence of factors like H-2, Fv-1, and a maternally transmitted 
resistance factor have mainly been studied by using different combinations 
of mouse crosses. The Fv-1 locus on chromosome 4 is кпошп to have several 
alleles, operating both in vivo and in tissue culture cells. Fv-1 
defines susceptibility to B-tropic virus and relative resistance to N-
tropic virus replication uihereas Fv-1 cells are relatively much more 
susceptible to N-tropic virus replication. Different types of Fv-1 
alleles are also кпошп which define different susceptibilities to N-
tropic virus replication. The Fv-1 allele of AKR mice dictates a 
very high suaceptibility to N-tropic virus replication. The Fv-1 allele 
present in RF mice gives rise to similar leuœls of resistance to B-tropic 
MuLV infection as the Fv-1 allele and therefore both alleles have 
been designated as N-type alleles (115,157). Ноше г, the Fv-1 allele 
confers resistance to spontaneous AKR-nuLV-induced lymphoma in crosses 
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with AKR mice (115). AKR mice (Fv-1 ;H-2 ) show high levels of infectious 
MuLV in tissues at 6 weeks of age and near 100$ leukemia at Θ-12 months 
of age. In Balb/c χ AKR (Fv-1 ' ; H-2 χ Fv-ln'n; H-2 ) mice, however, 
both the occurrence of virus and the incidence of spontaneous lymphoma 
are suppressed to very low levels (4$ after 1 year; 107). This suppression 
of AKR-MuLU-induced lymphomagenesis is mainly due to the Fv-1 allele 
inherited from the Balb/c parent, since this allele grossly prevents 
spreading of the endogenous N-tropic AKR virus derived from the AKR 
parent. Also, the Fv-1 allele of the AKR parent prevents spread of B-
tropic viruses that might arise from recombination between endogenous 
xenotropic MuLV and N-tropic AKR-MuLV (45,63,87,155,165). 
nice of the Balb/flo χ AKR/FU (H-2d| Fv-1b'b χ Н ^ ; Fv-ln'n) cross 
show a high incidence of leukemia at 6-9 months of age like AKR and 
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Balb/no mice. Tumor DMAs contain only reintegrated authentic M-PluLl/ 
and recombinant MuLV/ proviruses derived from the NB-tropic endogenous 
M-PluLl/ genome (no restriction by Fv-1 ' ) in Balb/Mo mice. Therefore, 
only the NB-tropic M-nuLU of the Balb/no parent is able to amplify 
and yield recombinant proviral DMAs while endogenous AKR-CluLV sequences 
are restricted by the Fv-1 ' genotype of the F1 mice (our unpublished 
results). Studies on (Balb/c χ AKR) Χ AKR backcross mice revealed further 
that there is also a marked correlation between FluLV titer and leukemia 
incidence, the animals with the highest titer showing the highest and 
also the earliest incidence of leukemia (107). These studies revealed 
in addition a marked influence of the H-2 haplotype (107,168): the H-2 
allele was found to suppress lymphomagenssis to a large extent (almost 
50$ in Fv-1 ' mice). The mechanism by which the H-2 allele exerts its 
suppressing activity on lymphomagenesis is probably similar to the one 
discussed in section b: the generation of a population of cytotoxic 
T-lymphooytas (CTL), ishich recognize virus-infected cells via an 
Н-2-viral-product combination on the surface of infected cells. Leukemia 
is also known to occur somewhat more frequently among females than among 
males of the AKR strain, although the backcross studies mentioned above 
did not reveal a significant difference between sexes. The H-2 type 
was further shown to have little or no effect on the early expression 
of MuLV in the backcross mice and its influence is presumably caused by 
immunosurveillance of CTLs on the outgrowth of transformed cells. 
4) Claternal effects on suppression of lymphomagenesis. 
The maternal effect of suppressing leukemogenesis was first observed 
in (Balb/c χ AKR)F1 X AKR mice crosses and other crosses with Fv-1 mice, 
Suppression was only observed in F2 animals when the mother was the Fv-1 
heterozygote (F1). According to the following scheme 50$ of the F2 mice 
are Fv-1 ' and these mice show a marked suppression of lymphomagenesis 
by maternal factor(s): 
50$ F2: Fv-1 ' : suppression 
4 by maternal 
(β Balb/c χ
 e
"AKR)F1 { X «/"AKR / faotor(s) 
'A , 
50$ F2: Fv-I n / : N-tropic 
virus is 
restricted 
by dominant 
Fv-1 allele. 
Fv· '-l
n/b Fv-1n/n 
45 
Absent" 
No expression or 
no replication 
(Fu-I allele of 
Qalb/Πο mouse 
suppresses N-tropic 
AKR-NuLV replication) 
Balb/Pio mouse strain 
Γ 
Endogenous virogenes 
.Present: 1) n-MuLV 
2) AKR-MuLV 
3) xenotropic I»luLl/ 
4) gp70—encoding genes e.g. defective 
xenotropic MuLV 
No suppression of replication 
BONE 
MARROU 
Transient expression of Mov-I M-CluLV 
secondary infections 
Infection of target cells of T-lineage 
I 
A m p l i f i c a t i o n of M-fluLU рго і г э і DNA 
THYMUS 
PRELEUKEMIC CELLS: 1) contain "randomly" integrated FI-MuLl/ 
copies 
2) no clonal expansion: 
a) not yet transformed by MCF 
b) immuno-surveillance 
Expression of other virogenes and/or virus-related genes: 
1) xenotropic MuLV at about 3 months of age 
2) other gp70-encoding genes e.g. the gene coding for the 
G -determinant (defective xenotropic MuLV ?) 
Replication of Cl-MuLV and expression and/or replication 
of xenotropic information in one cell 
-recombination 
Chronic immune stimulation 
1) a variety of MCF-type viruses are generated 
2) provides a large population of putative target cells 
3) immunoselection of MCF-type viruses 
Result: Transformed cells by: a) recombinant gp70 
b) promoter-insertion 
Disappearance of anti-viral neutralizing activity shortly 
before overt leukemia 
Clonal expansion of transformed cells containing M-MuLl/ and 
MCF 
Metastasis 
Outgro'in tumors: largely composed of descendants of one or a 
feu transformed cells 
Figure 4: Cascade model for tumor formation in Balb/Мо mice. 
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Similarly, the effect was obaerued in crosses of RF mice with AKR mice 
after backcrossing with AKR in the Γ2 generation (116). RF mothers 
transmit two lymphoma—suppressing factors, Fv/-1 allele and a maternal 
factor(s). The effect generated by the maternal factor(s) is transmitted 
from Fl mothers to F2 generation but not by Fl males, although the 
inhibition is seen in both sexes. In crosses of RF mothers with AKR 
fathers also a potent suppression of endogenous ecotropic MuLV expression 
is passed to their offspring by RF mothers. This effect was shown not to 
be transmitted to the (RF χ AKR) χ AKR backcross like the suppression of 
lymphoma. This indicates that there are in fact two different maternal 
effects probably mediated by two different factors. One maternal factor 
was suggested to represent an antiviral antibody. It was also concluded 
from such data (6,116) that high ecotropic MuLV expression seems to be 
necessary though not sufficient for development of spontaneous lymphoma. 
The maternal suppression of lymphoma seems to influence only the 
spontaneous occurrence of the disease since it was not observed for 
leukemias of RF mice induced by AKR Gross passage A virus, 3-methyl— 
cholantrene, and X-ray irradiation (116). 
DISCUSSION. 
The data summarized in this review indicate that many genetic factors 
from both host and virus are involved in the generation of MuLU-induced 
lymphomas. However, one can reduce the sequence of events to basically 
two steps: 1) the formation of preleukemic cells, and 2) the clonal out­
growth of preleukemic cells which have acquired leukemogenic properties. 
A cascade model shown in Figure 4 contains most of the data summarized 
above and places all the observed phenomena associated with leukemogenesis 
in a prospective order; since the different phenomena associated with 
leukemogenesis were actually observed in many different animal systems 
the sequence of events might show unique features in each strain which 
develops leukemia. The viral (FI-nuLV) etiology of leukemogenesis in 
Balb/do mice is shown as an example although probably the same scheme 
applies to Balb/c and 129 mice infected uhen newborn with M-PluLl/, to 
Г1(Ва1Ь/Мо χ AKR) mice, to AKR-HuLV-induced leukemias of AKR mice, and 
in general to mice which show MCF-type virus-expression during leukemo­
genesis (for review see Figure 1). Uhebher radiation-induced leukemias 
follow also part of this scheme or take a different route is not yet 
clear. The finding of recombinant qp70 molecules on the cell-surface 
of radiation-induced leukemias in NIH Suiiss mice, without concomitant 
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expression of virus, strongly suggests thet the etiology of these leukemias 
is associated u/ith the expression of dualtropic-MuLV-like gp70 molecules. 
Preleukemic cell formation. 
The basic molecular mechanisms which are associated with the formation 
of preleukemic cells which can be potentially transformed are not known. 
Preleukemic cells of N-PluLV-inoculated mice or Balb/do mice do show 
random integration of authentic M-MuLV genomes. Therefore it is not very 
speculative to assume that an effect caused by reintegrated authentic 
M-PluLV genomes is responsible for the formation of preleukemic cells in 
these mice. It might well be that preleukemic cells are in fact generated 
by the integration of an authentic Cl-CluLV genome in a limited number of 
chromosomal DNA sites o F lymphocytes. Such an integrated M-PluLV provirus 
might exert an effect by promoter-insertion or by some other mechanism 
disturbing cellular gene regulation e.g. the induction of cell-surface 
receptors. Promoter-insertion (i.e. the viral promoter in the large 
terminal repeat is used to transcribe a nearby cellular gene like a 
potentially transforming gene) was shown for Avian leukosis virus-induced 
3-":ell lymphomas in birds (130,131,149). The integration of an authentic 
M-MuLV in a limited number of different chromosomal sites in cells of the 
T-lineage might in fact explain the phenotypic heterogeneity of H-MuLU-
induced lymphomas (as detected by heterogeneity in cell-surface diffe-
rentiation antigens). However, this heterogeneity could also be explained 
by the variation in recombinant proviral DNA structures integrated in 
different tumors as discussed below. RNA-analyses of a variety of MuLV-
induced lymphomas will hopefully solve the issue whether or not authentic 
and/or recombinant MuLVs are involved in promoter-insertion. 
The switch from preleukemic to leukemic state. 
The mechanisms involved in the switch from preleukemic to leukemic 
state are still speculative. Several hypotheses have been postulated. 
The acquisition of leukemic potential by preleukemic cells reflected 
by the property of autonomous proliferation might occur via: 
1) a differentiation or dedifferentiation sequence, 
2) via somatic mutations, 
3) via chronic immune stimulation which is the driving force for the 
selection of leukemogenic recombinant viruses. 
Most data summarized in this review support the last hypothesis as 
discussed below. 
1) A differentiation or dedifferentiation sequence. 
Since many T-cell leukemias are cheracterized by proliferation of cells 
which are not fully differentiated T-cells one can imagine that a block 
in differentiation or even a dedifferentiation of such cells gives rise 
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to an accumulation of cells at certain rlevelopmental stages: feed—back 
control systems of mature cells or in general systems that regulate grou/th 
and size of T-cell populations could be suppressed. Houeuer, the observed 
v/ariation in differentiation stages involved in T-cell leukemogenesis 
is probably due to secondary effects: many tumors of different origin 
express antigens of embryonic origin (125) and this is probably due to 
a gross imbalence in gene regulation. 
2) Somatic mutations. 
Mutagenic agents have been shown to confer autonomy to preleukemic cells 
i.e. prcliferation in both normal and irradiated recipients (57). Different 
kinds of somatic changes conferred to tumor tissues can be observed like: 
a) chromosomal rearrangements or duplications e.g. trisomy 15 observed 
in spontaneous T-cell leukemias of AKR mice and radiation—induced 
leukemias of C570L/6 and 129 mice (31,187,214), but not in non-T-cell 
lymphomas (90); deleted or translocated chromosomes among X-ray-induced 
thymomas (31,214). b) Somatic amplification and reintegration of both 
authentic and recombinant proviral genomes in M-fluLlZ-induced tumors (159, 
206). Either шау of gene amplification (a or b) might give rise to an 
imbalence in gene products which contributes to autonomous proliferation 
of cells. It is also not very imaginary that the expression of dualtropic 
virus-specific receptors requires first somatic mutations or gene 
rearrangements in the receptor-coding sequences of the target cell; such 
a mechanism uas shoun to contribute to the variation in heavy chain 
variable regions in response to antigen (12). 
3) Chronic immune stimulation which is the driving force for the selection 
of leukemogenic recombinant virus. 
It might uell be that the suitch from preleukemic to leukemic state is 
determined by the results of a selection mechanism which eventually yields 
a recombinant virus that causes leukemia. Selection of a recombinant 
virus could probably occur via chronic immune stimulation by preleukemic 
cells. Chronic immune stimulation seems to be requir^H for loul^ emotjeiiesis 
sir оь il IVÎS been shown that CBA/N mice, when inoculated with M-CluLU as 
newborns, develop an acute viremia but do not develop leukemia or have 
detectable T-cell responses against the virus (100). The hypothesis that 
an immune response is required to generate appropriate target cell popu-
lations for virus-infection and/or transformation has been formulated as 
follows: 
a) acute viremia and expression of viral antigens leads to continuous 
recruitment of antigen-reactive T-cells, 
b) these T-cells produce a variety of soluble lymphokines which influence 
the proliferation and differentiation of cells of the immune system 
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(macrophage activation, proliferation of early T-cells, thymocyte differen-
tiation and maturation), 
o) such a chronic state of proliferation and differentiation might increase 
the probability of spontaneous events leading to transformation e.g. 
trisomy 15 (31,1B7,214) and might also be the driving force for selection 
of a recombinant virus. The result of such a selection mechanism seems to 
be a leukemogenic recombinant virus. 
The mechanism by which these recombinants are generated and selected 
are not yet understood. The generation of recombinant FICF-type viruses 
could be explained by molecular recombination betueen viral and cellular 
RNA in certain cells resident in the thymus. For the moment it remains 
unclear whether different cell types are involved in the formation of 
recombinant viruses. A rather straightforuard hypothesis defines pre-
leukemic cells as the original producers of recombinant MuLV« Preleukemic 
cells do contain "randomly" integrated M-CluLV genomes in Balb/do mice 
and M-MuLV RNA expression is probably restricted to these cells. The 
same preleukemic cells probably express xenotropic-MuLU-like information; 
its expression might be induced or enhanced by the ecotropic M-fluLV. 
Subsequently, recombination on RNA level could generate a great variety 
of recombinant viruses. Some of these viruses might superinfect pre-
leukemic cells uhich contain already M-fluLV copies, or might infect other 
target cells that are resident in the thymus. The thymic environment might 
be essential in this respsct since it regulates differentiation of lympho-
cytes into various phenotypically different cell types uith many different 
cell-surface receptors. Some of these receptors display affinity for MCF-
like gp70. Superinfection of a preleukemic cell by a recombinant and 
subsequent clonal growth of such a cell uould explain the finding of 
both integrated recombinant and authentic Pl-MuH/ in DNA from cells of 
outgrown tumors. Houever, pseudotype formation of authentic and recombi-
nant n-HuLU could also explain the presence of both types of proviral 
DNA in cells of outgrown tumors. Cells infected by such pseudotype virions 
would contain both authentic and recombinant CluLV genomes. Since cells 
in outgrown tumors of both AKR and Balb/Mo mice seem to express 
simultaneously antigenic determinants characteristic for both authentic 
and recombinant MuLU, it is very unlikely that different cell populations 
exist which contain either authentic or recombinant MuLV. 
The selection of a particular type of recombinant virus might be in-
fluenced by several factors. Since recombinant viruses have been isolated 
which carry recombinations extending into the gag-gene a selection a 
priori on the recombinational level does no1: seem to exist. The most 
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p l a u s i b l e explanat ion i s i n fact t h a t the recombinational event i s more 
or less random, generating a great variety of recombinant s t r u c t u r e s . 
Many d i f f e r e n t recombinant viruses are at t h i s stage produced by c e l l s 
i n the thymus. At t h i s l e v e l s e l e c t i o n for c e r t a i n types of recombinant 
v i ruses might occur: 1) recombinant viruses could be selected for t h e i r 
property to i n f e c t t a r g e t c e l l s which subsequently become transformed. 
Only recombinants u i t h c e r t a i n env-gene structures might be able to 
i n t e r a c t wi th thymocyte receptors (100,113,117,177,180). Chronic immune 
s t i m u l a t i o n would be required e i t h e r t o generate a populat ion of thymo­
cytes heterogeneous with respect to t h e i r c e l l - s u r f a c e receptors or to 
the MCF-type v i r u s which they produca. Selection f o r c e r t a i n recombinant 
v i ruses could be in f luenced by immuno—surveillance. P r e f e r e n t i a l se lect ion 
of recombinant v i ruses seems to occur uhich contain envelope antigens 
t h a t are mainly derived from the h o s t . This might have two advantages 
f o r the v i r u s . F i r s t , by exposing i t s e l f to the host environment via a 
host-der ived envelope p r o t e i n the v i r u s uould mora e a s i l y survive immuno-
s u r v e i l l a n c e by a d a p t a t i o n . Secondly, by using a host-der ived protein 
which se lects f o r receptors on thymocyte c e l l - s u r f a c e the v i rus would be 
able to i n f e c t c e l l s t h a t express ce l l -surface receptors f o r t h i s host-
p r o t e i n . 
The hypothesis based on chronic immuno-stimulation and select ion f o r 
leukemogenic recombinant v iruses explains the c o n s t i t u t i v e f i n d i n g of 
a c e r t a i n type o f recombinant p r o v i r a l DNA s t r u c t u r e i n a l l outgrown 
tumors (159,206). The data do n o t , Ьоше г , explain the transformed 
character o f lymphocytes which carry integrated recombinant p r o v i r a l 
genomes. The f o l l o w i n g remarkable features of MCF-type p r o v i r a l DNA 
s t r u c t u r e s which are c o n s i s t e n t l y detected i n DNA from outgrc jn tumors 
of both M-MuLV and AKR-duLV induced leukemias may shed more l i g h t on t h i s 
case. A l l MCF-type recombinant p r o v i r a l DNAs (both i n t e g r a t e d and un-
i n t e g r a t e d ) d i s p l a y a Bam HI r e s t r i c t i o n s i t e at p o s i t i o n 6.3 kbp from 
the S'-end, Recently several r e s t r i c t i o n maps of endogenous xenotropic 
v i ruses have become a v a i l a b l e . None o f the inducib le xenotropic p r o v i r a l 
genomes c a r r i e s a Bam HI s i t e at posi t ion 6.3 kbp. However, such a s i t e 
was detected i n cloned p r o v i m i DNAs of the non-inducible xenotropic 
MuLU-ol^ss v iruses which are present i n genomes of most mice l i k e also 
i n NIH Swiss mice (D.M. Young, personal communication). These non-
i n d u c i b l e xenotropic-MuLV-like sequences seem to represent defect ive 
p r o v i r a l genomes. They could be c e l l u l a r genes coding f o r e . g . thymocyte 
gp70 molecules which are r e l a t e d to the G ., -determinant, the antigen 
which i s detectable at low l e v e l s on e.g. 2-month-old AKR thymocytes. 
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Therefore, it is likely that this class of endogenous viral sequences 
provides the neu вп -д пв sequences in leukemogenic MCF-type viral 
genomes. This is supported by the finding of a recombinant-CluLV-gpTO 
on radiation-induced thyraomas in Suiss mice. The recombinant gp70 on 
these lymphomas uas shown to contain peptide characteristics of the gp70 
of the non-inducible xenotropic-fluLV-claas (40). From these data it can 
be suggested that gp7Q may be a transforming protein by itself. In fact 
the finding of such a recombinant gp70 on radiation-induced leukemias in 
Swiss mice without concomitant virus-replication supports this hypothesis. 
The high amount of recombinant gp70 molecules on the membrane of lympho­
cytes could be the cause of the transformed phenotype by changing 
physiology of a cell and/or cell-to-cell interactions. It might be that 
a recombinant gp70 molecule contains the information that uould be 
sufficient to specify the distinctive and characteristic phenotypes of 
leukemic cells (51,95,114,152,183,218). The phenotypic heterogeneity of 
PluLV-induced T—cell leukemias uould explain following observations. 
Certain recombinants are leukemogenic u/hile others are not (110,169); 
either the gp70 of the non-leukemogenic recombinants can not bind to the 
proper receptor of thymocytes (117,177) or ot lacks the transforming 
character. Different inbred strains of mice might encode genetic variants 
of these receptors and this would explain why a particular recombinant 
virus is not leukemogenic in some strains but leukemogenic in other strains 
(20,51,169,177). Also, within one mouse different preleukemia cells could 
carry different receptors and might therefore display cell-specific 
differences concerning susceptibility to transformation by recombinant 
viruses. Since HCF-type viruses have not only been isolated from T-cell 
lymphomas, but also from myelomas, erythroleukemias and recently also 
from mice showing neurological diseases and non-T-cell lymphomas their 
role as tumor-causing agents in general in mice becomes very likely. 
First, recombinant viruses or proteins display clearly tumor-associated 
appearance. Secondly, the heterogeneity in recombinant proviral DNA 
structures of the env-gena could well explain the great variety in 
malignancies. For example, the recombination in Moloney-MCF type viruses 
clearly involves the amino-terminal part of the env-gene and probably 
even the whole gp70-encoding region, Ho-PlCF-type viruses are associated 
with T-cell leukemias. The AKR-PICF type viruses display similar charac­
teristics. Rauscher HCF, however, is characterized by a recombinant env-
gene structure that carries newly acquired sequences in the middle part 
of the env-gene whereas the amino-terminal part is derived from the 
ecotropic parent. R-flCF is associated with erythroleukemias. 
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Finally, um are left uith the que-tion houi a particular cell type gaines 
its transformed character. Тыо main hypotheses remain still open to explain 
transformation : 
1) the recombinant gp7D molecules might be the actual transforming agents, 
or 
2) transformation is caused by newly acquired sequences in MCF-type genomes, 
that are located more proximal to the S'-end of the иігэі genome; most 
leukemogenic nCF-type proviral DNAs carry xenotropic-PluLV-like sequences 
in their S'-large terminal repeat ii/hile the pISF-encoding sequences are 
mainly derived from the ecotropic parent. The acquisition of "xsno-like" 
sequencer in the LTR could be responsible for an enhanced promoter 
activity of sequences in the LTR. The З'ЧТВ of en integrated MCF-type 
provirus might therefore function as a strong promoter for neighbouring 
cellular gequences (putative cellular transforming genes). 
Although most data support the first hypothesis, additional experiments 
including RNA-analyses and testing of a variety of cloned recombinant 
proviruses will ultimately resolve this matter. 
In conclusion, the results summarized indicate that M-fluH/ and AKR-CluLV 
induced leukemogenesis is associated with clonal outgrowth of tumor cells, 
containing somatically acquired [*ICF-type viruses. These MCF-type HuLVs 
are probably generated via random recombination with a particular sequence 
expressed in certain cells. Chronic immune stimulation is a necessary 
driving force. Probably the same xenotropic-CluLlZ-like cellular sequence 
is involved in the formation of different NCF-type viruses which are 
derived from the same parental CluLl/. The heterogeneity of nCF-type 
viruses is due to the mechanism (random rscombination) by which these 
viruses probably do evolve. 
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Summary 
Specific cDNA probes of Moloney and AKR murine 
leukemia viruses have been prepared to character-
ize the provlral integration sites of these viruses in 
the genomes of Balb/Mo and Balb/c mice. The 
genetically transmitted Moloney provlrus of Balb/ 
Mo mice was detected in a characteristic Eco RI 
DNA fragment of 16 ж 1 0 e daltons. No fragment of 
this size was detected in tissue DNAs from Balb/c 
mice infected as newborns with Moloney virus. We 
conclude that a viral Integration site, occupied in 
prelmplantation mouse embryos, Is not necessarily 
occupied when virus Infects cells in post-natal ani­
mals. Balb/Mo and Balb/c mice do carry the AkR 
structural gene in an Eco RI DNA fragment of 12 χ 
1 0 * daltons. Further restriction analysis of this frag­
ment Indicated that both mouse lines carry one 
AKR-type provlrus. Leukemogenesls In Balb/Mo 
and newborn infected Balb/c mice is accompanied 
by reintegration of Moloney viral sequences in new 
chromosomal sites of tumor tissues. Part of the 
reintegrated Moloney viral sequences are of sub-
genomlc size. The AKR viral sequences, however, 
are not found in new sites. Further restriction anal­
ysis revealed that the development of Moloney vi­
rus-induced leukemia in B a l b / M o mice does not 
lead to detectable structural alteration of the ge­
netically transmitted Moloney and AKR structural 
genes. Possible mechanisms of the reintegration 
process are also discussed. 
Introduction 
A mouse line (Balb/Mo) has recently been established 
which carries Moloney murine leukemia virus (M-
MuLV) as an endogenous virus (Jaenisch, 1976) The 
virus is transmitted from parent to offspring according 
to Mendelian expectations B a l b / M o mice carry the 
virus at a single Mendelian locus (Jaenisch, 1977). 
This locus has recently been mapped on chromosome 
number 6 of the Balb/Mo mouse genome (Breindl et 
al., 1979). 
Directly after birth, Balb/Mo mice express high 
titers of M-MuLV in the blood, and after a latency of 
several months they develop a thymus-dependent leu­
kemia (Jaenisch, 1977) Leukemogenesis is accom­
panied by amplification of M-MuLV sequences in tu­
mor tissues, whereas no amplification could be de­
tected in nontumor tissues (Jaenisch, 1979) This 
phenomenon is characteristic for Balb/Mo mice, since 
Balb/c mice normally do not spontaneously develop 
thymus-dependent leukemias before two years of age. 
When newborn Balb/c mice are injected with exoge­
nous M-MuLV, however, a thymus-dependent leuke­
mia follows the expression of high titers of the virus in 
the blood Moloney virus-specific sequences are 
found primarily in tumor tissues such as spleen and 
thymus, while none could be detected in nontumor 
tissues like brain and muscle (Jaenisch, Fan and 
Croker, 1975) Balb/Mo and Balb/c mice also carry 
an endogenous ecotropic virus which can be recog­
nized by a probe specific for AKR virus (Chatto-
padhyay et al , 1974; Berns and Jaenisch, 1976). 
This study was undertaken to analyze, on a molecular 
level, the structural relationship between the endoge­
nous M-MuLV and AKR-MuLV sequences in Balb/Mo 
mice. It was also our aim to characterize the integra­
tion sites of the somatically acquired M-MuLV copies 
in DNAs from tumor tissues and their relationship to 
the endogenous Moloney and AKR-type sequences. 
For this purpose, cDNA probes were prepared which 
could distinguish specifically M-MuLV and AKR-type 
sequences, respectively. These probes were used in 
an experimental design which allows the detection of 
single-copy genes among restriction fragments from 
cellular DNAs ; 
Results 
Characterization of Moloney and AKR cDNA Probes 
Two different cDNA probes were used in these exper­
iments to detect different sets of viral-relatea Se­
quences For both viruses, the cDNA probes were 
synthesized with the endogenous polymerase reaction 
(Fan and Baltimore, 1973) in the presence of random 
calf thymus DNA primer (Taylor, lllmensee and Sum­
mers, 1976) which yielded DNA fragments from 1 0 0 -
500 nucleotides long. 
The cDNAs obtained are highly representative and 
protect labeled viral RNA at low DNA.RNA ratios (Tay­
lor et al , 1976). To remove sequences that cross-
hybndize with sequences of endogenous mouse vi­
ruses, specific cDNA probes for M-MuLV and AKR-
MuLV were prepared as described, for preparation of 
specific M-MuLV cDNA, the total M-MuLV cDNA was 
absorbed with Balb/c mouse DNA (Jaenisch, 1977), 
and for preparation of cDNA specific for AKR-MuLV, 
the total AKR cDNA was absorbed with 129 mouse 
DNA, which does not contain the AKR-endogenous 
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virus (Berns and Jaenisch, 1976) The AKR-specific 
probe was further selected by hybridization to mer-
curated Moloney 70S viral RNA to absorb sequences 
which cross-hybridize with Moloney viral RNA Du­
plexes were removed by binding to an SH-agarose 
column (Woo et a l , 1977) as described in Experimen­
tal Procedures The characteristics of the nonselected 
and selected M-MuLV and AKR-MuLV-specific probes 
are summarized in Table 1 
For both specific probes, it has already been sug­
gested that these represent 30-35% of the respective 
viral genomes (Berns and Jaenisch, 1976, Jaenisch, 
1977) The sequences present in the Moloney-spe-
cific cDNA probe were found to recognize sequences 
on restriction enzyme DNA fragments which were 
mapped on the 3' and 5' end, as well as on the middle 
part of the nomntegrated linear M-MuLV proviral DNA 
(Yoshimura and Weinberg, 1979, A J Berns et al , 
manuscript in preparation) The probe displayed some 
preferential hybridization to the fragments which were 
mapped in the main loop structure of the heteroduplex 
between Moloney and AKR (Chien et al , 1978, A J 
Berns et al , manuscript in preparation) 
M-MuLV Sequences in Nontumor Tissues 
To map the Moloney proviral genome, DNA from Balb/ 
Mo mice was digested with Eco RI This enzyme does 
not cleave in vitro synthesized, full-length M-MuLV 
DNA (Verma and McKennett, 1978) Thus the size of 
cellular Eco RI DNA fragments containing Moloney 
proviral sequences will depend upon the occurrence 
of an Eco RI recognition site in the cellular sequences 
flanking the integrated provirus Proviruses integrated 
in different chromosomal sites will therefore in most 
cases be found in differently sized DNA fragments 
Mouse DNA was prepared as described in Experimen­
tal Procedures, and the fraction of DNA with a molec­
ular weight >25 χ 106 daltons (>90% of the prepa­
ration) was separated from lower molecular weight 
DNA by sedimentation through a sucrose cushion By 
using this purified DNA as a source for restriction 
enzyme analysis, we were able to rule out the possi­
bility that the detected Moloney proviral sequences 
were derived from unmtegrated proviral DNA mole­
cules Liver DNA (100-150 μς) from Balb/Mo mice 
Table 1 Cbaractenstlce of the Nonselected and Selected M MuLV and 
Cell DNA 
129 
NT 
52 
NT 
6 
AKR 
60 
94 
NT 
56 
was digested with Eco RI, and the fragments were 
separated on 0 4% neutral agarose gels (McDonell, 
Simon and Studier, 1977) DNA in gel fractions was 
analyzed for the presence of viral DNA sequences, as 
described in Experimental Procedures A single peak 
of hybridization was detected among fragments of 16 
x 10° daltons This position was localized between 
the Eco RI fragments of Ad5 and Ad2 viral DNAs of 
17 2 χ 106 and 13 6 χ 10e daltons, respectively, and 
estimated by interpolation to be 16 χ 10e daltons, as 
shown in Figure 1 
Moloney sequences of this size were consistently 
detected in Eco RI DNA fragments from Balb/Mo 
DNAs extracted from different tissues such as brain, 
liver and kidney No hybridization could be detected 
in Eco RI fragments isolated from DNAs of uninfected 
Balb/c mice This indicates that a specific M-MuLV 
cDNA probe does not recognize other endogenous 
viral sequences of Balb/Mo and Balb/c mice 
The detection of an Eco RI fragment carrying M-
MuLV-specific sequences confirms genetic studies 
which indicated that a single Mendehan locus for M-
MuLV is present in the genome of Balb/Mo mice 
(Jaenisch, 1976, 1977, Bremdl et al , 1979) Results 
obtained from restriction enzyme analysis using Hind 
III (see below) suggest that there is only a single Eco 
RI DNA fragment of 16 χ 106 daltons that carries M-
MuLV proviral sequences As a consequence, we 
conclude that the 16 χ 10е dalton fragment corre­
sponds to the genetically defined Mov I locus on 
chromosome number 6 (Bremdl et al , 1979) 
Results obtained using a nonspecific Moloney 
cDNA probe indicated a very extensive sequence 
homology of the Moloney genome with endogenous 
sequences present in the genomes of Balb/c and 
Balb/Mo mice The hybridization profile obtained with 
a nonspecific probe roughly followed the E260 profile 
of the distributed Eco RI DNA fragments in the gel, 
emphasizing the necessity of using specific probes 
for the detection of M-MuLV sequences 
Moloney Viral Sequences in Tumor Tissues 
It has been shown that the number of M-MuLV copies 
is increased from 1 up to 3-4 per haploid genome 
equivalent in tumor tissues of Balb/Mo mice (Jaenisch 
MuLV CDNA Probes 
Viral RNA 
Balb/Mo Mol 70S AKR 70S 
69 98 4B 
78 52 99 
75 88 4 
52 2 70 
Figures are given as perceniage of hybridization Cell DNA and viral RNA were In vast excess Hybridizations were carried out as described m 
Experimental Procedures (Berns and Jaenisch 1Θ76 Jaenisch 1977) 
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Figure 1 M MuLV Sequencee in Nontumor Tissues (Brain Liver) of 
BalD/c and Balb/Mo Mice 
Celtular DNA was extracted from mouse tissues purified from low 
molecular weight molecules (<25 ж 10 e dallons) 150 μο were 
digested with Eco RI and ttie differently sized DNA fragments were 
monitored for Ihe presence of M-MuLV-type sequences as described 
in Experimental Procedures The results are expressed as percentage 
of hybridization (as measured by nuclease SI resistance) The mo­
lecular weights indicate the positions of fragments of the genome of 
Ad2 generated by separate cleavage with the endonucleases Eco RI 
a n d Bam HI (Berk and Sharp 1Θ77) run In an adiacenl channel The 
sizes of these fragments indicated In units of dalton mass were used 
as standards 
et al , 1975. Jaenisch, 1979) We undertook this 
investigation to determine whether there exist specific 
integration sites for these amplified sequences Fur­
thermore, we studied the relation between the somat­
ically acquired copies and endogenous viruses 
The distribution of M-MuLV-containmg fragments 
from tumor DNAs was changed dramatically as com­
pared with normal tissues All tumor DNAs tested 
contained Moloney-specific sequences among Eco RI 
DNA fragments of 16 x 1 0 e dallons In addition, 
however, many Eco RI DNA fragments containing M-
MuLV sequences were detected in the molecular 
weight range from 4 χ 10" up to 12 χ 1 0 e daltons, as 
shown in Figure 2 These additional M-MuLV se­
quences were not detected under 25 χ 10 e daltons 
in undigested tumor DNA preparations Trapping of 
unmtegrated M-MuLV proviral sequences was ex­
cluded by loading low amounts of undigested DNA on 
the gel (see Experimental Procedures) SV40 circular 
DNA form I and II and Ad2 viral DNA fragments, 
obtained after cleavage with Bam HI, were added to 
serve as a control No trapping of these molecules 
was observed (data not shown) The additional frag­
ments found in tumor tissue DNA therefore reflect 
proviral sequences present in new sites, and probably 
represent the somatically acquired viral copies de­
tected by hybridization kinetics (Jaenisch, 1979) Our 
analysis of Eco Rl-digested DNAs shows that the viral 
structure at the Mov I locus is probably not modified 
as compared with that of the Mov I locus in nontumor 
DNA This suggests that integration of somatically 
acquired M-MuLV sequences does not occur in tan-
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Figure 2 M-MuLV Sequences in Tumor Tissues of Balb/Mo Mice 
As described m the legend lo Figure 1 the 23 ж 10е dalton marKPr 
corresponds to undigested Ad2 DNA The upper and lower panels 
show the profiles obtained for DNAs (150 jig each) from a leukemic 
thymus and a leukemic spleen respectively obtained from two dif­
ferent animals sacrificed at age 10 months 
dem with the endogenous M-MuLV genome 
Although the hybridization profiles obtained for in­
dividual tumors are not identical, all tumor DNAs 
tested displayed high hybridization values in the mo­
lecular weight range from 4 χ 10 е up to 10 x 1 0 e 
daltons The resolution of our system does not allow 
firm conclusions concerning the identity of integration 
sites between individual tumors It shows, however, 
thai multiple integration sites are present within one 
tumor and that different sets of integration sites are 
present in different tumors The detection of M-MuLV 
proviral sequences among Eco RI DNA fragments of 
molecular weight less than full-length proviral DNA 
(= 5 7 x 1 0 е daltons, Verma and McKennett, 1978) 
indicates the presence of incomplete, noncontiguous 
or rearranged Moloney proviral genomes in new sites 
of tumor tissue DNAs Since the 16 x 1 0 e dalton Eco 
RI restriction fragment was present in DNAs from both 
normal and tumor tissues we performed Hind III re­
striction analyses of the 16 χ 10 е dalton fragments to 
confirm that the Mov I locus was unchanged in tumor 
tissues Previous restriction data on in vitro synthe­
sized Moloney proviral DNA revealed that Hind III 
cleaves this DNA only once, yielding two fragments of 
3 6 x 10е and 2 4 x 1 0 е daltons (Verma and Mc­
Kennett 1978) 
1 mg of cellular DNA was digested with Eco RI, the 
Cell 
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fragments were separated on a 0 4 % agarose gel, 
and the DNA molecules with molecular weights be­
tween 12 x 106 and 18 χ 10 6 daltons were isolated 
as described in Experimental Procedures 15 ^ g of 
this DNA from both tumor and nontumor tissues were 
digested with the restriction enzyme Hind III and ana­
lyzed for the presence of M-MuLV sequences in dif­
ferently sized fragments, as described above Two 
fragments with molecular weights of 6 χ 105 and 2 5 
χ 106 daltons, respectively, were detected for DNAs 
from both tissues, as shown in Figure 3 
These results indicate that no detectable changes 
have occurred in the M-MuLV sequences of the Mov 
I locus after reintegration of Moloney-type sequences 
in the DNA of most of the cells in tumor tissues No 
integration in tandem to the viral genome present m 
the 16 x 106 dalton Eco RI fragment of tumor DNAs 
was observed, because a tandem should have yielded 
in the detection of three fragments after cleavage with 
Hind III Preliminary evidence further suggests that the 
6 χ 10 e dalton fragment represents a single Hind III 
fragment (A Berns et al , manuscript in preparation) 
Tumors In Balb/c Mice Infected as Newborns with 
Moloney Virus 
Injection of newborn Balb/c mice with a low dose of 
Moloney CLIA virus (about 10 infectious XC particles) 
leads to the development of leukemia in a few of the 
injected animals (Jaemsch et al , 1975) A low dose 
of virus was used to prevent primary infection of many 
cells From the animals which developed leukemia, 
DNA was extracted from tumor tissues (thymus and 
spleen) and analyzed as described These analyses 
revealed that M-MuLV-specific sequences were de­
tected in many Eco RI DNA fragments, ranging in size 
from 4 χ 10 e up to 13 x 1 0 6 daltons Thus in this 
respect no gross difference in the distribution of M·* 
MuLV-specific sequences in tumors of newborn m-
Balb/Mo ^ ^
 6 
»« NonTUMOfì 
20 — TUMOR 
•o Hndl l l 
S · 
•015 e "*с 
f \ 
β ? » 
i '-Л . l -
10 20 30 30 50 
(raction nuHöer 
Figure 3 M-MuLV Sequences in Hind HI Fragments Generaled f rom 
Eco RI Fragments o l В а І Ь / М о M i c e 
A s descr ibed in Ihe l e g e n d t o F i g u r e 1 E c o RI fragments of molecular 
weights between 12 χ 10° a n d 1 8 x 1 0 * daltons were isolated f r o m 
1 m g of both tumor ( thymus) a n d nontumor (liver) DNA of B a l b / M o 
mice These were d i g e s t e d w i l h H i n d III and monitored lor M-MuLV-
t y p e sequences as d e s c r i b e d in Experimental Procedures 
fected Balb/c mice can be delected when compared 
with the spontaneous tumors of Balb/Mo mice Pat­
terns obtained from tumors of several Balb/c mice 
infected as newborns did not show gross differences 
in the distribution of M-MuLV-specific sequences, a 
typical example is shown in Figure 4 (see also Figure 
5, lower panel) 
However, one significant difference between DNAs 
extracted from tumor s of Balb/Mo mice and newborn 
infected Balb/c mice can be seen no M-MuLV se­
quences could be detected in Eco RI fragments with 
a molecular weight of 16 χ IO 6 daltons This suggests 
that a viral integration site occupied in preimplantation 
embryos (Mov I) is not preferentially occupied when 
virus infects lymphatic cells in post-natal animals 
Endogenous AKR-Type Sequences 
To investigate whether the endogenous M-MuLV is 
integrated in or next to the ecolropic endogenous 
virus, Eco RI fragments from Balb/c and B a l b / M o 
DNAs were annealed with an AKR-specific probe Eco 
RI digestion of in vitro synthesized full-length AKR 
proviral DNA revealed that this enzyme does not 
cleave this proviral genome (I Verma, personal com­
munication) 
Hybridization to the ecotropic virus-specific probe 
could be detected among Eco RI DNA fragments 
having a molecular weight of approximately 12 x 1 0 6 
daltons The presence of AKR-type MuLV sequences 
in fragments of this size was detected in all normal 
and tumor tissues of Balb/Mo mice, of Balb/c mice 
and of Balb/c mice infected with M-MuLV as new­
borns The hybridization profiles are shown in Figure 
5 
The detection of a single fragment carrying eco­
tropic virus-specific sequences confirms previous ob­
servations that Balb/c mice carry one AKR-type pro-
virus (Robbms et al , 1977) The 12 x 1 0 e dalton 
Newborn inlected MWiiO 
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I r a c t o n number 
Figure 4 M-MuLV S e q u e n c e s m Tumor DNA f r o m N e w b o r n I n f e c t e d 
B a l b / c M i c e 
As d e s c r i b e d in Ihe l e g e n d to F igure 1 E c o Rl-d igested t h y m u s D N A 
( 1 5 0 μ9) f r o m a leukemic B a l b / c mouse ( infected w h e n n e w b o r n w i t h 
1 0 i n f e c t i o u s XC part ic les of M MuLV CLIA) w a s m o n i t o r e d for t h e 
p r e s e n c e of M M u L V sequences as d e s c r i b e d in E x p e r i m e n t a l P r o ­
c e d u r e s 
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fragment containing the endogenous AKR genome 
was further digested with Hind III as described Hind 
III cleaves the in vitro synthesized full-length AKR 
proviral DNA once (I Verma, personal communica­
tion) The Hind III hybridization patterns seen with 12 
χ 10θ dalton fragments from tumor and nontumor 
tissues of Balb/Mo and Balb/c mice were identical 
and showed two fragments of about 4 x 1 0 * and 2 6 
χ 10e daltons (data not shown) This indicates that no 
detectable changes have occurred in the AKR proviral 
genome structure in tumor and nontumor DNAs from 
Balb/Mo mice as compared with the structure in DNAs 
from Balb/c mice We can conclude that development 
of M-MuLV-mduced leukemia does not lead to de­
tectable structural alteration or amplification of the 
endogenous AKR-type sequences 
Discussion 
In the experiments described in this paper we used a 
technique which enables the detection of specific viral 
sequences in restriction fragments of Balb/Mo and 
Balb/c mouse DNAs We analyzed the genetically 
transmitted provirus (Mov I locus on chromosome 6, 
Bremdl et al , 1979) and the somatically acquired M-
MuLV genomes (3-4 per haploid genome, Jaemsch, 
1979) in tumors of Balb/Mo mice, using a specific 
cDNA probe Earlier studies revealed that the use of 
nonspecific probes in restriction enzyme analysis of 
integrated viral genomes in the mouse system results 
In the detection of many, hard to identify fragments 
that contain viral information (Steffen and Weinberg, 
1978, L Bachelor, personal communication) The 
specific M-MuLV cDNA probe we used represents 
30-35% of the viral genome (Jaemsch, 1977) Prelim­
inary results suggest that this probe can recognize 
different regions of the proviral DNA The probe does 
not hybridize with other endogenous sequences of the 
Balb/Mo mouse genome (see Figure 1) A second 
probe specific for AKR-type sequences was used to 
detect ecotropic endogenous viral sequences The 
use of these two probes enabled us to characterize 
and differentiate Moloney and AKR-type sequences 
among other endogenous viral information in the 
DNAs of Balb/Mo mice and Balb/c mice infected as 
newborns with M-MuLV 
Analysis of DNA digests with EcoRI, which does not 
cleave Moloney and AKR proviral DNA (Verma and 
McKennet, 1978,1 Verma. personal communication), 
resulted in the detection of a single M-MuLV-contam-
ing fragment of 16 χ 10* daltons No hybridization 
was detected among DNA fragments from uninfected 
Balb/c mice Purification of this Moloney provirus-
contatntng fragment and subsequent digestion of the 
fragment with Hind III generated two fragments of 6 
χ 10" and 2 5 χ 10" daltons, respectively 
Digestion of in vitro synthesized M-MuLV DNA with 
Hind III yields two fragments of 3 6 x 10" and 2 4 χ 
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DNAs were monitored tor the presence of M-MuLV and AKR-MuLV 
sequences as described In Experimental Procedures (see also Figure 
1) The upper panel shows the M-MuLV· and AKR-MuLV-type se­
quences in nontumor (liver) DNA (150 μς) of Balb/Mo mice the 
central panel shows both sequences In a tumor (thymus) DNA (100 
μ9) Irom a Balb/Mo mouse and the lower panel shows the profiles 
obtained for a tumor (thymus) DNA (150 μα) from a Bafb/c mouse 
infected when newborn with 10 Infectious ХС particles (M-MuLV) 
10" daltons, respectively (Verma and McKennett, 
1978) The M-MuLV sequences in the 16 χ 10е dalton 
Eco RI fragments therefore represent a single unique 
integration site, corresponding to the M-MuLV se­
quences of the Mov I locus Further structural analy­
ses using the restriction enzymes Hpa I, Bam HI and 
Pst I (Verma and McKennett. 1978) have confirmed 
this (A Berns et al , manuscript in preparation) 
Balb/Mo and Balb/c mice also carry endogenous 
ecotropic proviral sequences (Chattopadhyay et a l , 
Cell 
114 
6 7 
1974) These sequences can be detected by a spe­
cific AKR-MuLV cDNA without cross-hybridization to 
M-MuLV and other mouse viruses The use of this 
probe resulted in the detection of a single fragment of 
12 x IO 6 daltons in all Eco Rl-digested tissue DMAs 
from Balb/c and Balb/Mo mice The Hind III restric­
tion map of this fragment suggested that there is only 
one single Eco RI fragment of 12 χ 10 6 daltons 
carrying the AKR-type provirus This is in agreement 
with a previous observation that only one single AKR-
type endogenous virus is present m Balb/c mice 
(Robbms et al , 1977) The Hind III profile obtained 
for the 12 χ 10 e dalton fragment from Balb/Mo mice 
was identical to the one from Balb/c mice, which 
strongly suggests that the Moloney provirus is not 
integrated in tandem with the endogenous AKR-type 
provirus Apparently, infection of preimplantation 
mouse embryos with Moloney virus (Jaemsch et al , 
1975) does not necessarily result in tandem integra­
tion of the Moloney provirus with the endogenous 
AKR-type provirus in this Balb/Mo mouse line, al­
though there is considerable sequence homology be­
tween the Moloney and AKR viral genomes (Chien et 
al , 1978) Additional germ line integrations must be 
performed to substantiate our findings 
The Amplification of Viral Sequences in Tumor 
Tissues 
Leukemogenesis m Balb/Mo mice is accompanied by 
the increase of Moloney proviral sequences from 1 up 
to 3 - 4 per haploid genome equivalent (Jaemsch, 
1979) Previous hybridization studies did not show 
whether the additional copies found in DNAs from 
tumor tissues were due to the presence of integrated 
or nomntegrated proviral DNAs (Jaemsch, 1977) We 
could exclude the possibility of detecting nomnte­
grated proviral DNAs by using only DNA preparations 
from which DNA with molecular weights <25 χ 10 e 
daltons was removed Integrated Moloney viral se­
quences were detected in Eco RI fragments from 
tumor DNAs with molecular weights varying from 4 
χ 10 e up to 12 χ 10 e daltons Different individual 
tumors yielded similar though not identical hybridiza­
tion profiles All digested tumor DNAs displayed high 
hybridization values, around 6 - 7 χ 10 6 and 9 x 10 e 
daltons It is not clear whether these represent unique 
integration sites per se or just specific sites for a 
particular tumor It can be concluded thai multiple 
integrations are present within one tumor The detec­
tion of multiple integration sites is due either to a 
multiclonal origin of the tumor or to several integra­
tions in one cell 
Recent data suggest that tumors within one animal 
are monoclonal, tumors from three different tissues 
(spleen, thymus and lymph node) within one Balb/Mo 
animal displayed the same reintegration pattern for M-
MuLV-type sequences However, tumors from differ­
ent animals showed different hybridization patterns 
(D Jaehner. H Stuhlmann and R Jaemsch. manu­
script in preparation) 
Steffen and Weinberg (1978) suggested that the 
different patterns of proviral integration are due to the 
existence of multiple integration sites for proviral in­
formation in mouse as well as rat cells Multiple inte­
grations were also suggested by their observation that 
three independently MuLV-mduced thymomas in NIH/ 
swiss mice displayed different patterns of exogenous 
proviral integration Our results are compatible with 
theirs in that reintegration in tumors is found in many 
new sites The somatically acquired copies do not 
integrate at the Mov I locus or in tandem with the 
endogenous AKR provirus, since both endogenous 
proviruses seem to be unchanged 
The possibility cannot be excluded, however, that 
M-MuLV proviral sequences integrate proximal to xen-
otropic viral sequences not detected by our probes 
We also cannot rule out the possibility that only part 
of the cells have structurally modified sequences at 
the Mov I locus or in the AKR structural gene which 
have escaped detection because of the high back­
ground of nonmodified proviral genomes 
Amplification due to reintegration of viral sequences 
is observed in tumors of leukemic AKR (Canaani and 
Aaronson, 1979, our unpublished results), and Balb/ 
Mo- and M-MuLV-mfected Balb/c mice, as well as for 
M-MTV-type sequences in mice with carcinomas (Var-
mus et al , 1978) The differential amplification of 
specific viral sequences might be explained by a 
difference in integration site, the adjacent cellular 
sequences may govern the activity of a provirus 
(Keshet and Temin, 1978, Keshet, О Rear and Temm, 
1979) 
The extra integrated Moloney sequences in tumor 
DNAs might be explained by reinfection of cells by a 
virus containing at least partial M-MuLV-type infor­
mation Reinfection of cells might well play a role, 
since the onset of leukemia in AKR mice and in Balb/ 
с mice infected as newborns with M-MuLV can be 
prevented by immunizing the animals with antiserum 
against AKR-MuLV (Huebner et al , 1976, Schafer et 
a l , 1977) and M-MuLV proteins, respectively (Ρ 
Nobis and R Jaemsch, preliminary observations) Fur­
thermore, recombinants between Moloney virus and 
xenotropic viruses have been isolated from lympho­
mas of leukemic Balb/Mo mice (Vogt, 1979), and 
integrated recombinant viruses might provide the ex­
planation for the finding of M-MuLV-contaimng frag­
ments of subgenomic sizes in tumor tissues of Balb/ 
Mo mice and Balb/c mice infected as newborns with 
M-MuLV, since these recombinant proviruses might 
contain restriction sites for Eco RI Further restriction 
analyses must be carried out to reveal the precise 
structure of the integrated MuLV genomes Until now, 
cDNAs prepared with the endogenous polymerase 
reaction did not show enough specificity to use hy­
bridization to DNAs blotted on nitrocellulose filters 
In teg rat to η Sites of M-MuLV 
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Cloning of M-MuLV proviral DNA fragments is now in 
progress; these fragments will be used for hybridiza­
tion to DNAs blotted on nitrocellulose filters. 
ЕярегІпмпШ ProcwJurM 
Mice 
129 mice were obtained from ttie Jackson Laboratory All other 
strains of mice were obtained from colonies maintained at the animal 
care center of the Medical Faculty of the University of Nijmegen. 
Holland 
CeH Un— end Viru·*« 
M-MuLV CLIA was propagated in monolayers of CLIA ceHs (provided 
by Η Fan) m roller bottles on a Bélico autoharvester Cells were 
grown in BMEM containing 2% newborn calf serum Short harvest 
virus (1 5-2 hr) was concentrated from the cooled medium 50 fold 
with an Amicon DC2 concentrator (containing an HP 100 filter) the 
virus was subsequently aedimented through a 20% sucrose solution 
on a 60% sucrose cushion in TNE buffer [10 mM Trie-HCl (pH 7 4), 
100 mM NaCI 1 mM EDTA] usmg an SW27 rotor (4 hr at 20K. 40C). 
the material m the Interphase was resedimented through a linear 20-
60% sucrose gradient in TNE buffer for 16 hr al 20K in an SW27 
rotor at 4aC, the vims band was taken out, diluted and sedimentad 
through a 20% glycerol solution In TNE buffer, the pellets were 
suspended in TNE buffer containing 20% glycerol and stored at 
~ 0оС Virus preparations were tested for RT activity as described 
by Fan and Baltimore (1 7Э) AKR virus was propagated In mono­
layers of NIH cells and isolated as described for M-MuLV CLIA Ad2 
and Ad5 were propagated m suspension cultures of KB cells and 
purified as described by Doerfler (1969) 
Preparation and Selection of cDNA Prob·· 
Moloney and AKR viral cDNAs were prepared wilh the endogenous 
polymerase reaction In the presence of random calf thymus DNA 
primer (Taylor et a l , 1976) Reaction mixtures contained 50 mM 
Trls-HCI (pH θ 3). 3 mM MgAca, 60 mM NaCI, 20 mM OTT, 2 mg/ml 
calf thymus DNA primer, 50 μς/ΓηΙ actmomycin D. 0 016% NP40, 1 
mM dATP, 1 mM dGTP, 2 mCI3H-dTTP (Amersham, spec act 55 
Cl/mmole), 1 mCl 3H-dCTP (25 Ci/mmole), 1-2 mg of virus In a final 
volume of 1 ml, after 2 5 hr at 370C, the reaction was terminated by 
adding 50 μΙ 0 2 M of EDTA, 50 μΙ of 10% SOS, 50 μΙ of 6 N NaOH, 
after Incubation for 16 hr at 370C to degrade the RNA, the sample 
was neutralized by adding HCl After chromatography on a Sephadex 
G50 column equilibrated with 10 mM Trls-HCI (pH 7 6), 1 mM EDTA, 
fractions containing cDNA were extracted twice with phenol (neutral­
ized with 1 M Tris-HCKpH 7)] and chloroform This procedure yielded 
a b o u t o e x lO'- IO'cpm'H-cDNA^SOMgofcDNA) The M-MuLV 
cDNA sequences which cross-hybridize with other endogenous 
mouse viruses were removed by selection on mouse DNA from Balb/ 
с mice and further purified by hybridization to Moloney viral RNA 
(Jaemsch, 1977) 
AKR cDNA was purified from sequences which cross-hybridize 
with other endogenous mouse viruses by selection on mouse DNA 
from 129 mice and by hybridization to AKR viral RNA (Berns and 
Jaenisch, 1976) Sequences which cross-hybridize with Moloney viral 
RNA were removed by hybridization to mercurated Moloney viral RNA 
(Dale and Ward. 1975) About 7 χ 10s cpm of AKR cDNA were 
hybridized to 1 2 fig of mercurated Moloney viral RNA m hybridization 
buffer [1 M NaCI. 10 mM TES (pH 7 4), 1 mM EDTA and 2 μς/ΓηΙ 
polyvmylsulphate] for 3 hr at 7°С, diluted 10 fold and loaded onto 
a 0 2 ml SH-agarose column (Agarose-Ethane-Thtol, Ρ L Biochemi­
cal s) The nonbound traction containing the AKR-MuLV-speclfic 
cDNA was eluted with 10 mM TES (pH 7 0), 1 mM EDTA. 100 mM 
NaCI and 2 дд/ттіі polyvmylsulphate, according to the method of Woo 
et al (1977) 
Extraction of DNA 
DNA was isolated from mouse tissues according to a procedure 
modified from Klrby (1968) Tissues were homogenized with a Poly-
tron homogemzer at low speed in freshly prepared solutions of 0 5% 
NaCI 3% paraammosalicylate and 5 mM EDTA for 2-3 min, DNA was 
extracted by two successive extractions with phenol cresol B-hy-
droxyquinollne (100 14 0 1) and twice with Chloroform isoamyl alco­
hol (24 1 ). I he solution was adjusted to 0 3 M NaCI and the DNA was 
precipitated with 1 vol of cold ( - 20eC) ethanol, DNA was immediately 
spooled and dissolved in TE buffer [10 mM Tns-HCI (pH 7 6). 2 mM 
EDTA] incubated with DNAase-tree RNAase (50-100
 Mg/ml) for 1 hr 
at 370C in the presence of 0 5% SDS, twice extracted with chloro­
form isoamyl alcohol (24 1 ) and precipitated twice with ethanol, finally 
DNA was dissolved in 10 mM Tns-HCI (pH 7 6). 0 2 mM EDTA Low 
molecular weight molecules (<25 χ 10e daltons) were removed by 
selective sedimentation, up to 3 mg of DNA (θ ml) were loaded on a 
30 ml solution of 12 5% sucrose In TE buffer containing 300 mM 
NaCI, centrlfugatran was performed for 15 hr at 24K (15QC) In an 
SW27 rotor, the DNA pellet was dissolved in 10 mM Tns-HCI (pH 
7 5). 0 2 mM EDTA and stored at 4°C These purified DNA prepa­
rations were ueed as sources for restriction analyses Viral DNAs 
from Ad2 and Ad5 were isolated from purified vinons as described by 
Doerfler, Lundholm and Hirsch-Kauffmann (1972) 
Restriction Enzymes and Incubation Condition· 
Eco RI and Hind III were obtained from Microbial Products (England) 
Digestion of DNA with Eco RI was performed with 2 υ/μα DNA and 
10-20 pg DNA per 50 μΙ solution [100 mM Trls-HCI (pH 7 5) 50 mM 
NaCI. 5 mM MgClj, 100 м/т\ gelatine and 1 ^g/ml bovine serum 
albumin) for 4 hr at 37°С Incubation solutions were adjusted with 
storage buffer (9 1) which is described in the Microbial catalog Hind 
III digestions were performed also usmg 2 υ/μο DNA in 10 mM Trle-
MC1 (pH 7 6), 50 mM NaCI. 10 mM MgCb 14 mM DTT and 5% (v/v) 
storage buffer) Ad2 DNA was included In the reactions to serve as a 
control for the extent of digestion 
Electrophoreele, Elution end Hybridization of DNA 
Fragments of digested DNAs were separated on size by electropho­
resis in 0 4 or 0 6% neutral agarose gels the buffer contained 40 
mM Trls-HCI (pH 7 9). 5 mM NaAc. 1 mM EDTA (McDonell el a l . 
1977) and 0 5 μς/ιηΙ ethidium bromide, gels were prepared in the 
same buffer Eco Rf-dlgested DNAs were loaded at a maximal con­
centration of 1 μς/ΠΗη3 DNA, while nondigested DNAs were loaded 
up to О 06 pg/mm3 DNA DNA was eluted and concentrated from gel 
slices (2-4 mm) by electrophoretic elution for 16 hr in a device similar 
to that described by Alllngton et al (197Θ), 50 μα of calf thymus DNA 
were added as carrier, and elution was earned out at 100 V In a 
buffer containing 5 mM Tns-HCI (pH 7 0) and 1 mM EDTA, subse­
quently. samples (400 μΙ) were adjusted to 0 75 N NaOH and 1 mM 
EDTA In Eppendorf 1 5 ml tubes, and Incubated at 100oC for 15 mm 
to remove any contaminating RNA molecules and lo reduce the size 
ot the DNA molecules to 200-400 nucleotides Samples were neu­
tralized with HAc and precipitated with ethanol. DNA was dissolved 
m hybridization buffer containing 700 cpm of 3H-labeled M-MuLV- or 
AKR-MuLV-specific cDNA probe Hybndtzalton was carried out for 
72 hr at 67°C and duplex formation was monitored by SI nuclease 
(Vogt, 1973) Preparative elution of DNA fragments from agarose gel 
slices was performed as mentioned above except that no earner was 
added Fragments were purified by two successive phenol 8-hy-
droxyqulnolme ( 100 0 1. phenol saturated with TE buffer) extractions, 
two chloroform isoamyl alcohol (24 1) extractions and two precipita­
tions with ethanol 
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Molecular Cloning of Unintegrated and a Portion of Integrated 
Moloney Murine Leukemia Viral DNA in Bacteriophage 
Lambda 
ANTON J. M. BERNS," M. H. T. LAI,2 R. A. BOSSELMAN,2 M. A. McKENNETT,2 
L. T. BACHELER,2 H. FAN,2 E. С ROBANUS MAANDAG,1 H. v.o. PUTTEN,1 AND 
INDER M. VERMA2 
Tumor Virology Laboratory, The Salk Institute, San Diego, California 92138* and Laboratory of 
Biochemistry, University of Nijmegen, 6525 EZ Nijmegen, The Netherlands1 
A covalently closed circular form of unintegrated viral DNA obtained from 
NIH 3T3 cells freshly infected with Moloney murine leukemia virus (M-MLV) 
and a portion of the endogenous M-MLV from the BALB/Mo mouse strain have 
been cloned in bacteriophage lambda. The unintegrated viral DNA was cleaved 
with restriction endonuclease tfmdIII and inserted into the single ifmdIII site of 
lambda phage Charon 21A. Similarly high-molecular-weight DNA from BALB/ 
Mo mice was cleaved sequentially with restriction endonucleases £coRI and 
¿/indili and separated on the basis of size, and one of the two fractions which 
reacted with an M-MLV-specific complementary DNA was inserted into the 
Hindlll site of Charon 21 A. Recombinant clones containing M-MLV-reacting 
DNA were analyzed by restriction endonuclease mapping, heteroduplexing, and 
infectivity assays. The restriction endonuclease map of the insert derived from 
unintegrated viral DNA, λ-MLV-l, was comparable to published maps. Electron 
microscope analysis of the hybrid formed between λ-MLV-l DNA and 35S 
genomic M-MLV RNA showed a duplex structure. The molecularly cloned λ· 
MLV-1 DNA contained only one copy of the long terminal repeat and was not 
infectious even after end-to-end ligation of the insert DNA. The insert DNA 
derived from endogenous M-MLV, X-MLV^-l, contained a DNA stretch mea­
suring 5.4 kilobase pairs in length, corresponding to the 5' part of the genomic 
viral RNA, and cellular mouse DNA sequences measuring 3.5 kilobase pairs in 
length. The viral part of the insert showed the typical restriction pattern of M-
MLV DNA except that a single restriction site, PvuIL, in the 5' long terminal 
repeat wis missing. Reconstructed genomes containing the 5' half derived from 
the integrated viral DNA and the 3' half derived from the unintegrated viral DNA 
were able to induce XC plaques after transfection in uninfected mouse fibroblasts. 
In the life cycle of RNA tumor viruses, the 
viral genetic material is converted into DNA, 
some of which integrates in the host chromo­
somal DNA (2, 31). Several forms of viral DNA, 
ranging from linear to covalently closed circles, 
have been identified in infected cells (33). How­
ever, a detailed knowledge of the structure of 
the intermediates leading to the integrated 
forms of viral DNA remains largely obscure. The 
study of the integrated murine leukemia viruses 
(MLVs) has been hampered by the large number 
of related endogenous viral sequences in unin­
fected cells. Use of recombinant DNA tech­
niques, however, make it feasible to enrich and 
amplify DNA fragments of single-copy genes of 
eucaryotes. The BALB/Mo mouse strain (12) 
contains the Moloney MLV (M-MLV) as an 
endogenous virus, which has been localized in a 
single £coRI fragment of 27 kilobases (kb) (27). 
This fragment is derived from the Μου-1 locus 
of BALB/Mo mice (5). BALB/Mo mice are 
viremic from birth and develop lymphatic leu­
kemia later in life (13), indicating the presence 
of a complete active M-MLV genome. In this 
study, we report the molecular cloning of (i) 
unintegrated circular forms of M-MLV DNA 
isolated from cells freshly infected with M-MLV 
(the DNA was cleaved with restriction endonu­
clease Ηindili to generate the linear form) and 
(ii) a portion of the integrated form of M-MLV 
present in BALB/Mo mice (the 27-kb £coRI 
cell DNA fragment was cleaved with restriction 
endonuclease Hinàlll to generate a fragment of 
about 8.9 kb which contains M-MLV sequences). 
Both the unintegrated circular M-MLV DNA 
cleaved with НтаШ. and the 8.9-kb tfindlll 
fragment from the mouse DNA were cloned in 
the unique tfindlll site of lambda phage Charon 
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VOL 36,1980 M MLV VIRAL DNA 
21A D N A (3). The natures of the cloned D N A s 
were examined by restriction endonuclease map­
ping, R-loop formation, and infectivity assays. 
MATERIALS AND METHODS 
Preparation of unintegrated closed circular 
DNA. About 5 χ 10" NIH 3T3 cells were infected with 
a 24-h tissue culture supernatant from M-MLV-pro-
ducing clone 4A cells at a multiplicity of infection of 
1 At 16 h postinfection, cells were harvested and a 
Hirt supernatant was prepared After RNase treat­
ment and ÊcoRI digestion, circular DNAs were sepa-
rated from linear DNA by centrifugaron in cesium 
chlonde-ethidium bromide gradients (30) The mate-
rial banding at the bottom one-third was collected, the 
ethidmm broni'de was removed by isopropanol extrac-
tion, and the DNA was dialyzed 
Preparation of mouse DNA fragmente contain-
ing M-MLV sequences. High-molecular-weight 
mouse DNA was prepared from livers of 2-month-old 
BALB/Mo mice as previously described (15, 27) The 
DNA was digested to completion with icoRI at 2 U/ 
pg for 4 h, and the fragments were separated by zonal 
centnfugation in a BXXIX rotor of an International 
centrifuge A 50-mg amount of DNA yielded about 1 
mg of 18- to 35-kb DNA fragments After cleaving 
with endonuclease Hindill, the fragments were sepa-
rated on agarose gels and electroeluted, and the frac-
tions hybridizing with an M MLV-specific probe were 
used for cloning 
Cloning. DNA from lambda phage Charon 21A 
was digested with restriction endonuclease Htndlll, 
followed by treatment with bacterial alkaline phos-
phatase to reduce self-hgation of the phage arms (5 
U/>g of DNA m 50 mM Tns-hydrochloride, pH 9 0, 
for 30 mm at 560C) For cloning unintegrated M-MLV 
DNA, about 10 to 20 ng of tfmdIII-cut M-MLV DNA 
was mixed with 150 ng of tftndlll-cut, phosphatase-
treated Charon 21A vector DNA and precipitated with 
ethanol, and the pellet was incubated for 1 h at 42°C 
in 3μ1 of DNA ligase buffer (66 mM Tris-hydrothloride 
[pH 7 5], 10 mM dithiothreitol, 7 mM MgCU, 80 μΜ 
ATP) to allow the DNA to dissolve, 0 4 U (1 μΐ) of T4 
DNA ligase was added, and after incubation at room 
temperature for 2 h the DNA was packaged in vitro 
into infectious lambda phage particles with M-l buffer 
by the protocol provided by Blattner and colleagues 
The efficiency of packaging of Charon 21A DNA alone 
was 3 x 10* PFU/fig After digestion with //mdlll and 
treatment with bacterial alkaline phosphatase and 
ligation, the efficiency of packaging of phage DNA was 
±105 PFU//ig, ligation of the insert DNA to the 
Hindill cut bacterial alkaline phosphatase-treated 
Charon 21A DNA increased the efficiency of packag­
ing by a factor of 5 Generally, the efficiency of pack­
aging varied from 1 χ 10' to 5 Χ 105 PFU/fig of 
substrate-vector DNA For cloning integrated M-MLV 
DNA, the same protocol was used except that about 
2 ^g of an 8 9-kb #mdIII fragment was ligated with 5 
μξ of phosphatase-treated Charon 21A arms 
Screening of recombinants. The recombinants 
were plated on 14-cm plates, and the DNA from the 
plaques was adsorbed onto nitrocellulose filters essen­
tially by the technique of Benton and Davis (1) 
Plaques that showed hybridization to M-MLV com-
255 
plementary DNA (cDNA) probes (7, 27) were further 
subcloned until pure recombinant plaques were ob­
tained The recombinant phages were propagated in 
Escherichia coli DP50 ьирР in NZYDT broth as 
described in the protocols designed by Blattner et al 
(3) and Leder et al (17) AU experiments were per­
formed in a P2 laboratory facihtv, and certified EK2 
or EK1CV vectors were used The National Institutes 
of Health Guidelines were followed for the entire 
cloning procedure 
Restriction endonuclease analysis. The natures 
of the cloned DNAs were examined by restnction 
endonuclease mapping as described previously (31) 
The restriction endonuclease digested DNA was frac­
tionated on agarose gels ranging from 0 5 to 1 2f¡ m a 
buffer containing 40 mM Tris base, 1 mM EDTA, and 
5 mM sodium acetate, adjusted with acetic acid to pH 
7 9 (20) The fragments were identified either by etnid-
lum bromide staining (24) (present at 0 5 jig/ml in 
both the gels and electrophoresis buffer) or by the 
Southern blotting technique (26), using either a Mo-
loney cDNA probe (7) or nick-translated DNA frag-
ments (19) DNA fragments were nick translated with 
[a-J2P]dCTP (2,000 to 3,000 Ci/mmol) from Amer-
sham Corp , E coll polymerase I from Boehrmger 
Mannheim Соф, and DNase I from Worthington 
Biochemicals Corp After incubation at 150C for 90 
mm, sodium dodecyl sulfate and KDTA were added to 
final concentrations of 0 b% and 10 mM, respectively 
Proteinase К was added at 200/ig/ml, and the mixture 
was incubated for 30 mm at 370C and passed over a 
Sephadex G 50 column to remove unincorporated nu­
cleotides 
Hybridization to nitrocellulose-bound DNA was 
performed аь described previously (32) The sizes of 
the restnction fragments were computed from the 
standard molecular weight markers in the same gel 
(lambda DNA cleaved with EcoRI 22 2, 7 3, 5 75, 4 9, 
and 3 8 kb, lambda DNA cleaved with HmdIII 24 2, 
9 9, 6 7, 4 4, 2 2, and 195 kb, M13 replicative form 
digested with Hpatt 1 6, 0 82, 0 65, 0 54, 0 47, 0 45, 
0 38, 0 18, 0 16, and 0 13 kb) 
Electron microscopy. Samples of DNA and RNA 
were dissolved in a solution containing 80% formamide, 
0 4 M NaCl, 001 M PIPES [piperazine-iV-N'-bis(2-
ethanesulfomc acid)] (pH 6 3), and 0 001 M EDTA at 
3 and 1 fig/ml, respectively The DNA was heated 
separately at 68°C for 5 mm and then mixed with 
RNA, followed by incubation at temperatures which 
slowly decreased from 55 to 51 "С over a 4-h period 
Molecules were prepared for electron microscopy, and 
contour lengths of the molecules were measured as 
described previously (4) 
Infectivity assays. Infectivity of cloned M-MLV 
DNA was assayed by the XC plaque assay (22) DNA 
was transfected m NIH 3T3 mouse fibroblasts by the 
calcium phosphate method (9) Briefly, 4 x 105 cells 
were plated onto 35-mm plates the day before trans-
fection The DNA to be assayed was coprecipitated 
with calcium phosphate as described previously (16) 
and added directly to the recipient cells After 5 h, the 
DNA was removed, and the cells were treated briefly 
with 20% dimethyl sulfoxide After overnight recovery, 
cells were transferred to new plates at 10% confluency 
After 5 days, the cells were UV irradiated and overlaid 
with XC cells XC plaques were counted at day 9 after 
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fixing and staining the cells with hematoxylin. 
RESULTS 
Identification and characterization of the 
clone derived from unintegrated M-MLV 
DNA A«MLV-1. (i) Physical mapping by re­
striction endonuclease. Figure 1A shows the 
restriction endonuclease map of in vitro-synthe-
sized M-MLV DNA (8, 31). Since the recombi­
nant clone was made by utilizing the Htradlll 
site, Fig. IB shows the physical map of λ-ML V-
1 with the ЯіпаІІІ cleavage site at 0 map unit. 
Virion RNA cap--
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FIG. 1. Characterization of \-MLVl. (A) Physical map of linear viral DNA (8, 31). The shaded areas 
indicate the location of the L TR. (B) Physical map of λ · ML V-1 with HmdIII at 0 map unit. The shaded area 
is the location of the LTR from the 3' end of the genome. The dashed-line triangle is the expected position of 
the second LTR at the 5' end. (C) Ethidium bromide staining of restriction endonuclease-digested \-MLV-l 
DNA. (D) Physical map of the insert derived from λ-MLV-l DNA. Lanes 1 to 13 are autoradiographs of 
restricted endonuclease-digested λ-MLV-l DNAs, followed by Southern transfer and hybridization to total 
M-MLV cDNA. λ-MLV-l was cleaved with HindJII, followed by digestion with the enzymes specified in the 
figure. 
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A single recombinant clone, λ-MLV-l, which 
hybridized to M-MLV cDNA was obtained from 
a primary screening of about 5,000 plaques. Fig­
ure 1С, lane 1, shows the size of the insert in λ· 
MLV-1 to be 8.2 kb after cleavage with ffindlll. 
Digestion with restriction endonucleases Sail, 
Xhol, Sad, Smal, Xbal, BamHl, Kpnl, Pstl, 
BgR, and Pvull revealed a pattern which is in 
agreement with the map shown in Fig. 1A. How­
ever, only one of the two Pvull sites shown in 
the long terminal repeat (LTR) of Fig. IA could 
be detected (see below). The results also indi­
cated that λ-MLV-1 contains only one copy of 
the LTR shown in Fig. IA and B. For instance, 
digestion with Hmdl l l and SamHI should gen­
erate four fragments. The largest fragment 
should be about 5.4 kb if it contained two copies 
of the LTR. However, Fig. ID, lane 7, shows 
that the largest fragment is only 4.8 kb. Diges­
tion with λ · MLV-1 DNAs cleaved by P W Í I I 
(lane 11) and S a d (lane 4) did not show a 600-
bp fragment, which would be expected if two 
copies of the LTR were present (Fig. IB). 
(ii) Heteroduplex formation. Figure 2A 
shows a heteroduplex formed between λ-MLV-
1 and 35S M-MLV genomic RNA. Only a single 
loop structure of an average size of 8.0 ± 0.73 kb 
can be seen. An enlargement of the RNA-DNA 
hybrid loop of the heteroduplex is shown in Fig. 
2B. The results indicate that λ · MLV-1 contains 
sequences homologous to those present in the 
M-MLV genomic RNA. 
Identification and characterization of t h e 
clone derived from integrated M-MLV 
DNA, \«MLVin/-l. A single recombinant clone 
which hybridized to M-MLV cDNA was ob-
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Fie. 4—continued 
tained from a primary screening of approxi­
mately 12,000 plaques. The nature of the recom­
binant clone was identified as about 5.4 kb of 
viral and 3.5 kb of cellular sequences. The re­
striction map of the viral sequences agreed with 
that shown in Fig. 1A, except that only one 
РІІЫІІ site was detected in the 5'-end LTR in­
stead of the reported two sites (8). The restric­
tion map of the cellular sequences agreed with 
the map determined for the 27-kb EcoRI frag­
ment obtained from BALB/Mo mice (v.d. Put-
ten et al., unpublished data). To ascertain that 
X-MLVmt-l was derived from the DNA corre­
sponding to the Mov-1 locus of the BALB/Mo 
mouse strain, we hybridized the Xhol to Hpal 
cellular fragment of this clone (after labeling 
with [tt-32P]dCTP by nick translation) to South-
em blots of EcoRI-digested DNA from the 129, 
BALB/c, and BALB/Mo mouse strains (Fig. 3). 
This probe recognized an 18-kb fragment in 129 
and BALB/c DNAs and a 27-kb fragment in 
BALB/Mo mouse DNA, indicating that λ· 
MLV„/-1 is indeed derived from the Μου-l locus 
of BALB/Mo mice. Furthermore, it showed that 
integration of M-MLV has occurred without 
causing large deletions in the cellular DNA, as 
the size difference between the EcoRI fragments 
recognized in BALB/c and BALB/Mo mice cor­
responds with the genomic size of M-MLV. The 
A-MLVmrl contains one copy of the LTR at its 
5' end. Digestion with restriction endonucleases 
Pvull and Kpnl showed the presence of a 280-
bp fragment, expected from the LTR (Fig. 4B, 
lane 10). Thus, it appears that as do avian sar­
coma viruses (11, 23) integrated M-MLV con­
tains a copy of the LTR at its 5' end. Figure 4A 
to С shows the characterization of X-MLV„(-1 
by utilizing several restriction endonucleases 
and different probes; Fig. 4B shows an autora-
diograph obtained with M-MLV cDNA as a 
probe, whereas in Fig. 4C, a plasmid probe con­
taining the insert of X-MLV^-l was used. 
Therefore, the fragments seen in Fig. 4C but 
absent from Fig. 4B contain exclusively mouse 
sequences, whereas fragments seen at a relative 
higher intensity in Fig. 4C as compared with Fig. 
4B comprise both mouse and viral sequences. A 
detailed physical map of λ · MLV„/-1 is shown in 
Fig. 4D. 
Infectivity. The λ-MLV-l recombinant clone 
derived from unintegrated closed circular DNA 
was not infectious in any of the following forms: 
(i) A-MLV-l DNA, (Ü) X-MLV-l DNA cleaved 
with Hindlll, (Ш) λ-MLV-l DNA plus tfwdlll 
and the insert of 8.9 kb isolated on agarose gels 
(Fig. 5, lane A), and (iv) isolated insert ligated 
end-to-end by T4 DNA ligase (Fig. 5, lane В). 
None of these forms of DNA were infectious as 
assayed by the XC plaque assay (27). The λ-
MLV„rl lacked the 3' half of the viral genomic 
information and thus remained uninfectious. 
However, when λ·MLVlл^-l was supplemented 
with viral DNA representing the 3' half of the 
genome, it was found to be infectious. Figure 6 
shows a diagrammatic sketch of how the infec­
tious DNA molecule was constructed. The λ-
76 
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transfection. The lanes shown are auioradiographs 
of unligated and ligated fragments after agarose gel 
electrophoresis, followed by Southern bhtting trans­
fer and hybridization to M-MLV-1 cDNA. (A) Iso­
lated insert from \-MLV-l DNA; (В) same insert as 
visualized in (A) but after ligation; (C) isolated 
Hindlll to PstI fragment derived from \-MLV-l 
DNA; (D) isolated insert derived from \-MLV
m
rl 
DNA; and (E) Hindlll to PstI fragment (C) plus the 
isolated insert shown in (D) after ligation. 
MLV-1 DNA was cleaved with restriction en-
donucleases PstI and San. The HinálU to PstI 
fragment of 4.1-kb size contained the З'-half viral 
genomic sequence and about 0.51-kb sequences 
from the 5' end of the genomic RNA (from Psil 
to Äpnl as in Fig. 1A). The 4.1-kb Hinàlll to 
Ps i l fragment (Fig. 5, lane C) treated with bac-
terial alkaline phosphatase and the 8.9-kb λ· 
MLV„,-1 insert (Fig. 5, lane D) were ligated with 
T4 DNA Ugase (Fig. 5, lane E). In another 
experiment, we digested the A-MLV-I DNA 
with Hindl l l and Xhol (Fig. 1A and 6). The 5.1-
kb Hindl l l to Xhol fragment was ligated to the 
8.9-kb insert of X-MLV^l . Table 1 shows the 
specific infectivity of the in vitro-constructed 
infectious DNA molecules. Unligated DNA frag­
ments were not infectious. Since M-MLV is NB 
tropic, we wanted to determine the tropism of 
the virus released by cells infected with in vitro-
constructed DNA molecules. Table 2 shows that, 
like the parental vims, the virus released from 
cells infected with reconstructed DNA was NB 
tropic. 
DISCUSSION 
An unintegrated circular form and a portion 
of an integrated form of M-MLV DNA were 
cloned in lambda phage Charon 21 A. Since M-
MLV DNA has a single Hindlll site (8, 31),. 
unintegrated closed circular M-MLV DNA was 
linearized by cleaving with restriction endonu-
clease Hwdl l l and ligated into the unique 
Hindlll site of Charon 21A phage DNA (3). An 
integrated form of M-MLV DNA was obtained 
from the BALB/Mo mouse strain (12), which 
contains M-MLV as an endogenous virus. This 
endogenous virus is present in a single Mende-
lian locus (Mov-1) which has been mapped ge­
netically on chromosome no. 6 (5), and M-MLV 
is expressed in hematopoietic tissues from early 
life on (12,13). The expression of the endogenous 
virus leads to the development of a lymphatic 
leukemia later in life (13), accompanied by the 
amplification of M-MLV sequences in the tumor 
tissues. Restriction endonuclease cleavage of 
BALB/Mo mouse DNA from nontarget tissues 
such as brain and liver, followed by hybridiza­
tion with M-MLV-specific probes, has indicated 
that the genetically transmitted M-MLV ge­
nome can be detected in a single 27-kb .EcoRI 
fragment (27). This .EcoRI fragment was isolated 
and cleaved with Hindlll, generating two M-
MLV-containing fragments of 8.9 and 3.9 kb. 
The 8.9-kb Hindll l fragment was cloned into 
the Hindlll site of Charon 21A. The relative 
inefficiency of the Charon 21A cloning vehicle in 
accommodating DNA fragments larger than 6 to 
7 kb in a unique restriction site may be respon­
sible for the identification of a single M-MLV-
reacting plaque obtained from either uninte­
grated or integrated M-MLV DNA. The physi­
cal map of the λ · MLV-1 was comparable to the 
published maps (8, 31) except that only a single 
600-bp LTR was present and one РІУМІІ site was 
missing. The exact positions of the various re­
striction sites (8) on the viral genome have been 
mapped more precisely, λ · MLV-1 lacks one of 
the two Р ш І І sites in the LTR (Fig. 1A). The 
nucleotide sequences of the 5' LTR from λ· 
MLVferl (26b) and of the 3' LTR from a cloned 
M-MLV cDNA transcript (26a) have been de­
termined. In both cases only one PDMII site could 
be detected in the LTR (Fig. 1A). A comparison 
of the LTR sequences from M-MLV with that 
of murine sarcoma virus (R. Dhar, W. С. Mc-
Clements, L. Enquist, and G. F. van de Woude, 
Froc. Natl. Acad. Sci. U.S.A., in press) reveals a 
direct duplication of 73 nucleotides in the latter 
case. The direct duplication contains the addi­
tional PvuTl site. The absence of the direct re­
peat of 73 bp from the LTR of λ-MLV^-l or 
λ · MLV-1 does not appear to be essential for 
infectivity, as the in vitro recombinant DNA is 
able to produce infectious virus (Table 1). It has 
been reported that molecularly cloned retroviral 
77 
VOL. 36,1980 M-MLV VIRAL DNA CLONES IN BACTERIOPHAGE LAMBDA 261 
A MLV. -1 
Hind III 
ï I 3 Й f 
η 
a. 
X 
LTR 
Cellular Viral 
Xhol 
Я7Я t 
В 
Separation on agaroso 
gels 
ν -
•о 
с 
Χ 
I 
ι 
i 
•TRANSFECTION 
FIG. 6. Flow sheet showing the in vitro construction of infectious DNA molecules. 
TABLE 1. Specific activity of in vitroconstructed 
infectious DNA molecules 
Nature of DNA 
X.MLV^l(8.9kb) 
AMLV^-l Qigated) 
ЯіжШІ to Psil (4.1 kb) 
ЯшаШ to Pstl (ligated) 
HmdintoXhoKSlkb) 
НтаШ to Xhol (ligated) 
λ - M L V ^ l (8.9 kb) plus 
Я и а Ш to Pstl (4.1 kb) 
X-MLV«-! (8.9 kb) plus 
Я и м і т to Xhol (5.1 kb) 
Amt of 
DNA 
used 
(№) 
0.24 
0.21 
0.18 
0.18 
0.50-
0.60 
0.02 
0.06 
0.18 
1.5 
No. of 
XC 
plaques 
(avg of 
two 
plates) 
0 
0 
0 
0 
0 
0 
2 
7 
26 
300 
XC 
P F U / « 
of DNA 
100 
116 
144 
150 
DNAs can lose one or two LTRs, presumably by 
homologous recombination (10, 14, 28). Simi­
larly, it is possible that λ-MLV-l has lost one 
LTR during molecular cloning. 
The insert DNA was not infectious when 
transfected in any of the following forms: (i) λ · 
M-MLV DNA, (Ü) λ · M-MLV DNA cleaved with 
Я т а І П , (Ш) λ-M-MLV DNA cleaved with 
Hindm and the insert isolated on agarose gels, 
and (iv) isolated insert, end-to-end ligated by T4 
DNA ligase (Fig. 5, lane В). This result suggests 
either that a mutation has occurred somewhere 
in the 5' two-thirds of the viral genome or that 
the presence of two LTRs is essential for infec­
tion. However, when λ-MLV-l was annealed to 
M-MLV genomic RNA and analyzed by SI map­
ping, only a single band of an average size of 8.5 
kb could be detected on alkaline agarose gels (I. 
M. Verma, unpublished data). Thus, it appears 
7 η 
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ТАЧГ E 2 Tropism of the virus released from cells 
transfected with in vitro constructed infectious 
DNA" 
XC plaque-forming titers (PFU/ml) 
In vitro 3 1 x 105 0 8 x 105 2.9 x 102 
recombinant 
M-MLV 5.8 x 105 1.8 x IO6 103 
" After two transfers of NIH 3T3 cells transfected 
with in vitro-reconstructed DNA molecules (0.18 ßg of 
DNA, Table 1), 24-h tissue culture fluid was assayed 
on NIH 3T3 cells (N-tropic), BALB/3T3 cells (B-
tropic), and F 2408 (rat) cells. For a comparison, 24-h 
tissue culture fluid from mouse fibroblasts chronically 
infected with M-MLV was also assayed m parallel. 
that λ-MLV-l has no major deletion. A similar 
phenomenon is observed with cloned Moloney 
murine sarcoma virus DNA; only insert DNAs 
containing two copies of the LTR gave rise to 
focus formation (30). In contrast. Oliff et al. (21) 
have recently shown that molecularly cloned 
Friend MLV containing one copy of the LTR is 
able to infect cells and produce Fnend MLV. 
The reason for this discrepancy remains obscure 
for the moment. The clone containing the insert 
derived from the integrated M-MLV DNA has 
been characterized by restriction endonuclease 
mapping (Fig. 4). The viral portion of the insert 
was comparable by restriction endonuclease 
mapping from in vitro- and in vivo-synthesized 
M-MLV viral DNAs (8, 31), except for the ab­
sence of one Pvull site from the 5' LTR. The 
restriction fragments characteristic for the Mov-
1 integration site (fragments containing both 
viral and cellular sequences) could also be gen­
erated from this clone, with the exception of 
some fragments which were generated by en­
zymes sensitive for DNA methylation. Further­
more, a ^P-labeled fragment (Xhol to Hpal) 
derived from the cellular part of this clone rec­
ognized specifically a 27-kb ЕсоШ fragment in 
DNA from BALB/Mo mice, whereas an 18-kb 
fragment was detected in DNA from the BALB/ 
с and 129 mice, which were the parental strains 
of the BALB/Mo mouse strain (12). The ob­
served difference in size of 9 kb between BALB/ 
Mo and its parental strain (Fig. 3) is in agree­
ment with the insertion of a single M-MLV 
genome and suggests that no major deletions 
have occurred in the cellular DNA during the 
integration process. Analysis with a variety of 
restriction enzymes did not allow us to deter­
mine whether the germ line integration of M-
MLV took place into the BALB/c or 129 ge­
nome, since the same restriction fragments were 
J VIROL 
generated from both strains. A more detailed 
analysis will be necessary to clarify this point. 
To study the biological activity of X-MLVuu-
1 DNA, the insert was hgated to the 4.1-kb 
tfmdIII to Psil fragment or the 5.1-kb Hmdlll 
to Xhol fragment from the λ-MLV-l cloned 
DNA. These fragments contained the З'-end ge­
nomic sequences missing from λ • MLV,,,,-! DNA. 
These reconstructed genomes (Fig. 6) were in­
fectious, indicating that no defect has been in­
troduced in the mouse-derived clone during the 
cloning procedure. The same conclusion can be 
drawn for the 3' part of λ-MLV-l DNA. The 
specific infectivity of the reconstructed mole­
cules was similar to that observed for in vitro-
synthesized genome-length DNA (16) but much 
lower than that reported for unintegrated M-
MLV (25) or integrated, molecularly cloned 
AKR MLV DNA (18). It is, however, difficult to 
get an exact estimate as the hgated molecules of 
the right length were not individually isolated. 
It is interesting to note that a molecular clone 
derived from an integrated viral genome, which 
is not expressed in the tissue from which the 
DNA was isolated (mouse liver), is infectious. 
Therefore, we will focus our attention on the 
regulatory functions, specified by the cellular 
sequences present in this clone, as well as on the 
extent of base modification present in the inte­
grated M-MLV, which is expected to be related 
to the expression of the M-MLV genome speci­
fied by the Mov-1 locus (6). 
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Summary 
M-MuLV-speclfic DNA probes were used to estab­
lish the state of integration and amplification of 
recombinant proviral sequences in Moloney virus-
induced tumors of Balb/Mo, Balb/c and 129 mice. 
The somatically acquired viral sequences contain 
both authentic M-MuLV genomes and recombinants 
of M-MuLV with endogenous viral sequences. All 
reintegrated genomes carry long terminal repeat 
(LTR) sequences at both termini of their genome. In 
the preleukemic stage a large population of cells 
exhibiting a random distribution of reintegrated M-
MuLV genomes are seen, but during outgrowth of 
the tumor, selection of cells occurs leaving one or 
a few clonal descendants In the outgrown tumor. In 
this latter stage recombinant genomes can be de­
tected. Although these recombinants constitute a 
heterogeneous group of proviruses, characteristic 
molecular markers are conserved among many in­
dividual proviral recombinants, lending credence to 
the notion that a certain recombinant structure Is a 
prerequisite for the onset of neoplasia. The struc­
ture of these recombinants shows close structural 
similarities to the previously described mink cell 
focus-inducing (MCFHype viruses. 
Introduction 
Murine leukemia viruses can induce leukemogenesis 
in a wide variety of mice The endogenous C-type 
virus is part of the mouse genome and is transmitted 
from parent to offspring In contrast, the exogenous 
murine retroviruses are acquired horizontally and so 
are normally not part of the germ line However it is 
possible to introduce Moloney murine leukemia virus 
into the germ line of mice by infecting preimplantation 
embryos at the 4 - 8 cell stage (Jaemsch, 1976, 1977, 
Jaemsch et al , 1981) The Balb/Mo mouse stram 
carries Moloney murine leukemia virus (M-MuLV) as 
an endogenous virus (Jaemsch, 1976, 1977) in a 
single Eco RI DNA fragment of 27 kb (van der Putten 
et a l , 1979, Jaehner et a l , 1980) at a single Mende-
han locus (Mov-1 ) on chromosome number 6 (Breindl 
et al , 1979) While these Balb/Mo mice are viremic 
from birth and develop a thymus-dependent leukemia 
of viral (M-MuLV) etiology (Nobis and Jaemson, 1980) 
after a latency of several months, Balb/c and 129 
mice do not develop this disease spontaneously at 
this age (Peters et al , 1973, Jolicoeur et al , 1978) 
However, when newborn Balb/c or 129 mice are 
injected with M-MuLV, a thymus-dependent leukemia 
follows the expression of high titers of the virus in the 
blood (Jaemsch et al , 1975, Reddy et al , 19Θ0) 
Leukemogenesis in Balb/Mo and newborn-infected 
Balb/c and 129 mice is accompanied by somatic 
amplification (Jaemsch et al , 1975, Jaemsch, 1979) 
and reintegration of Moloney viral sequences in new 
chromosomal sites of tumor tissues (van der Putten et 
a l , 1979, Jaehner et al , 1980) The endogenous virai 
integration site occupied in preimplantation embryos 
is not preferentially occupied when newborn Balb/c 
mice are infected with M-MuLV Some of the reinte­
grated Moloney sequences do not contain the contig­
uous genomic information characteristic for M-MuLV 
but are composed of incomplete, rearranged or re-
combmed Moloney proviral genomes present in new 
sites in the chromosomal DNA (van der Putten et al , 
1979, Jaehner et al , 1980) 
Recombinants between Moloney virus and xeno-
tropic viruses have been isolated from lymphomas of 
leukemic Balb/Mo mice (Vogt, 1979) Heteroduplex 
studies revealed that these are env-gene recombi­
nants of M-MuLV with xenotropic viruses (Bosselman 
et al , 1979) This type of virus has been implicated in 
malignant transformation of erythroid and lymphoid 
cells in several mouse strains, and the presence of a 
recombinant virus with such a distinct structure in the 
DNA of every virus-induced lymphoma would suggest 
a role for recombinant viruses in the leukemogemc 
process Therefore we have searched for common 
features of integrated recombinant viral genomes in 
Moloney virus-induced tumors of leukemic Balb/Mo, 
Balb/c and 129 mice 
Until now this kind of analysis has been severely 
hampered by extensive nucleotide sequence homol­
ogy between the endogenous viral DNA sequences 
and the nucleic acids of M-MuLV and other exogenous 
retroviruses To avoid this problem we prepared two 
kinds of molecular probes that recognize M-MuLV 
without interacting with other endogenous viruses M-
MuLV-specific cDNA probes prepared by absorption 
of the sequences that M-MuLV has in common with 
other retroviruses and M-MuLV-specific DNA frag­
ments molecularly cloned in the plasmid pBR322 We 
report the physical mapping of M-MuLV-related ge­
nomes integrated in the DNA of a series of preleu­
kemic and leukemic tissues of Balb/Mo, Balb/c and 
129 mice 
Results 
Characterization of M-MuLV-Specific DNA Probes 
M-MuLV-Specific cDNA 
The M-MuLV-specific cDNA probe was prepared by 
a procedure slightly modified from those described 
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previously (van der Putten et al., 1979; Bacheler and 
Fan, 1981; Jaehner et ai., 1980) and is outlined in 
Experimental Procedures. The resulting M-MuLV-
specific cDNA probe detects only M-MuLV se­
quences; other endogenous viral sequences (Keshet 
et al., 1980) in Balb/Mo, Balb/c and 129 mice were 
not recognized (Figure 1A). Furthermore, the M-
MuLV-specific cDNA probe displayed hybridization 
with genomic fragments derived from different loca­
tions of cloned M-MuLV proviral DNA (Gilboa et al., 
1979; Yoshlmura and Weinberg, 1979; Berns et al., 
1980; С. Shoemaker, personal communication) as 
shown in Figure IB. Some preferential hybridization 
was seen to fragments which map in the substitution 
loop structures of heteroduplexes between M-MuLV 
full-length cDNA and AKR (Chien et al., 1978) and 
Moloney mink cell focus-inducing (MCF) viral RNA 
(Bosselman et al., 1979). The results indicate that M-
MuLV cDNA-specific sequences are present at many 
locations on the M-MuLV genome and the cDNA 
probes can be used successfully to detect M-MuLV 
subgenomic fragments in cellular DNA. 
Molecularly Cloned M-MuL V- Specific DNA 
Fragments 
A random population of in vitro synthesized M-MuLV 
double-stranded DNA was cloned in the plasmid 
pBR322 by (dC-dG) tailing method as described in 
Experimental Procedures. Three of the M-MuLV-spe-
cific probes (MS-2, MS-3 and MS-4) were mapped at 
different positions of the M-MuLV genome is shown in 
Figure 1D. The size of the inserts was rather small 
(from 150 to 200 nucleotides). Both the selected 
cDNA probe and the MS probes recognize M-MuLV-
specific sequences distributed throughout the M-
MuLV genome. More importantly, the results in Figure 
1С show clearly that these specific probes are capa­
ble of recognizing M-MuLV-specific sequences 
among the background of endogenous viral genomes. 
Integration Sites of Somatically Acquired 
Sequences in Tumors 
Earlier studies have shown that somatically acquired 
M-MuLV sequences (Jaenisch et al., 1975; Jaenisch, 
1979) are found in many sites of the mouse genome 
(van der Putten et al., 1979). A distinct pattern of 
reintegrated M-MuLV genomes is seen in outgrown 
tumors of individual animals indicating a monoclonal 
origin of the tumors (Jaehner et al., 1980). 
Study of the patterns of reintegrated viruses, how­
ever, have provided little insight into the structure of 
reintegrated M-MuLV sequences both in the early and 
later stages of the disease. Therefore, DNAs from a 
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Figure 1. Characterization of the M-MuLV-
Spectfic DNA Probes 
(A) 10 μβ of 129. Balb/c and Balb/Mo brain 
DNA were cleaved by Eco RI and analyzed for 
M-MuLV-specific sequences by a selected 
cDNA probe as described in Experimental Pro­
cedures. The M-MuLV-spectfic cDNA probe 
<cDNAJ recognizes specifically the Mov-1 M-
MuLV proviral DNA among other endogenous 
viral sequences, while a M-MuLV total cDNA 
probe (cDNA) recognizes many endogenous 
viral sequences 
(B) DNA from M-MuLV proviral DNA (contain­
ing one LTR) cloned Into phage Charon 21A 
(Berns et al.. 1980) was cleaved with Hind III, 
Htnd Hi-Bam Hi and Hind Hl-Kpn I; each lane 
represents an equlmolar amount of M-MuLV 
DNA as present in tissue DNA from a homo­
zygous Balb/Mo mouse (2 copies/diploid ge­
nome equivalent). Fragments were transferred 
to nitrocellulose sheets and hybridized to M-
MuLV-specific cDNA as described in Experi­
mental Procedures The line figure shows the 
restriction map of molecularly cloned lamda, 
MuLV-1 (Berns et al.. 1980) Since the M-
MuLV viral DNA was cleaved at the unique 
Hind III site and cloned in the unique Hind Ml 
site of Charon 21 A. the tine diagram shows 
the structure of the permuted M-MuLV DNA. (Broken line at 8.2 kb indicates the 5' end of the nonpermuted M-MuLV genome ) The molecular 
weights of the M-MuLV-specific restriction fragments are indicated in the figure. Marker DNA fragments that have been used for these and 
subsequent analyses were Eco RI. Hind III. Bam HI and Kpn I digests of Ad2 viral DNA and phage lambda DNA: molecular weights Indicated in this 
and subsequent figures were determined from log molecular weight versus mobility curves. 
(С) Юмд of 129. Balb/c and Balb/Mo brain DNA cleaved by Eco RI, were analyzed by hybridization to MS-2. MS-3 and MS-4 probe. All these 
probes yielded the same result: no hybridization to endogenous viral sequences in 129 and Balb/c mouse DNAs and specific recognition of the 
Mov-1 M-MuLV proviral DNA in the characteristic 27 kb Eco RI DNA fragment of Balb/Mo brain DNA. 
ÍD) The positions of the MS probes on the linear map of the M-MuLV genome are shown The plasmid MS-3 mapped in the gag gene region, while 
MS-4mappedin the putative carboxy terminal part of the po/gene (Chien et a!.. 1978. Sutciiffeet al.. 1980) MS-2 mapped m the LTR indicating 
that terminally redundant sequences of different MutVs display unique sequences 
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series of tumors of Balb/Mo and Balb/c mice (the 
latter infected with M-MuLV when newborn) were an­
alyzed in more detail by restriction endonuclease map­
ping using a selected cDNA probe and M-MuLV-spe-
cific (MS) plasmid probes. High molecular weight 
DMAs (van der Putten et al., 1979) were cleaved with 
Eco RI and analyzed by Southern blotting (Figure 2). 
The MS-2 plasmid probe, which recognizes M-MuLV-
speciflc sequences In the large terminal repeat (LTR) 
hybridized to the same array of Eco RI fragments as 
the selected cDNA probe. This Indicates that each 
reintegrated M-MuLV genome or subgenomic frag­
ment contains M-MuLV-speclflc LTR sequences. In 
contrast, the plasmid probes MS-3 and MS-4, which 
correspond to regions in gag and pol, respectively, 
hybridized to about half the fragments detected by 
MS-2 or the selected cDNA probe. The detection of 
fragments smaller than 8.8 kb suggests the involve­
ment of internal rearrangements of the proviruses 
(Figure 2). Apparently the somatically acquired M-
MuLV genomes are often modified, deleted or recom-
blned. More detailed analyses of the integrated M-
MuLV genomes revealed a rather specific recombi­
nation event leading to the acquisition of an Eco RI 
site within the recombinant genomes. Therefore the 
detection of multiple M-MuLV-contalnlng Eco RI DNA 
fragments Is not due to a large variety of structural 
rearrangements within provlral genomes but rather to 
integrations In different sites of the host genome. No 
preferential sites seem to exist, since outgrown tumors 
of different animals show a distinct Integration pattern 
specific for each individual animal (Jaehner et al., 
1980; data not shown). 
In contrast, preleukemic Balb/Mo (Jaehner et al., 
1980; our unpublished results) and Balb/c mice (in­
fected with M-MuLV when newborn) do not display 
this pattern of Integrated recomblned M-MuLV se­
quences in the DNA of their target tissues. However, 
these tissues do contain ' randomly' integrated M-
MuLV genomes as shown by analyses with restriction 
TOTAL с *4Л SPECIFIC cDNA MS , " b 
endonucleases Ava I and Kpn I. For example, restric­
tion endonuclease Ava I cleaves M-MuLV DNA ten 
times to generate 11 fragments of 2.45, 1.85, 1.5, 
1.2 kb and a number of fragments ranging from 80 to 
600 nucleotides. The four major Ava I fragments and 
the Kpn I fragments characteristic for M-MuLV proviral 
DMA (Figure 4B) can be detected in all preleukemic 
target tissues as well as In Balb/Mo and Balb/c tumor 
DNAs. 
Molecular Structure of M-MuLV Sequences In 
Tumors 
Most recombinant viruses isolated from leukemic 
Balb/Mo mice (Vogt, 1979) and from other strains 
with a high incidence of leukemia are env gene recom­
binants (Elder et al., 1977; Hartly et al., 1977; Chien 
et al., 1978; Donoghue et al., 1978; Faller et al., 
1978; Rommelaere et al., 1978; Shih et al., 1978; 
Bosselman et al., 1979; Lung et al., 1980; Rowe et 
al., 1980). They are composed mainly of ecotropic 
MuLV parental sequences, and therefore differences 
in restriction endonuclease patterns with M-MuLV can 
be expected to be derived mainly from the env gene 
region. To detect recombinant M-MuLV sequences, 
tumor DNAs were cleaved by restriction endonuclease 
Kpn I which cleaves M-MuLV proviral DNA in the LTR 
at map positions 0.5 and 8.7 kb, and within the coding 
region at position 3.4, 6.05 and 7.35 kb(Gi lboaeta l . , 
1979; Berns et al., 1980; Shoemaker et al., 1980). 
The genetically transmitted Mov-1 M-MuLV DNA in 
both tumor and nontumor DNA of BALB/Mo mice is 
cleaved at nearly identical positions (Figure 3). 
All BALB/Mo, BALB/c and 129 tumor DNAs dis­
played one or more new Kpn I DNA fragments in 
addition to those derived from the endogenous M-
MuLV (BALB/Mo) or the exogenous M-MuLV clone 
1A provlral DNA (BALB/c and 129) as shown in Figure 
4. Since unlntegrated provlral DNAs were removed 
from our DNA preparations (van der Putten et al., 
1979), the new Kpn I DNA fragments must be derived 
Figure 2 M-MuLV Sequences in Eco RI Frag­
ments of Cellular DNAs 
Each panel represents an individual gel with 
five lanes containing, respectively, Eco RI 
fragments of Balb/c brain DNA. Balb/Mo 
brain DNA. two Balb/Mo (mouse M9 and M10) 
tumor DNAs. and a newborn-infected Balb/c 
mouse (503; infected with 10 XC plaques of 
M-MuLV clone 1 A) tumor DNA Southern blots 
were screened with a representative M-MuLV 
cDNA probe, a selected M-MuLV-specific 
cDNA probe, and nick-translated plasmid 
probes of MS-2. MS-3 and MS-4. respectively, 
as described in Experimental Procedures 129 
mouse DNA displays the same characteristic 
features when hybridized to a total or selected 
cDNA probe as Balb/c DNA, the major differ­
ence is the presence of the endogenous Akv 
genome in Balb/c DNA. which is not present 
In the 129 mouse genome (see also Quint et 
a l , 1981) 
Cell 
732 
-4-
Balb/Mo Mov-1 
НШІ 
Figure 3 Restriction Map of the Mov 1 M MuLV DNA and Flanking Cellular Sequences 
This map was constructed by combining restriction data from the cloned 5' viral DNA-eellular DNA 8 9 kb Hmd til fragment (Berns et al 1960) 
and additional restriction analysis of Balb/Mo tissue DNAs (brain) and Isolated Mov-1 M MuLV DNAs from both tumor and nontumor tissues (see 
also Figure 5) Balb/Mo DNA was cleaved with several restriction enzymes and screened with a M MuLV-specific cDNA probe as described in 
Experimental Procedures The presence of the Sma I site at position β θ kb and the Pvu II alte at position θ 32 kb are still presumptive these sites 
have been mapped in cloned M-MuLV proviral DNA (our unpubllahed resulta Shoemaker et al 19Θ0) but not yet in the integrated Mov 1 M MuLV 
DNA Also the 3 Kpn I fragment (7 Э5- 7 kb) contains a small deletion (60-BO nucleotides see for example Figure 4A) when compared to M-
MuLV clone 1A proviral DNA (see for example Figure 4E) 
from integrated vtral DNAs Although a variety of Kpn 
I fragments could be observed in some tumors (Figure 
4A, lanes 5, 7, 9,10) all tumor DNAs contained a 5 2-
5 6 (5 4) kb and/or 4 0-4 θ (4 4) kb Kpn I DNA 
fragment It thus appears that outgrown tumors within 
each mouse (tumors from different anatomical loca­
tions showed the same pattern) contain a specific 
subset of M-MuLV-denved sequences, integrated in 
different chromosomal sites In the preleukemic tis­
sues (thymus and spleen) the additional Kpn I frag­
ments (Figure 4B) observed in DNA from outgrown 
tumor tissues were not detected (unless after ex­
tremely long exposures, Figure 4B lanes 9-13) 
Therefore, the appearance of these new Kpn I DNA 
fragments coincides with the outgrowth of 'umor cells 
All new Kpn I DNA fragments around 5 kb, identified 
in DNA from tumors of Balb/Mo mice or newborn-
infected Balb/c and 129 mice, could be cleaved by 
Eco RI (Figure 4C), resulting in the generation of a 3 6 
kb fragment and one or more fragments of approxi­
mately 1 7 kbp, in two instances a 4 kb fragment was 
found in addition (Figure 4C, lanes 6 and 9) The 
presence of an Eco RI site in these Kpn I DNA frag­
ments indicates that non-M-MuLV sequences consti­
tute part of these fragments (Verma and McKennett, 
1978, Smotkm et al , 1976) 
The Kpn I DNA fragments around 5 kb as well as 
the 3 6 kb fragment (Kpn l-Eco RI) are all recognized 
by the MS-4 plasmid probe (Figure 4D) which maps In 
the putative carboxy-termmal region of the poi gene 
(Figure 1D) 
Hybridization studies with MS-2 and MS-3 were 
performed to determine whether sequences derived 
from the gag and LTR regions were contained in the 
5 4 and 4 4 kb Kpn I DNA fragments Kpn l-digested 
tumor DNA was hybridized to MS-3 probe, which had 
been localized in the gag gene region (Figure 1) 
Figure 4E shows that while M-MuLV-speciftc cDNA 
recognizes the additional Kpn I fragments in tumor 
DNA from three different 129 mice, the MS-3 probe 
only recognizes the M-MuLV-specific 2 9 kb Kpn I 
DNA fragment MS-2 (which maps in the LTR region) 
recognized the 5 4 kb tumor-specific Kpn I fragments 
whereas the 4 4 kb fragments were not detected (data 
not shown) Based upon these hybridization results 
with MS-2, MS-3 and MS-4 probes, the location of the 
recombinant Kpn I 5 4 kb fragments extends from 
map position 3 4 toward the 3' end and the 4 0-4 θ 
kb fragments from 3-3 5 to 7 4 kbp Therefore both 
contain the information for a recombinant em gene 
In animal 14 (Figure 4D, lane b) Eco RI + Kpn I 
digestion generated, in addition to the 3 6 kb frag­
ment, a fragment of 4 0 kb also recognized by MS-4, 
suggesting the presence of yet another organization 
of recombinant proviral DNA Since this fragment can 
also be obtained by cleaving the 4 4 kb Kpn I fragment 
by Eco RI it is probably derived from position 3-7 35 
on the corresponding M-MuLV map Apparently re­
combinations deviating from the one described above 
can be fixed in tumor DNA although with much lower 
frequency We want to emphasize, however, that they 
are only formed in addition to the recombinant de­
scribed earlier and never constitute the single recom­
binant genome type in tumor DNA Upon digestion of 
tumor DNA with Eco Rl-Kpn I, besides a homogene­
ous 3 6 kb fragment, heterogeneous smaller frag­
ments of around 1 7 kb can be detected which are 
not seen in nontumor DNA (Figure 4C) These small 
fragments correspond to the region 3' terminal of the 
Eco RI site in the recombinant viral sequences The 
heterogeneity in fragment sizes observed seems 
mainly to be due to variation in LTR sequences of the 
recombinant proviral DNAs (data not shown) The 
variation in size of these smaller fragments is also 
reflected In the heterogeneity of the 5 4 kb Kpn I DNA 
fragments (Figure 4C) 
The variation in size of the 4-4 8 kb Kpn I fragments 
might be caused by the position of the recombination 
site around map position 7 35 kb Several Kpn I sites 
probably are present in the parental genomes around 
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Figure 4. M-MuLV-Specific and Recombinant M-MuLV Sequences In Baib/Mo and Balb/c Mouse Tumors 
(A) 10 μβ of Balb/Mo tissue DNAs were cleaved by Kpn I, fractionated on 1 % agarose gel and screened with a selected cDNA probe as described 
in Experimental Procedures. Lanes represent DNAs from Balb/Mo tumors from mouse M9 (spleen), MIO (spleen). M28 (spleen). M27 (tnymus). 
Μ26 (thymus). M23 (thymus). M l 9 (spleen). M18 (spleen). M14 (spleen). M13 (spleen). M l 2 (spleen). M i l (thymus), and Balb/Mo brain DNA 
The differences in hybridizations between tumor DNAs do not reflect differences in amount of DNA loaded in each lane; they merely reflect 
differences In numbers and amounts of reintegrated M-MuLV and recombinant sequences in individual tumors. 
(B) Balb/c preleukemic and leukemic tissues. Lanes represent DNAs analyzed as in A. Balb/Mo and Balb/c DNAs are shown for reference (lanes 
1 and 2). Lanes 3-13 represent tissue DNAs from Balb/c mouse 503 (spleen: infected with 10 XC plaques of M-MuLV when newborn, sacrificed 
at 6 months of age), from 5 Balb/c mice (infected with 10' XC plaques of M-MuLV when newborn; sacrificed at 3-6 weeks of age; lanes 4-8 
contain either spleen or thymus DNA) at preleukemic stage and from 5 Balb/c mice (10e XC plaques) sacrificed at 10-12 weeks of age (lanes 9 -
13. either thymus or spleen), when leukemic. No additional Kpn I fragments can be detected in preleukemic tissue DNAs: leukemic tissue DNAs 
do display new fragments characteristic of integrated recombinant M-MuLV genomes in addition to fragments specific for authentic M-MuLV 
genomes. The lower part of the autoradiogram is not shown (see Figure 4E) and was identical to Figure 4E (only a doublet of 1.3 kb). 
(C) 10 pg of Balb/Mo DNAs. cleaved by Kpn I + Eco RI, were screened with a selected cDNA probe as described In Experimental Procedures 
Lanes represent the same tissue DNAs as shown in A The lower part of the x-ray film was exposed for a longer period in order to visualize the 
smaller fragments. 
(D) Each set of lanes represents a Kpn I (lane a) and Kpn l-Eco Bl (lane b) digest of Balb/Mo mouse tumor DNA as shown in A, and hybridized 
to the MS-4 Plasmid probe which maps In the putative carboxy terminal part of the pol gene (Figure 1 ). Both the Kpn I DNA fragments (5 4 and 4 4 
kb) and the Kpn I-Eco RI DNA fragments (3 6 and 4 0 kb) diagnostic for recombinant M-MuLV genomes hybridize to MS-4 probe. The 2 9 kb 
fragment derived from integrated authentic M-MuLV genomes is also detected by MS-4 probe 
(E) 10 μg of 129 tumor DNAs (obtained from three individual 129 mice, injected with about 10 XC plaques of M-MuLV clone 1A and sacrificed at 
6 months of age) were cleaved by Kpn I and analyzed with a selected cDNA probe and the M5-3 Plasmid probe as described in Experimental 
Procedures The recombinant Kpn I DNA fragments do not hybridize to the MS-3 Plasmid probe. 
this position, giving rise to a variety of recombinant 
Kpn I fragments depending on the exact site of recom­
bination. So far we have not determined the genomic 
location of the Kpn I fragments of around 1.3 kb seen 
in tumors of some Balb/Mo mice (Figure 4A, lanes 5, 
9, 10). 
To establish a fine structure map of the rearranged 
M-MuLV genomes, the detailed restriction map of the 
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Figure 5 Structures of the Mov-1 M-MuLV and Recombinant Proviral DNA 
(A) Lanes represent Moy-1 M-MuLV DNA (20-100 kb Eco RI DNA fraction from Balb/Mo brain: [van der Putten et al., 1979P. equivalent to 10 
μο of Balb/Mo brain DNA and cleaved with restriction endonucleases as indicated. Lanes 2-5 show the Mov-1 M-MuLV DNA fraction cleaved with 
Kpn I and an additional enzyme, while lanes 7-10 represent similar analyses with Sac I and another enzyme as indicated. Fragments were 
separated on 1 % agarose gel and analyzed with a selected M-MuLV-speciflc cDNA probe as described in Experimental Procedures (the upper 
band in the Bgl I digestion is a partial cleavage product). 
(B) Lanes represent 10 ;ig of tumor DNA from Balb/Mo mouse M9. analyzed as in A. Both the Mov-1 M-MuLV-speciflc restriction fragments and 
the new fragments specific for recombinant M-MuLVs ere shown In this map. No hybridization was detected >5 8 kb. Sma I does cleave the Mov-
1 M-MuLV DNA from Balb/Mo tumor M9 (this was also confirmed by cleaving the isolafed Mov-1 M-MuLV DNA in the 20-100 kb Eco Hl DNA 
fraction from Balb/Mo tumor DNA), but no from brain due to tissue-specific methylation. 
(C) 10 fig of tumor DNA from Balb/c mouse 503, infected with M-MuLV when newborn, was analyzed In each lane as In B. Lane 2 shows two Bam 
HI DNA fragments of 2 2 and 2 5 kb, respectively, diagnostic for recombinant M-MuLV genomes in addition to the 3 kb fragment characteristic for 
authentic M-MuLV proviral DNA '. -
(D) Lanes represent 10 дд of 129 tumor DNA, isolated from three animals with a distinct integration pattern of M-MuLV sequences (same animals 
as analyzed in Figure 4E) after cleavage by 8am HI The first three lanes show the analysis with a selected M-MuLV-speciflc cDNA probe while 
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genetically transmitted M-MuLV (Figure 3) was com­
pared with the physical map of somatically acquired 
M-MuLV genomes Cleavage of tumor DNA from both 
Balb/Mo and newborn-infected Balb/c and 129 mice 
revealed the presence of internal fragments charac­
teristic of authentic M-MuLV in addition to fragments 
derived from integrated recombinant viruses (Figure 
5C, lane 2 shows two additional Bam HI fragments of 
2 2 and 2 5 kb compared to Figure 5A, lane 7) Figure 
5C lane 4 shows, in addition to the Kpn l-Sac I 
fragments of 2 9, 2 65, 1 3 and 1 25 kb characteristic 
for M-MuLV, the 4 4 kb Kpn I fragment diagnostic for 
the presence of a recombinant M-MuLV genome The 
2 2 kb Bam HI fragment was found in every tumor 
DNA, like the 3 6 kb Eco Rl-Kpn I fragment Also, the 
2 2 kb Bam HI fragment was recognized by the MS-4 
probe For example, the DNA of three M-MuLV-m-
duced tumors of different 129 mice with each a dis­
tinct integration pattern of M-MuLV sequences (Figure 
5D, lanes 1,2,3) contained the same 2 2 kb Bam HI 
recombinant DNA fragment in addition to the 3 kb 
fragment characteristic for M-MuLV The resulting 
physical maps of the two slightly different integrated 
recombinant viruses is depicted in Figure 5E 
Discussion 
Amplification of viral sequences is observed in tumors 
of Moloney virus-induced leukemias of Balb/Mo, 
Balb/c and 129 mice (van der Putten et a l , 1979, 
Jaenisch et a l , 1975, Jaenisch, 1979, Jaehner et a l , 
1980) Similar phenomena have been reported for 
MuLV-mduced thymomas in NIH/Swiss mice (Steffen 
and Weinberg, 197Θ) and in tumors of leukemic AKR 
mice of several inbred sublines and Akv congenie 
mice (Canaam and Aaronson 1979, Steffen et al , 
1979 Quint et al , 1981), in M-MTV-mduced carci­
nomas (Varmus et al , 1978, Morris et al , 1980), in 
bovine leukemia virus (BLVHnduced lymphocytosis 
(Kettmann et al , 1980), and avian leukosis virus 
(ALVHnduced metastasizing lymphomas (Neiman et 
al , 1980) Somatic acquisition of viral sequences 
seems therefore to be a frequently observed phenom­
enon dunng virus-induced tumor development 
M-MuLV-induced leukemias of Balb/Mo, Balb/c 
and 129 mice display a unique pattern of reintegrated 
M-MuLV sequences for each animal and no common 
reintegration sites are detected (Jaehner et a l , 1980) 
Hybridization studies with M-MuLV-specific Plasmid 
probes and a selected cDNA probe show that all 
outgrown tumors contain both somatically acquired 
authentic M-MuLV genomes and recombinant provi ral 
genomes, each integrated in a different site of the 
chromosomal DNA These recombinants carry an Eco 
RI site, cleavage with Eco RI generates fragments of 
subgenomic size, all of which hybridize to a probe 
recognizing the LTR region (MS-2) The smaller frag­
ments do not, however, hybridize to a 5'-speciftc 
probe (MS-3) or to a probe recognizing a region 
proximal to the recombinant region (MS-4) This sug­
gests that the majority of these smaller fragments 
represent 3' portions of recombinant proviruses How­
ever, the fragments that hybridize to MS-3 also hy­
bridize to MS-4 and are almost exclusively larger than 
6 9 kb indicating that deletions in the 5' half of inte­
grated recombinant viruses (with an Eco RI site at 6 9 
kb) are rare The relative simple patterns of proviral 
restriction fragments confirm this notion A strong 
selection pressure during the outgrowth of the tumor 
might give rise to tumor cells with relatively low num­
bers of defective recombinants Alternatively, if defec­
tive recombinants are generated later in tumor devel­
opment they might escape detection by our analysis 
since they will be Integrated in multiple sites at low 
copy number However, heteroduplexes formed be­
tween genome-length M-MuLV cDNA and Balb/Mo 
thymoma RNA showed only one major substitution 
loop in the п region, suggesting the absence of 
aberrant species of viral RNA in addition to nondefec-
tive recombinant viral genomes (Bosselman et a l , 
1979) whose structure we have identified here at the 
DNA level 
Preleukemic tissues only contain authentic contig­
uous M-MuLV genomes integrated randomly in the 
host genome (see also Jaehner et al , 1980) Leu­
kemic tissues, however, harbor specifically integrated 
M-MuLV as well as recombinant proviruses Clonal 
selection of cells (McGrath et a l , 1980) must therefore 
take place after the preleukemic phase, giving rise to 
the distinct integration pattern seen in the outgrown 
tumor 
The molecular structure of two recombinant proviral 
genomes in Balb/Mo, M9 and Balb/c 503 tumor 
DMAs, respectively, is characterized by a recombma-
ttie last Ihree lanes show the hybridization results ol MS-4 probe with the same filler The M-MuLV-specltlc selected cDNA probe recognizes both 
the cellular-viral DNA lunctlon fragments and the Internal M-MuLV (3 kb) and recombinant (2 2 kb) specific Barn HI DNA fragments MS-4 
recognizes only the authentic M-MuLV-speciflc 3 kb Bam HI DNA fragment and the maior recombinant specific 2 2 kb Bam HI DNA fragment The 
faint hybridization of MS-4 to a 6 and 1 75 kb Bam HI DNA fragment cannot yet be explained although these might represent other recombinant 
proviral organizations like detective recombinant 
(E) The upper line represents the map of the Mov-1 M-MuLV DNA as derived for both tumor and nontumor DNA The two lower lines show the 
structures of the recombmanl Kpn I DNA fragments from tumor DNA of Balb/Mo mouse M9 (5 4 kb) and Balb/c mouse 503 (4 0 kb) respectively 
the newly acquired sequences in the mink cell focus-inducing (MCFVtype proviral DNAs are Indicated by a double line The newly acquired 
restnctlon-endonuclease recognition sites are also shown as well as the position of the recombinant specific Bam HI (2 2 kb) and Kpn l-Eco RI 
(3 6 kb) DNA fragments detected in all tumors and diagnostic for recombinant provbral DNA The presence ol the Bgl I and Bgl II sites In the ΜΘ 
recombinant and their absence m the 503 recombinant have been established by adntional digestions The lowest part of the Figure Indicates the 
location of the п gene which starts at position 6 4 kb (C van Beveren personal ccjmmunicatlon) 
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Hon with cellular sequences between map positions 
5 9 and 7 35 kb from the 5' end of the M-MuLV 
genome (Figure 5E) Although the recombination at 
around map position 7 35 kb seems to vary slightly in 
different recombinant proviral organizations, the re­
gion coding for the carboxy terminus of gp70 and the 
nucleotide sequence for pi 5E (Sutcliffe et al , 1980a, 
1980b) are probably not affected by the recombma-
tional event and are derived from the ecotropic paren­
tal genome (in agreement with heteroduplex data, 
Bosselman, 1979) The newly acquired genetic infor­
mation has nearly the same length as the substituted 
M-MuLV sequences and contains several new restric­
tion sites at fairly similar positions in different recom­
binants isolated from different strains of mice A Bam 
HI DNA fragment of 2 2 kb (detected by MS-4, Figure 
5D), specific for somatically acquired recombinant 
sequences, is detected in all Balb/Mo, Balb/c and 
129 mouse tumor DMAs analyzed so far Tumors of 
AKR mice also display Bam HI DNA fragments of 2 2 
kb and contain similar recombinants (Quint et al , 
1 9 8 1 , W Herr, personal communication) Proviral 
DNA of the leukemogenic Akv recombinant virus MCF 
247 isolated from AKR thymus, also carries an Eco RI 
site 6 9 kb from the 5' end (Pedersen et al , 1980) 
Therefore, these recombinants almost certainly rep­
resent MCF proviruses The location of the substitu­
tion in the two analyzed recombinants agrees well with 
a recombination in the env gene The newly acquired 
sequences probably are derived from endogenous 
xenotropic viral sequences since it was shown that 
substitution loops disappear by hybridization of MCF 
viral RNA to New Zealand Black (NZB) or Balb virus-
2 cDNA (Bosselman et al , 1979) The heterogeneity 
in length of the 5 4 kb recombinant Kpn I DNA frag­
ments from tumors of different mice (Figure 4A) prob­
ably reflects variation in the LTR sequences of the 
recombinant M-MuLV genomes (van Beveren et al , 
1980, Rands et al , 1 9 8 1 , Ju et al , 1980, Chueng et 
al , 1980) The variation in size of the 4 0 - 4 В kb 
recombinant Kpn I DNA fragment can be explained by 
the presence of several Kpn I sites in the parental 
genomes at around map position 7 35, the exact site 
of recombination determines the length of the Kpn I 
fragments Despite variations in site of recombination, 
all tumor DNAs contain integrated recombinant pro-
viral DNAs with the same type of recombination with 
the NH ? terminus of the env gene (which starts at 
position 6 4 kb [C van Beveren, personal communi­
cation]) derived from the xenotropic parent 
Our data show lhat molecular probes can be pre­
pared that can reveal the structure of rearranged 
MuLV sequences among a background of related 
endogenous viruses m mouse DNAs This seems a 
prerequisite for revealing changes in viral structures 
mtrinsicly related to the leukemogenic process The 
relative inefficiency of cloned MCF viruses in the leu­
kemia acceleration test has led to doubt concerning 
the role of these env recombinant viruses in the leu­
kemogenic process Because of their general occur­
rence some of our observations seem relevant to virus 
induced leukemogenesis Authentic M-MuLV ge­
nomes are integrated randomly in the DNA of preleu-
kemic tissues Outgrown tumors contain authentic M-
MuLV genomes as well as recombinant genomes in­
tegrated in unique sites of the chromosomal DNA The 
recombinants integrated in multiple copies in the dif­
ferent tumor tissues (we analyzed more than 30) show 
a striking similarity in structure all are env gene 
recombinants with a genomic size similar to the pa­
rental M-MuLV, which have acquired xenotropic-
like ' sequences approximately between map posi­
tions 6 kb and 7 5 kb from the 5' end corresponding 
to the NH2-terTTiina1 port of the envelope glycoprotein 
Every lymphoma induced by M-MuLV (or AKR, Quint 
et al , 1981 ) in a variety of mouse strains harbors the 
same type of recombinant virus integrated in its DNA, 
suggesting that similar xenotropic-hke sequences 
are available for recombination in different mouse 
strains, although no xenotropic virus can be induced 
from some of these strains 
The structural similarities of integrated recombinant 
viral DNAs observed in a large number of lymphomas 
induced by MuLV in several mouse strains strongly 
support the hypothesis that the formation of defined 
recombinants is related to the leukemogenic transfor­
mation The coincidence of the formation of these 
recombinants with the clonal outgrowth of trans­
formed cells is clearly illustrated, the progenitor cell 
of the outgrown tumor carries this recombinant virus 
in addition to the ecotropic virus integrated in its DNA, 
whereas the preleukemic target tissues contain almost 
exclusively the parental ecotropic provirus These ob­
servations suggest a double role for the MuLV in 
lymphomagenesis generating lymphomagenic re­
combinants (Cloyd et al , 1980, Vogt, 1979) and 
acting as a helper by facilitating infection of MCF 
genomes by genomic masking (Haas and Patch, 
1980) or by another helper function still obscure 
Since integration of defined recombinants seems 
directly related to clonal outgrowth of transformed 
cells, we favor a direct role of the recombinant genes 
in the transformation event It might reflect a specific 
property that enables the infected cells to complete 
the different final steps in the metastatic process 
(Poste and Fidler, 1980) Testing a variety of cloned 
recombinant viruses identified first by the type of 
approaches described in this paper will shed more 
light on their generation and exact role in the leuke­
mogenic process 
Experimental Procedures 
Mice, СеИ Line· end Viruses 
The origin of mice cell lines and Isolation procedures of M-MuLV 
clone 1A AKR-MuLV and Balb virus-2 have been described previ­
ously (Bosselman el al 1979 van der Pullen et al 1979) 
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The injection of newborn Balb/c and 129 mice was performed as 
described by Jaenisch et al (1975) 
Selection of cDNA Prob« 
a-32P-labeled M-MuLV cDNA was prepared ae described for 3H-cDNA 
(van der Putten et a l , 1979), a-^P-dCTP (Amersham, spec act 
2000-3000 Ci/mmole) was used as precursor About 5 x 10e cpm 
^P-cDNA were obtained m typical reactions containing 250 μΟι a· 
"P-dCTP. 1 mM dTTP. 1 mM dGTP. 1 mM dATP, 2 mg/ml calf 
thymus DNA pnmer, 50 mM Trls-HCI (pH θ 3), 3 mM MgAc3. 60 mM 
NaCI, 20 mM DTT, 50 μfl/ml Aclmomyclne D. 0 016% NP-40 and 
0 15-0 2 mg of virus m a final volume of 150 μ\ 
M-MuLV cDNA sequences that crosshybndize with other mouse 
viruses were removed by selectron on a mixture of AKR viral RNA (2-
3 μ9) and RNA (200 μg) from livers of NZB mice which express 
xenotropic virus information (Levy, 1973, Levy et a l , 1Θ75) This 
procedure was used to absorb the major part of M-MuLV sequences 
that reacted with AKR and xenotropic viral sequences as shown by 
heteroduplex analysis (Chien et a l , 1976. Bosselman et a l , 1979), 
5 x 108 cpm cDNA were hybridized to the mixture of RNAe m 10 mM 
TES (pH 7 4), 1 mM EDTA. 2 дд/т і polyvlnytaulfate and 0 5 M NaCI 
for 3-5 hr at 65CC Hybrid formation was assayed by SI nuclease, 
50-55% was usually Si resistant at maximal hybridization, and 
hybrids were removed by chromatography on hydroxy-apatlte The 
M-MuLV cDNA probe was further depleted of sequences present In 
the Balb/c mouse genome by hybridization to an excess of Balb/c 
mouse DNA followed by hydroxy-apatlte chromatography (Jaenisch, 
1977, van der Putten et al , 1979), the remaining single-stranded 
DNA traction (about 1 5 x 1 0 " cpm) was used as a M-MuLV-spectfic 
cDNA probe 
Restriction Analysis 
Preparation of high molecular weight DNAs from tissues, restriction 
analysis, electrophoresis and elutlon of DNA fragments from agarose 
gels has been described (van der Putten et at , 1979, Quint et al., 
1ΘΘ1) Phage λ DNA was included in the reactions to serve as a 
control for the extent of digestion Reaction conditions were as 
described In the manufactures protocols (New England BioLabs, 
Boehrmger-Mannheim) 
Blotting Hybridization 
After electrophoresis the DNA was transferred with Ю х or 20x SSC 
to nitrocellulose filters (Southern. 1975) 
cDNA Hybridization» 
Before hybridization, the fitters were incubated for 2 hr at 42*C in a 
volume of 100 μΙ/cm3 prehybrldlzatlon mix (50% formamide, 5 x 
SSC. 5 x Denhardt s solution. 250/ig/ml of denatured salmon sperm 
DNA and 0 05 M sodium phosphate (pH 7,0) Hybridization was 
performed m 50% formamide, 5 x SSC, 1 X Denhardt s solution, 
0 02 M sodium phosphate, 10% dextran sulfate, 100 мд/ті of de­
natured salmon sperm DNA (Wahl et al , 1979) and 0 5-1 x 10e 
cpm/ml M-MuLV cDNA for 16 hr at 420C After hybridization, Alters 
were washed with hybridization mix without probe and dextran sulfate 
for 2 hr at 42*0. once for 15 mm with 2 x SSC, 0 1% SDS at 50oC, 
once with 0 1 χ SSC, 0 1 % SDS at 50°С. and finally 15 min at 650C 
Autoradiography was performed as described (Quint et a l , 1961) 
Plasmid Probe» 
Conditions were as described for the cDNA probe except for prehy-
bndizatlon was for at least 4 hr, hybridizations were for at least 32 hr 
without dextran sulfate and with 1-15 x 10e cpm/ml denatured 
Plasmid probe, filters were washed with hybridization mix three times 
for 1 hr each in freshly prepared solutions The SSC washing proce­
dures were carried out at 450C and 50 a C-55 0 C, respectively, for 15 
min each 
Cloning of Moloney Virus-Specific (MS) Plasmid Probes 
A random population of (n vitro synthesized double-stranded M-MuLV 
DNA (Verma, 1976) was cloned In the Pst I site of pBR322 by the dG-
dC tailing method (Chang et al . 1978) Transformants resistant to 
tetracycline but sensitive to ampicillin were screened with M-MuLV, 
AKR-MuLV and Balb virus-2 cDNA probes, prepared by the endoge­
nous polymerase reaction Clones displaying hybridization with M-
MuLV but not with AKR or Balb virus-2 cDNA were analyzed for their 
ability Lo recognize M-MuLV proviral DNAs Several M-MиLV-specific 
(MS) probes were obtained which detected exclusively M-MuLV se­
quences Details on their preparation and identification will be de­
scribed elsewhere 
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APPENDICES CHAPTER IU. 
AI. NAPPING OF THE NS-PROBES. 
DNA from Charon гіА/п-ГПиИ/ clone 
Charon 21A/M-MLV+HmdlII a s d e s c r i b e d i n t h B l e^nd to 
Figure 1 шаз cleaved with restric­
tion enzymes as indicated and an 
amount of each digest equimolar to 
5x10 /ig of M-PluLV DNA was loaded 
in each lane and subsequently 
screened with a HS-plasmid probe 
as indicated. The rightuard part 
of the Figure shous restriction 
fragments of the clone as detected 
by a representative cDNA probe of 
M-MuLV. The positions of the MS-
probes on the linear map of the 
PWIuLl/ genome are shown in the 
lower part of Figure 1. 1*15-3 was 
mapped more precisely to the 3'-
end of the Pst I site (at position 1.15 kbp from the S'-end); 1*15-3 recognizes 
the Pst I-Sal I fragment.which ranges from position 1.15 to 4.2 kbp from the 
S'-end of the M-MuLl/ proviral DNA and is therefore localized to the З'-епа 
of the Pst I site (at 1.15 kbp) and to the 5»-end of the Pvu II site (at 2.5 
kbp) as shown on the linear map in Figure 1. 1*15-2 is localized on both sites 
of the Pvu II site at position 0.12 kbp in the S'-LTR (and .6В kbp in the 
S'-LTR of M-MuLV proviral DNAs containing two LTR sequences) as both a 1. 
and a 0,2 kbp fragment can be detected by this probe. Therefore the 1*15-2 
probe recognizes both 3' and 5' LTR sequences of integrated M-PluLV proviral 
DNAs. 
A2. MONOCLONAL CHARACTER OF OUTGROUN TUMORS. 
Figure A2a shows the integration patterns of PWluLV sequences in tumors 
from various anatomical locations of three Balb/cio mice. Although the pat­
terns of reintegrated l*luLU sequences in tumors of different animals are 
clearly unique for each animal, the patterns of reintegrations in tumors 
from different anatomical sites of the same animal are identical. This 
indicates that tumors within one animal are largely derived from one or 
a few transformed cells as also observed by others (Oaehner et al., 19B0; 
Varmus et al., 197 ). Figure A2b shows that tumor DNAs isolated from 
different anatomical sites of a single animal display identical Kpn I 
patterns. This indicates that outgrown tumors within each mouse contain 
a specific subset of M-MuLV derived recombinant l*luLV sequences integrated 
in different chromosomal sites as shown in Figure A2a. 
Although one can define tumors as being largely monoclonal it seems not 
unlikely that tumor tissues are in fact composed of a few clonal cell popu­
lations each composed of different numbers of calls. For example it is not 
known whether the two tumor-specific Kpn I fragments in tumor DNA from 
mouse 1*18 (see A2b) are present in each tumor cell or whether each fragment 
is characteristic for one population of tumor cells containing only that 
particular recombinant proviral DNA. 
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Figure А2а! The integration sites of M-fluLU in Balb/lOo mouse tumors. 
10 ug of tissue DMA uas cleaved by Eco RI, fractionated on a 0.6 % agarose 
gel and analyzed for M-MuLU specific sequences by a selected cDNA probe 
as described in Experimental Procedures. Lanes represent DMAs from Balb/c 
and Balb/no brain; Balb/Mo mouse MB spleen, thymus, peripheral and visceral 
lymph-nodes, and liver highly infiltrated by lymphatic cells; Balb/Mo mouse 
Ю spleen, liver, lymph-nodes, and infiltrated kidney; Balb/Vlo mouse 1*110 
spleen, and thymus·. Other tumor tissues that have been screened were gut-
associated lymph-nodes (Payets Patches) and large lymphatic tumors along 
the digestive tract; a largely monoclonal character uias observed for out-
groun tumors in each animal. 
A2b; Balb/Mo tumors: different anatomical locations. 
As described for DNAs in A2a, but nou cleaved with Kpn I. Lanes represent 
DNAs from tumors of two Ва1Ь/|*1о mice (1*18 and Ю); Balb/c and Balb/do brain 
DNAs are shown for reference. L= liver; l-n= lymph-nodes; S= spleen; T= 
thymus; K= kidney. 
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A3. INTEGRATION SITES OF SOHATICALLY ACQUIRED SEQUENCES IN PRELEUKEMIC 
TISSUES. 
Injection of one-day-old Balb/c mice uith about 10 XC-plaques of n-MuLU 
leads to thymic enlargement and splenomegaly at 10-12 ueaks of age. All 
the leukemic animals carried several integrated M-CluLV genomes in their 
tumor DNA with a unique distribution for each individual animal (Figure 
A3a), while identical patterns were found in tumors from different ana­
tomical locations of a single animal as shown in Figure A2a. In contrast, 
preleukemic Balb/c mice at 3-6 weeks of age did not display a distinct 
pattern of integrated PWluLU sequences in the DNA of their target tissues 
as shown by Eco RI analysis (Figure A3a). However, these tissues do contain 
integrated CI-MuLU genomes as shown by analysis with restriction enzyme 
Ava I (Figure A3b) and Kpn I (Figure 48): Ava I cleaves M-nuLU DNA ten 
times to generate 11 fragments of size 2.45, 1.85, 1.5, 1.2 kbp, and a 
number of fragments ranging from 80-600 nucleotides. Figure A3b shows 
that the 4 major Ava I fragments can be detected in all preleukemic 
target tissues as well as in Balb/c tumor DNA. DNA from Balb/c tumor 
503 and ВаІЬ/Мо brain showed partial cleavage products of M-CluLU DNA by 
Ava li the Ava I recognition sequence contains a CpG base pair, and 
methylation prevents cleavage by Ava I. These results therefore reflect 
differences in the extend of base methylation of n-CluLU genomes integrated 
in different chromosomal sites and-also shows that the Clov-I M-WuLU DNA 
in Balb/no brain is methylated at many Ava I recognition sequences. The 
basic conclusions from these studies summarized are: 1) PI-PluLl/ genomes 
are randomly integrated in preleukemic tissues, and 2) outgrown tumors 
within each individual are composed largely of clonal descendants of one 
or a few transformed cells. Similar results have been obtained for 
preleukemic tissues and tumors of Balb/По mice (3aehner et al,,1980; our 
unpublished results). 
Figure A3: The integration sites 
of PWluLl/ in preleukemic and 
leukemic tissues of newborn in­
fected Balb/c mice. 
A3a: Lane 1 and 2 represent Eco 
RI digestions of ВаІЬ/По and 
Balb/c brain DNA for reference. 
Lane 3: tumor DNA from Balb/o 
mouse 503, infected when newborn 
with about 10 XC-plaque equivalents 
of PI-MuLU clone 1A and sacrificed 
at 6 months of age. Lanes 4-8 repre­
sent thymus DNAs from 5 individual 
Balb/c mice, infected with 10 XC-
plaque equivalents of M-MuLl/ clone 
1A and sacrificed at 3-6 weeks of 
age (preleukemic mice). Lanes 9-12 
represent DNAs from Balb/c mice, 
also infected with 10 XC-plaque 
equivalents of the same virus-stock 
but sacrificed at 10-12 weeks of age (leukemic). All lanes represent Eco RI 
digestions. The preleukemic animals did not show enlargement of spleen or 
thymus whereas these organs were greatly enlarged in the leukemic mice, 
PreleuBemic tissues show randomly integrated n-WuLU genomes while outgrown 
tumors within each individual show a distinct integration pattern for each 
animal. The lower part of the X-ray film was exposed for a longer period in 
order to visualize the smaller fragments, АЗЬ: lanes represent Ava I digest­
ions of the preleukemic tissue DNAs as analyzed in A3a (lanes 4-8), The 
presence of characteristic M-fluLl/ proviral DNA fragments indicates integra­
tion of n-PluLU sequences in preleukemic tissue DNAs, 
gJBsttMiìMBfi ^ ц ^ ^ 
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A4. THE MOU-I LOCUS AND REINTEGRATION OF AUTHENTIC n-HuLl/ GENOMES. 
The Kpn I fragment proximal to the S'-end of the Mov-I H-TOuLV DNA is 
60-Θ0 nucleotides smaller that the З'-Крп I fragments of cloned, uninte-
grated n-MuLV DNA of mass-infected 3T6 cells (Bacheler and Fan, 1980) or 
tumors of Balb/c and 129 mice infected uihen пеыЬогп with n-PluLU. This 
deletion is localized either in or directly next to the LTR and does not 
interfere udth the biological activity of the virus produced by the Πον-Ι 
locus since high titers of infectious n-MuLV are expressed in these animals 
already before amplification of proviral copies is detectable, and further­
more the offspring virus retains the same deletion (unpublished results), 
Restriction analysis using Pvu II revealed that the deletion is localized 
to the S'-end of the Pvu II site at position Θ.1 kbp In M-MuLl/ proviral 
DNA| therefore the deletion is almost certainly localized uithin the LTR 
sequence. Heterogeneity in LTR sequences of retroviruses has been observed 
previously (Du et al., 1980; Rands et al., 1981). Differences in terminal­
ly redundant sequences of a DNA virus (AAV) have also been detected uhen 
comparing early and late passage, infected cell cultures (Chueng et al., 
1980). Therefore, the observed deletion at the 3'—end can almost certainly 
be classified under frequently occurring rearrangements often seen in 
redundant sequences. 
The 1.25 kbp Kpn I DNA fragment, characteristic for the S'-end of the 
Ио -1 M-nuLl/ proviral DNA can also be detected in digests of somatically 
acquired proviral DNAs (after removal of the Mov-I M-MuLV containing 
Eco RI DNA fraction of 20-100 kbp: Eco RI dugested tumor DNA шаз fractio­
nated on size and the fragments smaller than 20 kbp (the Mov-I containing 
FI-MuLV proviral DNA is present in a 27 kbp Eco RI DNA fragment) pooled 
and cleaved uith a variety of restriction endonucleases among which also 
Kpn I). All n-FluLV specific fragments шеге detectable in this fraction 
whereas no junction fragments diagnostic for the Hov-I locus were 
detectable. Also, the S'-end 1.25 kbp Kpn I DNA fragment uas detected in 
this fraction and could be identified as S'-terminal fragment by its 
hybridization with NS-2 probe. Therefore, the tumors harbor both somatical­
ly acquired recombinant as well as authentic M-MuLV genomes as observed 
for newborn infected mice, and the deletion in the S'-terminal Kpn I 
fragment can be inherited by somatically acquired copies. 
A5. SOMATICALLY ACQUIRED SEQUENCES IN TUTORS OF F1(AKRxBalb/ио) MICE. 
Since the endogenous M-MuLV of /Balb/Мо mice is a ΝΒτ-tropic virus (i.e. 
grows equally well in both Fv-1 ' e.g NIH and Fv-1 ' e.g Balb/c mice 
and cell lines) the amplification of these viral sequences should also 
occur/during, leukemogenesis in miQi derived from crosses between AKR ( 
Fv-1 n / n; H-2 ) and Balb/Мо (Fv-1 ' ; H-2 ) mice. F1 mice develop 
spontaneous thymus-dependant leukemias with high frequency similar to 
Balb/Мо and AKR mice. The endogenous AKR-MuLV sequences· however, would 
not be able to replicate due to restriction by the Fv-1 allele of the 
F1 mice, which is/a dominant trait. Therefore tumor DNA from Fl(Balb/Mo 
xAKR) mice (Fv-1n' ; H-2 ' ) was screened for amplification of both 
M-MuLV and AKR-PluLV specific sequences. The results (data not shown) 
indicate that only M-CluLV type sequences are amplified while the endo­
genous AKR-MuLV sequences did not reintegrate. Furthermore, new restric­
tion fragments were detected in tumor DNAs, diagnostic for the presence 
of recombinant proviral DNAs that display a characteristic structure as 
shown to be present in other M-MuLU-induced tumors (Figure 5). These 
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results indicate that M-PluLV-induced Івиквтодвпезіз in Fl(ВаІЬ/noxAKR) 
mice is also associated with the emergency of characteristic recombinant 
proviral DNAs as observed in tumor tissues from Balb/Mo, Balb/c and 129 
mice, and confirm the ubiquity of these recombinants in M-PluLV-induced 
Isukemias. The amplification of AKR-CluLV sequences as observed in AKR-
MuLU-induced leukemias of AKR mice is restricted in F1(Balb/floxAKR) mice; 
this is probably the result of Fw-1 restriction in vivo. Other factors 
that might be involved in determining the latency of the disease in 
similar crosses have been discussed in the introduction (Chapter I). 
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DNase I Sensitivity and Clathylation of Genetically Transmitted and 
Somatically Acquired Proviral DMA Sequences in ІЧ-МиИ/ Induced Tumors. 
1 1 2 1 Herman van der Putten, Wim Quint, Inder M. l/erma, and Anton Berns. 
1 2 
Laboratory of Biochemistry, Tumor l/irology Laboratory, 
U n i v e r s i t y of Nijmegen, The Salk I n s t i t u t e , 
Geert Grooteplein N21, San Diego, 
6525 EZ Nijmegen, Cal . 9213B, U.S.A. 
The Netherlands. 
ABSTRACT. 
The DNase I sensitivity of chromosomal DNA regions, carrying integrated 
proviral genomes of FI-fluLU, AKR-PluLV and the cellular homologue of the mos-
gene of FISI/ (c-mos), шаге studied in tumor tissues of leukemic mice. Using 
DNase I sensitivity to probe for structural alterations of chromatin, potentially 
active in transcription, it appeared that the genetically transmitted genomes 
of M-FluLl/ and AKR-MuLU and also the c-mos gene are all in DNase I resistant 
chromatin conformations in M-FluLV induced tumors. A feu of the somatically 
acquired M-MuLl/ related sequences mere hypersensitive to DNase I uhereas the 
other reintegrated proviral sequences displayed a configuration with a moderate 
sensitivity to DNase I. The hypersensitive sites ш гв found in the cellular 
sequences juxtaposed to the S'-LTR. Both the coding sequences as uell as the 
31—flanking sequences of recombinant proviruses did not reveal such hyper­
sensitive sites. The extent of base methylation at the Hpa II/ Изр I 
recognition sequences of somatically acquired integrated MuLU sequences in 
tumors urns greatly deminished as compared to the genetically transmitted 
Mov-I M-MuLV DNA in Balb/Πο mice; this proviral DNA is extensively methylated 
at the Hpa II/ Msp I sites in both tumor and non-tumor tissues. No gross 
differences in methylation ш г observed betueen reintegrated MuLV DNAs 
moderately sensitive to DNase I or FluLVs displaying a DNase I hypersensitive 
configuration at their 5'-end. 
INTRODUCTION. 
Moloney (N-MuLV) and AKR (AKR-MuLV) murine leukemia viruses can induce 
leukemogenesis in a variety of mouse strains. Leukemogenesis is accompanied 
by somatic amplification and reintegration of n-FluLl/ (9-11,35,36) and AKR-fluLW 
(1,4,24,30,31) sequences respectively in new chromosomal sites of tumor tissues. 
M-CluLl/ and AKR-FluLl/ induce predominantly thymus-dependent leukemias in 
appropriate hoste. Leukemia development follous the expression of high titers 
of the virus in the blood (10,26). The thymus-dependsnt leukemia of viral 
(M-PluLl/) etiology in Balb/do mice (22) is probably due to the transient 
expression of the endogenous M-CluLU genome (Mov-I; 9,35,36) on chromosome 
number 6 (2), which leads to infection of the lymphatic target tissues u/here 
virus-specific RNA can be detected (11) concomitantly uith proviral DNA 
amplification (9,11,35,36). 
Although Balb/no, Balb/c and AKR mice carry AKR-MuLV as an endogenous provirus 
(24,30,31,35), the expression of this virus is only seen occasionally later 
in life of Balb/c mice (12). Apparently, the expression of the AKR endogenous 
provirus is under strong host control in these mice in mhich the Fv-1 locus 
could well play a major role (13,17), 
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Previous studies haue shouin characteristic features of H-MuLV (9,35,36) and 
AKR-MuLV (4,24,30,31) induced leukemias. Otgroum tumors, largely composed of 
one or a few clonal cell populations, harbor recombinant proviral genomes 
integrated in multiple unique sites of chromosomal DMA. The recombinant 
proviral DMAs are all env-qene recombinants, ufhich have acquired cellular 
sequences in the 3-portion of the viral genome comprizing information for 
the amino-terminal part of the env-glycoprotein. Every lymphoma induced by 
M-PluLV or AKR-PluH/ harbors this same type of recombinant provirus, although the 
copy number varies in different tumors (1G,36). This uould favor- a model which 
defines a recombinant provirus as a prerequisite for the onset and maintenance 
of the transformed state. No common integration sites, providing a promoter for 
neighbouring cellular sequences (as observed for ALI/ in ALV-induced tumors in 
birds; 8,21,23) have been detected so far. 
If the expression of a recombinant proviral genome is required for the 
maintenance of the transformed state then at least some of the reintegrated 
genomes are expected to be localized in active chromatin regions. Several 
DNase I probing studies of chromatin have provided convincing evidence that 
"active" chromatin has an altered, more accessible configuration (28,29, for 
ге іеш see 20). The sensitivity to DNase I has been correlated with the 
commitment or competence to synthesize a given gene product (29,40a). Furthermore, 
chromosomal domains active in transcription have been identified as contiguous 
chromosomal structures exhibiting high and moderate DNase I sensitivity (28,29). 
DNase I hypersensitive sites have been detected almost exclusively at the 5 1-
ends of potentially active genes (6a,15,27,29,40a,41) and probably reflect 
exposed DNA sequences which are essential for gene activation (40,40a). Lie 
have analyzed the preferential sensitivity of viral genomes for DNase I. It 
appears that chromatin comprizing proviral genomes in outgrown tumors can be 
divided in three different DNase I sensitivity classes i.e. in configurations 
resistant, moderately sensitive and hypersensitive to DNase I. Somatically 
acquired proviral genomes, displaying moderate sensitivity or configurations 
hypersensitive to DNase I, are hypomethylated whereas the genetically 
transmitted copy (Mov-l) is extensively methylated at the Hpa II/ Msp I 
recognition sequence. 
MATERIALS AND METHODS. 
Mice, cell lines, viruses, oDNA probes and hybridizations. 
nice, cell lines and isolation procedures of ñ-MuLV clone 1A and AKR-MuLV 
have been described previously (35). The injection of newborn Balb/c mice with 
M-FluLU clone 1A was performed intraperitoneally (10,35,36), 
The selection of M-fluLl/ and AKR-PluLV specific cDNA probes, and hybridization 
procedures have also been outlined previously (24,35,36). 
Preparation of cell nuclei. 
Nuclei were isolated by a procedure modified from those described before (3, 
28), in order to reduce the activity of endogenous DNases. All manipulations 
were carried out at 0 to 4 C. Either frozen (-80 "c) or fresh mouse tissues 
(0.2-0.8 g) were homogenized in 10 ml PAP l\l buffer (17.1 % sucrosej 15 ml*] 
Tris-HCl, pH 7.5; 0.5 mM spermidine; 1 ml*! EDTA; 0.1 mN EGTA; 25 ml»! KCl) by 
douncing Ю х in a dounce homogenizer (Pistol A); 5 ml PAP IV + 0.2 % NP-40 
were added in two portions and dounced 1x and 2x respectively; the homogenate 
was filtered through cheese cloth and centrifuged 5 min at ЗОООхд; the nuclei 
were washed twice with PAP IV buffer without NP-40 and resuspended in 5 ml 
PAP IV buffer; the suspension was filtered through scrynell nylon and E260 
was determined by sampling into 1 % SOS, 0.2 Π NaOH. Nuclei were pelleted 
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Sensitiyity to DNass I of Mov-I, Aku, c-mos, and somatically 
acquired MuLUs in M-fluLU-induced tumors. 
Nuclei were isolated from tumor tissues of a Balb/no mouse (СШ; IA) and 
a newborn infected Balb/c mouse (1B) as described in naterials and 
Methods and incubated ujith different concentrations of DNase I as 
indicated (0-2,4^jg/ml). DNA from each sample uas subsequently purified, 
10 ^jg restricted uith Eco RI and screened uith different probes after 
Southern blotting. И-ИиИ/ and AKR-MuLU specific probes шеге prepared 
as described previously (24,36). For detection of cellular mos-sequences 
(c-mos) a nick-translated probe of рП5и-31 mas used (14). The arrous 
indicate reintegrated ItuLU sequences hypersensitive to DNase I, The 
fragment indicated by a small arrow indicates the genetically 
transmitted Που-Ι n-CluLU DNA in Balb/Mo mice. The fragment, neuily 
emerging after DNase I digestion and subsequent cleavage by Eco RI ia 
indicated by an open arrou. 
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once mora, uiashed in 5 mi RSB,- buffer (10 mi"! Tris-HCl, pH 7.5; 10 mi"! NaCl; 
5 mM ПдС1„) and finally resuspended in RSB buffer at a DNA concentration of 
1 mg/ml, EGTA mas added to a final concentration of 0.2 ml*!. Exogenous DNase I 
(Sigma) digestions were carried out for 2 min at 25,С in Eppendorf tubas 
containing 1.4 mM CaCl« and 0.3-5 mg/ml DNase Τ (1505 Kunitz/mg protein). 
DNase I storage buffer contained: DNase I, 1 mg/ml; 0.15 mfl NaCl; 1 mg/ml 
BSA. Reactions шеге terminated by adding 1 volume 1 % SDS; 5 mM EDTA; 20 mM 
Tris-HCl, pH B.0, and incubated for 1 min at 60 "e. DNA uas purified by Proteinase 
К (50-100 mg/ml) treatment, subsequent extractions uith phenol and chloroform 
and tuio precipitations uith ethanol. 
Restriction analysis. 
Restriction analysis of high molecular weight DNAs from tissues ш г carried 
out as described previously (24,35,36). Elution of DNA fragments from agarose 
gel slices u/as performed either by electroelution (24,35) or by adsorption to 
glass beads (З ). Marker DNA fragments for size determination as shou/n in Fig. 
1,3 and 4 represent Hind III fragments of phage lambda DNA. 
RESULTS. 
Chromatin conformation of Hov-I, Akv, c-mos, and somatically acquired MuLVs. 
Previous studies revealed an increase in M-CluLV specific RNA sequences, 
concomitantly uith proviral DNA amplification, in target tissues of Balb/flo 
and newborn infected Balb/c mice (10,11). Although it has been reported that 
the majority of the new somatically acquired sequences in tumors are 
preferentially digestible by DNase I (3), these studies did not indicate 
whether a difference in sensitivity to DNase I existed between the individual 
reintegrated and genetically transmitted viral copies. Furthermore, it remained 
unclear whether DNase I sensitivity is confined to specific proviral copies 
(authentic or recombinant MuLVs) or to specific sequences of proviral DNA. 
Therefore the DNase I sensitivity of chromosomal DNA regjons, carrying 
integrated proviral genomes of authentic and recombinant H-MuLUs were studied 
in tumor tissues of leukemic mice. The DNase I sensitivity cf two cellular 
sequences, thm AKR-MuLl/ proviral genome (24,35) and the cellular hcmoloyue of 
the mos-gene of MSV (c-mos; 14), were taken for reference, 
Nuclei were isolated from both tumor and поп-tumor tissues of individual 
mine (both Balb/ño and Balb/o). The differential sensitivity of th4 individual 
proviral n-MuLV genomes for DNase I was determined after incubating nuclei 
with different concentrations of DNase I: DNA was extracted, digested with 
Ecn RI, DNA fragmenbs separated on siza and after Southern transfer hybridized 
to a N-CliO specific cDNA probe (Fig. 1). The results show that some of the 
reintegrated MuH/ sequences are hypersensitive to DNase I (open arrows). The 
Mov-I M-MuLV proviral locus in both non-tumor (brain) and tumor tissues is not 
sensitive to DNase I. Even at considerably heighar DNase I concentrations 
(2.5-5 fiq/ml) the Mov-I M-fluLl/ DNA was relatively resistant whereas the 
somatically acquired MuLV copies were all more sensitive, liihen nakod DNA was 
probed with DNase I both the Mov-1 M-MuLV DNA and the reintegratnd MuLV genomes 
were not preferentially digested with DNase I (data rot shown). These analyses 
show that the different MuLU sequences in M-MuLU-induced tumors show a 
differential sensitivity to DNase I. All reintafjrateil genomes are more 
sensitive to DNase I than the genetically transmitted genome. 
In order to relate the DNase I sensitivity of the Mov-1 M-MuLl/ DNA and 
reintegrated MuLl/ DNAs with other proviral and cellular genes the blots shown 
in Fig. 1 were hybridized with an AKR-MuLV specific cDNA probe (24) and a 
mos-specific plasmid probe (14). The single genetically transmitted ecotropic 
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Tig. 2 A) Recombinant MuLU DNA in tumors, 
The position (in kbp) of some relevant 
restriction sites are indicated on the 
linear map of authentic and recombinant 
Г-ПиИ/ prov/iral DIMA. Black boxes represent 
LTR sequences. The dashed area indicates 
sequences that are recombined in Pl-CluLU 
deriued recombinant prouiral DNAs. Sites 
marked by one asterisk denote пешіу 
acquired restriction sites in recombinant 
MuLUs; the new Bam HI site (at 6.3 kbp) 
and Ceo RI site (at 6.9 kbp) are 
characteristic for recombinant MuLU 
DNA, found in every lymphoma (24,36). 
These neu sites are responsible for the 
detection of tumor-specific Bam HI 
(2.2 kbp) and Kpn I-Eco RI (3.6 kbp) 
DNA fragments diagnostic for M-HuLU-
induced tumors. In acditian, recombinant 
ñuLU DIMA in the Balb/no tumor П9 carries 
also a Sac I site at 7,6 kbp (36), 
Sites below the line are M-PluLU prouiral 
DNA specific sites that are lost in 
recombinant HuLl/ DNA; the Kpn 1* site 
is only occasionally lost. Regions 
MS-2, 1*13-3, and lvlS-4 represent those 
sequences that are recognized by the 
rs^pective M-TOuLU specific plasmid 
probes (36), 
Fig, 2 B) PI-fluLU specific sequences in DNA fragments sensitive to DNase I, 
Lanes 1-7 contain 10 ^jg of Eco RI restricted DNA from Balb/c brain (lane 1), 
Balb/Mo brain (lane 2), Balb/Mo М9 tumor (lanes 3-7), Southern blots were 
hybridized to a rWluLU specific cDNA probe (lanes 1-4) or to M-fluLU specific 
plasmid probes as indicated. Lane 3 contains an Eco RI digest of М9 tumor DNA, 
whereas lane 4 contains an Eco RI digest of П9 tumor DNA, isolated from nuclei 
treated with DNase I (2,1 iig/ml) as shown in Гід, 1A, The 27 kbp fragment 
represents the По -І PI-MuLU genome. The arrows indicate the two DNA fragments 
located in chromatin hypersensitive to DNase I, The newly emerging DNA fragment 
at 7,0 kbp (lane 4) is marked by an open arrow. The upper DNA fragment (>27 kbp) 
hypersensitive to DNase I, hybridized to 1*15-2, MS—3, and И5-4 probes, but was 
only visible after long exposures (not shown), 
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AKR proviral DNA (in a 20 kbp Eoo RI DNA fragments; 24) appeared in a DNaae I 
resistant chromatin conformation in both tumor and non-tumor (not shown) tissues 
from Balb/no and Balb/c mice. Other endogenous uiral sequences can cross^-react 
uiith AKR-HuLV/ cDNA probe using hybridization conditions allouing some base-pair 
mismatching (24) (Fig. 1, panel 2). These cross-reacting endogenous prov/iral 
sequences also appeared rather resistant to DNase I, In addition ше probed the 
DNase I sensitivity of the cellular homologue of Ио-РІЗ specific mos-ssquences 
as an internal reference of a cellular non—viral gene. These sequences uere 
previously identified in a 14 kbp Eco RI DNA fragment from uninfected mouse 
cells (14). The cloned cellular DNA fragment contains an uninterrupted stretch 
of about 1.1 kbp homologous to no-ClSV-specific sequences; a clone, рМЗ -ЗІ (14), 
containing this mos-specific DNA fragment was used as a probe. These analyses 
revealed that also the cellular homologue of the viral mos-sequences is in a 
DNase I resistant chromatin conformation in n-MuLV-induced tumors. 
In conclusion, proviral genomes in M-MuLV-induced tumors were detected in 
three different DNase I sensitive classes of chromatin; the genetically 
transmitted AKR-PluLV and Mov-1 M-nuLV DNA nere found in DNase I resistant 
configurations like the с-чпоз gene and proviral genomes cross-reacting ujith 
AKR-duLV cDNA probe. Somatically acquired FI-MuH/ related sequences in tumors, 
houever, fall into two classes, one displaying moderate sensitivity, and one 
showing hypersensitive configurations to DNase I. 
Location of DNase I sensitive sites uiith respect to proviral genomes. 
Previously it was established that PI-CluLV-induced tumors contain both 
authentic and recombinant MuLU proviral sequences that display a general 
structure as shown in Fig. 2A (36). The recombinant ñuLV proviral DNAs display 
some very characteristic restriction sites not present in authentic ("l-MuLV 
proviral DNA: an Eco RI site at 6.9 kbp and a Bam HI site at 6.3 kbp. To 
determine whether fragments hypersensitive to DNase I comprize S'-ends of 
recombinant MuLV genomes or sequence information for authentic PI-fluLV and/or 
a S'-part of a recombinant MuLl/, Eco RI DNA fragments of the tumor (Fig. 1A) 
were hybridized to three rWluLV specific plasmid probes (36). These probes 
recognize different parts of the M-nuLV/ genome (Fig. 2A). Fig. 2B shows that 
fragments that are hypersensitive to DNase I all hybridize to 1*15-2, МЗ-З and 
1*15-4. This indicates that these fragments contain either an authentic M-CluLV 
genome and/or a S'-part of a recombinant MuLV DNA (up to the Eco RI site at 
6.9 kbp). Furthermore, the intensities of hybridization of some Eco RI DNA 
fragments indicates the presence of at least two proviral copies among such 
fractions. Additional restriction analyses (see last section) revealed that 
the two DNase I hypersensitive Eco RI fractions (Fig. 1A) contain only a S'-end 
of a recombinant MuLV provirus. None of the fragments which only hybridized to 
1*15-2 and therefore contain S'-parts of reintegrated recombinant proviruses 
were hypersensitive to DNase I. 
A striking feature of the DNase I analyses of tumor tissue chromatin from 
both Balb/l*lo and Balb/c mice was the appearance of a new fragment of 7.0 kbp 
after DNase I digestion of nuclei and subsequent cleavage by Eco RI. This 
fragment (Fig. 1 A and B, and Fig. 2B, open arrows) was only detected after 
Eco RI digestion of DNA uhich was isolated from nuclei treated with DNase I 
and could not be detected after DNase I treatment of chromatin without 
subsequent restriction or after low-level digestion of pure DNA with DNase I. 
To elucidate the structure of this new fragment DNA fractions were isolated 
after Eco RI digestion of DNA which was isolated from nuclei treated with 
DNase I at a concentration of 2.1 pg/ml as shown in Fig. 1A. Subsequently, 
DNA from each fraction was cleaved by Bam HI, Pst I, and Sac I (Fig. 3). 
Lane В represents a fraction containing predominantly 7.0 kbp Eco RI DNA 
fragments. The newly emerging 7.0 kbp DNA fragment appeared to be derived 
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Fig. 3 M-CluLU sequences in the neuly emerging 7.0 kbp fragment. 
300 ^jg DNA, isolated from nuclei (Balb/pio tumor Πθ) treated ujith 2.1 /Jg/ml 
DNase I (rig. ΙΑ), was restricted uith Eco RI, fragments separated on a 
0.6 % agarose gel and the gel part containing the 6.5-7.5 kbp Eco RI DNA 
fractions was sliced into 11 fractions (lane 1= 6.5 kbp; lane 11= 7.5 kbp); 
each fraction uas subsequently analyzed by further restriction uith Bam HI, 
Pst I and Sac I respectively, and Southern blots were screened with a M-fluLl/ 
specific cDNA probe. Lanes 12 contain an Eco RI digest of tumor N9 DNA, 
isolated from DNase I treated (2.1 jjg/ml) nuclei. Large numbers indicate 
the length of fragments hybridizing to the M-MuH/ specific cDNA probe in 
each gel slice. 
Fig. 4 Restriction map and location of DNase I hypersensitive site on 
recombinant MuLU proviral DNA. 
Lanes 1 and 2 show the blot-hybridization results of Eco RI restricted DNA 
from ВаІЬ/Ио tumor 149 without (lane 1) and with (lane 2) prior treatment 
of nuclei with DNase I. Fragments ara marked as in Fig. 1 and 28. The 
restriction maps obtained for the 7,0 and 6.7 kbp fragments are shown; the 
dashed area indicates the recombined sequences. 
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from the S'-part of one or several reintegrated recombinant proviruses since 
only restriction fragments diagnostic for recombinant WuLV DMA (Гід. 2Д) were 
detected in this neu fragment (Fig. 4). Therefore, the specific degradation 
of some recombinant proviral DNAs in chromatin by DNase I must be ascribed to 
a DNase I hypersensitive site around the junction of the S'-LTR and cellular 
DMA sequences (Fig. 4). The location of this DNase I hypersensitive configuration 
was further confirmed by hybridizing the Pst I blot (Fig. 3) with 1*15-2 probe 
which is complementary to a region at the start of ths LTR; in lane θ a single 
fragment of 1.1 kbp uas detected (not shown). The coding sequences of these 
recombinant HuH/s, however, are not hypersensitive to DNase I but show moderate 
sensitivity like most somatically acquired MuLV proviral sequences. 
Lane 3 (Fig. 3) represents the fraction containing predominantly 6.7 kbp 
Eco RI DNA fragments. The 6.7 kbp Eco RI DNA fragment represents a S'-part of 
a recombinant FluLV genome as shown by the differential hybridization 
characteristics against the MS-plasmid probes (Fig. 2B). Cleavage by Bam HI, 
Pst I,and Sac I (Fig. 3) revealed a restriction map for this S'-part of a 
recombinant MuLV (Fig. 4) which shows that no DNase I hypersensitive site 
could be mapped in the S'-part of this recombinant DNA and also not in the 
4.В kbp of cellular sequences following the S'-LTR sequence. Ide could not find 
any evidence for other З'-Eco RI DNA fragments of recombinants hypersensitive 
to DNase I which suggests that only the S'-ends of some reintegrated recombinant 
proviruses are in a "active" chromatin conformation. 
DNase I sensitivity and methylation of proviral DNAs in tumors. 
Differences in methylation patterns of both genetically transmitted and 
somatically acquired PI-nuLV sequences have been observed. In tumor tissues the 
Ptov-I M-MuLV DNA has a different methylation patterns e.g. Sma I and Sal I cleave 
the ΓΊον-Ι M-MuLV DNA from tumor tissues but not from brain (36) and also other 
tissue-specific differences in methylation of the Mov-I M-PluLV DNA have been 
observed using other enzymes (Ava I, Xho I) for target and non-target tissues 
(data not shown). Further analyses of tumor DNAs by Hpa II/ Wsp I , Hha I, 
Sal I, Ava I, Sma I, and Xho I revealed that somatically acquired proviruses 
are hypomethylated at these sites when compared to the genetically transmitted 
Mov-I M-fluLV DNA from both tumor and non-tumor tissues. 
In this study we analyzed whether hypomethylation of somatically acquired 
CluLU genomes is correlated with moderate or hypersensitivity to DNase I. Also 
the extent of methylation at Hpa II/ Clsp I sites was determined for the 
genetically transmitted Clov-I M-MuLV DNA. Therefore, Eco RI DNA fractions 
containing several of the reintegrated proviral sequences were isolated and 
cleaved by Kpn I. This enzyme yields differently sized fragments for authentic 
and recombinant proviral genomes (Fig. 2A)j Eco RI-Kpn I fragments of 3.6 and 
1.Θ kbp are diagnostic for recombinant MuLV DNA whereas authentic genomes 
yield fragments of 2,6 and 1.3 kbp respectively (Fig. 2A; 36), In addition each 
Kpn I digested Eco RI DNA fraction was cleaved by Hpa II and Nsp I respectively 
(Fig. 5). Hpa II and Msp I are isoschizomeres from which Nsp I cleaves the 
recognition sequence independent whether this site is methylated or not (34). 
Our analyses revealed that both authentic and recombinant reintegrated M-fluLU 
genomes are largely hypomethylated at the Hpa II/ Msp I recognition sequences 
when compared to the Plov-I M-CluLl/ genome (Fig. 5, panel A) which is extensively 
methylated at these sites. 
Although only some of the reintegrated proviral genomes display flanking 
chromatin regions hypersensitive to DNase I, these proviral DNAs display grossly 
a similar extent' of hypomethylation at their Hpa II/ Msp I sites when compared 
to the proviral copies moderately sensitive to DNase I. Similar results were 
obtained after analyzing Eco RI DNA fractions directly with Hpa II/ Msp I 
(data not shown). Since all somatically acquired MuLU sequences are moderately 
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sensitive to DNase I (Fig. I) the data might suggest a correlation of this 
moderate sensitivity to DNase I and hypomethylation. However, there is no 
direct correlation between hypersensitivity to DNase I and hypomethylation 
of reintegrated proviral genomes at the Hsp l/ Hpa II sites. 
•• • 
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Fig. 5 Methylation at Hpa II/ Hsp I restriction sites in tumor tissue DNA. 
Several Eco RI DNA fractions, containing Mov-I H-fluLU DNA or reintegrated 
proviral sequences шаге analyzed by Southern blotting after cleavage with 
Kpn I (lanes 1), Kpn I + Plsp I (lanes 2), and Kpn I + Hpa II (lanes 3), by 
hybridization to a M-^uLU specific cDNA probe. Panel A shows the results for 
the По -І M-nuLU containing fraction (indicated by the small arrow); this 
fraction also contains a S'-end of a recombinant provirus (displaying a 
hypersensitive configuration to DNase I), indicated by the characteristic 
3.6 kbp Eco RI-Kpn I DNA fragment (Fig. 2A). The faint hybridizing fragment 
of 2.5 kbp represents the S'-virus-cellular DNA junction fragment of the 
Mov-I Pl-CluLU DNA, whereas the fragments around 2,9 and 1.3 kbp are characteristic 
internal fragments of authentic n-CluLU proviral DNA (Fig. 2A; 36). Panels B-F 
show analyses of reintegrated proviral DNAs; the 1.8 kbp fragment (Panels C, 
E, and F, lanes 1) is derived from the S'-end of recombinant proviral DNA 
(Flg. 2 A ) . Fragments are further indicated as in Fig. 2B. 
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DISCUSSION. 
Several DNase I probing studies of chromatin haue provided convincing 
evidence that "active" chromatin has an altered, more accessible configu­
ration (39). Such DNase I sensitive conformations have bean observed for 
the globin gene sequences in nuclei of cells actively expressing these 
genes (28,29), for the ovalbumin gene in the hen oviduct (16), for rDNA in 
various organisms, and for integrated viral genomes of both DNA and RNA (6a) 
tumor viruses (for г івш see 20), for heat-shock loci in Drosophila tissue 
culture cells (15,41), and for chromatin sequences complementary to a total 
population of nuclear RNA (20). 
This more accessible configuration results in a more DNase I sensitive 
chromatin structure when compared ujith overall nontranscribed chromatin. 
More recent studies have demonstrated that there are sites in chromatin 
idhich are hypersensitive to DNase I. Such sites have been mapped at the 5'-
ends of several heat-shock genes in Drosophila melanogaster (15,41). Also, 
embryonic chick-red-blood-cells display a DNase I hypersensitive site close 
to the beginning of the embryonic p-globin (29) and presumed o(—type U— 
gene (40a); both embryonic and definitive red cells show a DNase I hyper­
sensitive site near the S'-end of both o(-type globin genes (40a). Further, 
the Drosophila melanogaster histone gene repeat also exposes DNA segments 
near the 5'-terminus of all five histone genes (27), Recently it шаз found 
that the transcriptionally active endogenous retrovirus locus ev—3 in chick 
cells also contains DNase I hypersensitive sites in each of its tuo long 
terminal repeats ujhile the inactive ev-1 locus does not display such sites 
(6a). These results suggest that mainly sequences around promoter regions 
of actively transcribed genes are hypersensitive to DNase I uhereas the 
coding sequences are not. Coding sequences of actively transcribed genes, 
houever, are always found in chromatin conformations more sensitive to 
DNase I than non-transcribed genes. 
In order to probe for potentially active proviruses ше have determined the 
DNase I sensitivity of genetically transmitted and somatically acquired 
proviruses in M-fluLV-induced tumors. These studies revealed that the 
genetically transmitted Mov-I Fl-MuLl/ genome in both tumor and non-tumor 
tissues of Balb/No mice is not in a DNase I sensitive conformation. The 
genetically transmitted endogenous AKR-MuLV genome (24,35) and other 
endogenous viral sequences that can cross—react with AKR-WuLl/ cDNA (24) 
are also not in DNase I sensitive conformations in these tissues from both 
Balb/Mo and Balb/c mice. The non-viral, cellular homologue of Mo-PlSV specific 
mos-sequences (14) was also found in a DNase I resistant conformation in 
chromatin from M-MuLV-induced tumors. The somatically acquired MuLV sequences 
in n-MuLU-induced tumors of Balb/ño and Balb/c mice can be divided in two 
classes according to their sensitivity to DNase I: most proviral DMAs 
display a moderately sensitive conformation to DNase I whereas some expose 
a DNase I hypersensitive configuration at their S'-end. A new fragment of 
7.0 kbp arises after DNase I digestion of chromatin and subsequent cleavage 
with Eco RI, This fragment contains sequences derived from the S'-part of 
recombinant proviruses: from the S'-LTR up to the Eco RI site at 6.9 kbp. 
A DNase I hypersensitive configuration is located probably slightly in front 
of the S'-LTR. No S'-ends of recombinant proviruses and their S'-flanking 
cellular sequences have bssn found to be hypersensitive to DNase I. Also, 
the analyses did not reveal whether reintegrated authentic N-HuLl/ genomes 
display DNase I hypersensitive configurations since none of the tumors 
analyzed contained an Eco RI DNA fraction comprizing exclusively an authentic 
proviral genome. Other restriction enzymes are currently being tested to 
solve this issue. The results indicate that some reintegrations occur near 
DNase I hypersensitive chromatin regions or these reintegrations generate 
in some instances DNase I hypersensitive configurations in chromatin at 
their site of insertion. 
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The function of the exposed sequences at the 51—ends of proviral DNA is 
still obscure. Previously, exposed sequences have been mapped at the initial 
portion of the mRNA leader sequences of the histone genes H3, H4, H2A, and 
H2B in Drosophila melanogaster (19). Therefore, the exposed sequences might 
represent interaction sites uith specific regulatory proteins or present 
exposed DNA sequences for binding of RNA-polymerase. Weintraub (19Θ0; 40) 
postulated that regions of DNase I hypersensitivity may be involved in 
orienting regulation signals on DNA with respect to their associated 
nucleosomes and also uith respect to the coiling of the DNA in the chromosome 
fiber· A remarkable feature of the DNase I hypersensitive sites juxtaposing 
the recombinant proviruses is their location: 400-500 nucleotides before the 
TATA-box and Cap-site in the 5»-LTR (33). A subdomain of chromatin defined 
by a DNase I hypersensitive site approximately mithin 500 bp before the 5 1-
end of the first oi-globin gene in the active ^ -gene cluster in definitive 
erythrocytes of chickens has been reported recently (40a), 
The relative broadness of the band, representing the neuily emerging 
fragment at around 7,0 kbp after DNase I digestion and Eco RI cleavage 
(Fig, 1) suggests the presence of several closely positioned DNase I 
hypersensitive sites in front of or at the start of the S'-LTR of some 
recombinant proviruses. Such closely positioned sites, uhich can span up to 
300 bp, have also been found at S'-ends of heat-shock genes in Drosophila 
melanogaster (15,41), 
Since hypomethylation has also been postulated as a characteristic though 
not sufficient marker associated uith active genes (6,6a,19,25,32,37,40a) uie 
have also determined the exten*", of base methylation at Hpa II/ Msp I 
recognition sequences. All somatically acquired authentic and recombinant 
MuLV genomes are hypomethylated (as observed previously for somatically 
acquired FI-PITV sequences in carcinomas; 5) uhereas the genetically trans­
mitted M-MuLV copy is extensively methylated at the Hpa II/ Msp I recog­
nition sequences, MuLV proviral copies that display a hypersensitive site 
to DNase I at their S'-end display grossly the same extent of mthylation at 
their Hpa II/ Map I recognition sequences as compared to copies moderately 
sensitive to DNase I. All reintei_patec proviral DNAs are at least moderately 
sensitive to DNase I; this might therefore suggest a correlation between 
moderately DNase I sensitive sequences and hypomethylation. It has been 
reported for other genes that sequences sensitive to DNase I are hypomethyl­
ated, whereas Ιοω-І і methylation does not a priori imply DNase I sensi­
tivity (16,19), The lack of extensive methylation of somatically acquired 
sequences might simply be due to inefficient de novo methylation and not be 
related to chromatin conformation, lile have also observed that during aging 
of a Balb/c mouse the extend of methylation at Hpa II/ Msp I sites of 
endogenous viral sequences (those that can cross-react with AKR-MuLV cDNA) 
is deminished while these sequences are not preferentially digested by 
DNase I. 
Previously it was shown that the Nov-I Fl-WuLV DNA is hypomethylated at 
Sal I and Sma I sites in target tissues as compared to non-target tissues 
(36), although this proviral DNA is extensively methylated at the Hpa II/ 
Msp I sites in tumor tissues. Also, the По -1 ГМЧиИ/ proviral DNA is not 
preferentially digested by DNase I in tumor tissues. These data suggest that 
this locus is inactive in transcription in tumor tissues. 
Tumors of different mice contain variable numbers of reintegrated recombinant 
and authentic M-fluLV proviral genomes, A certain recombinant proviral genome 
(Fig. 2A) seems to be required for transformation (24,36). Whether these 
proviruses exert their transforming activity by promoter-insertion or via 
a recombinant env-gene product is still obscure. However, those recombinant 
FluLV copies, displaying a flanking cellular DNA region hypersensitive to 
DNase I are probably the best candidates for proviruses active in transcrip­
tion in each tumor. Also, these copies are therefore most likely responsible 
for leukemic transformation. 
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Cloning of these proviral sequences, selected by virtue of their DNaee I 
hypersensitive configuration, uill hopefully enable us to study the role 
of these recombinant genomes and flanking cellular sequences in the 
transformation process. 
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genese reguleren. Het gp70 van een recombinant virus kan in dit model 
gezien urarden als een receptor; overproductie van dergelijke receptoren 
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